2014 HBV Meeting navigation menu
Liver Cancer Connect
Visit our Baruch Blumberg Institute of Living Science
PA Biotech
HepB United
World Hepatitis Alliance Member

News Archives: 2010-2014

*Please Note: Links to archived articles may have expired. If you are unable to access the page via the links below, try searching the HBV Research List Archives at http://archive.mail-list.com/hbv_research/

ARCHIVES: 2014 | 2013 | 2012 | 2011 | 2010
See Older News Archive (2005-2009)


December 29, 2014


Viral Hepatitis More Deadly Than HIV, But Unfunded


WHO: Liver Cancer Moves to the 2nd Leading Cause of Cancer Deaths in the World


Hep B Cure Could Be Discovered in Bucks Co.


Preventing, Treating HBV Reactivation During Immunosuppressive Therapy


Antiviral Treatment among Pregnant Women with Chronic Hepatitis B


HBV: Community-Based Programs May Improve Care


Fighting Hepatitis B and Liver Cancer in West Africa


Are US Veterans Being Appropriately Tested and Treated for Hepatitis B?


Tenofovir Continues to Work Well Against Hepatitis B Virus for 8 Years


Increase Seen in Liver Injury Caused by Herbals, Dietary Supplements

2014 News

Effectiveness of Drugs to Prevent Hepatitis Among Patients Receiving Chemotherapy
Dec 22 – Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus related hepatitis and HBV reactivation, compared with the antiviral drug lamivudine, according to a study in the December 17 issue of JAMA. Read more.

Entecavir and Tenofovir Work Well for People with Resistant Hepatitis B Virus
Dec 22 – A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus in people with resistance to other antivirals, according to results from the ENTEBE study. Another study, however, showed that for some resistant patients, tenofovir worked equally well on its own. Read more.

NICE to Support Device for Diagnosing Liver Damage Without Surgery
Dec 22 - NICE is consulting on draft guidance on a device, called Virtual Touch Quantification (VTq) that aims to diagnose and monitor liver damage, without the need for surgery in patients with chronic hepatitis B or C who need assessment of liver disease.  Read more.

Not Just for the Holidays, Mistletoe Could Fight Obesity-Related Liver Disease
Dec 22 – Mistletoe hanging in doorways announces that the holidays are just around the corner. For some people, however, the symbolic plant might one day represent more than a kiss at Christmas time: It may mean better liver health. Read more.

Potential Cure for Hepatitis B Enters Phase 1/2a Clinical Trial
Dec 15 – A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus infection is now recruiting patients for a phase I/2a clinical trial. Read more.

Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
Dec 15 – Antiviral treatment patterns for chronic hepatitis B among pregnant and nonpregnant women provides a baseline for assessing changes in treatment patterns in this open source article written by CDC authors. Increased use of antivirals to prevent breakthrough perinatal hepatitis B infection is anticipated. Read more.

Prize-winning Hepatitis B Mobile App Diagnostic Tool
Dec 15 – Students and faculty from Stanford University have developed a portable device that can be used to run diagnostic tests including the detection of the hepatitis B infection, which can be completed within 10 minutes. Read more.

Mold on Corn Can Cause Liver Cancer
Dec 15 – Certain molds that may grow on corn, pistachios, and peanuts, produce a deadly carcinogenic toxin that is a risk factor for liver cancer. Professor Felicia Wu and her team at Michigan State are working to identify cost-effective, feasible aflatoxin prevention methods in developing countries. Read more.

Preventing, Treating HBV Reactivation During Immunosuppressive Therapy
Dec 8 - Patients who are to undergo immunosuppressive therapy but are at high risk for reactivation of hepatitis B infection should receive antiviral prophylaxis, rather than being monitored for reactivation and treated only if it develops, according to a new guideline published online in Gastroenterology. Read more.

Tumor Microenvironment of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Dec 8 – Scientists review critical issues of tumor microenvironment in hepatocellular carcinoma (HCC) summarizing the components and mechanisms to demonstrate underlying themes and the inherent complexity of these interacting systems in the initiation and progression of HBV associated HCC. Read more.

Pakistani Blood Transfusions Spreading Hepatitis, HIV
Dec 8 – Lax oversight of blood banks means about a fifth of patients in Pakistan who get regular transfusions have been infected with viral hepatitis. Read more.

Delhi Govt Launches Online Hepatitis Immunisation Campaign
Dec 8 – An online campaign to spread awareness about hepatitis immunization was launched by the Delhi government's health department in collaboration with the Institute of Liver and Biliary Sciences (ILBS) as part of the Hepatitis Awareness Week. Read more.

Many IBD Patients Don't Get Hepatitis B Vaccine
Dec 1 – Most patients with inflammatory bowel disease (IBD) do not receive screening for or vaccination against the hepatitis B virus, according to a new study looking at a large tertiary gastroenterology practice. Read more.

Hepatitis B Vaccine Produced Cheaply and Efficiently Using GMO Corn
Dec 1 – A small technology venture, called Applied Biotechnology Institute (ABI) has developed a method to genetically modify corn to produce an affordable, easy-to-administer vaccine for hepatitis B. Read more.

A Project for a Vaccine Against Hepatitis C and B Rewarded by the French National Academy of Medicine
Dec 1 – The Hepatibivax project funded by ANR has been awarded the Drieu-Cholet prize from the National Academy of Medicine for its progress in the development of a vaccine targeting the viruses of both hepatitis B and C. Read more.

Tenofovir Continues to Work Well Against Hepatitis B Virus for 8 Years
Nov 27 - Most chronic hepatitis B patients treated with tenofovir (Viread) for 8 years continued to maintain viral suppression, researchers reported at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2014. Read more.

Study Implicates Triclosan in Development of Liver Fibrosis and Cancer in Mice
Nov 27 – Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items, but despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical. Read more.

Survivor of 4 Brothers Determined to Fight Liver Cancer
Nov 27 – Baltazar Lucas lost all of his siblings to liver cancer caused by hepatitis B in a five-year period, from 2008 to 2013. Today, he is in danger of losing his own life, having been diagnosed late last year with the same dreaded disease, which decimated his family. Read more.

AGA's Journals Highlight Important Updates Into Treatments for Cirrhosis, NAFLD
Nov 27 – Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. A new promising probiotic for liver disease and additional NAFLD treatment information are highlighted in December AGA journals. Read more.

Hepatitis B Flares are Common During Cancer Chemotherapy: Presented at AASLD
Nov 17 – The abrupt elevation of serum alanine aminotransferase (ALT) over 5 times the upper limit of normal indicates flare-up of hepatitis B virus infection, and is a common occurrence during cancer chemotherapy, according to results from a retrospective study presented at the Liver Meeting 2014. Read more.

Hundreds of Former Patients Tested for HIV or Hepatitis After 'Unhygienic' Dentist is Accused of Ignoring Infection Control Rules
Nov 17 – More than 22,000 patients of an “unhygienic” dentist are thought to be at possible risk for hepatitis B, hepatitis C and HIV, and have been urged to come forward for testing in what is believed to be the biggest recall in UK medical history. Read more.

Drug Combo Disappoints in Hepatitis B
Nov 10 – Treatment with a combination of tenofovir and pegylated interferon cured only a small fraction of patients with chronic hepatitis B, though the combination treatment was better than either drug alone, or a shorter combination of the two, as reported at the annual AASLD Liver Meeting. Read more.

New Study Focuses On Improving Care for Hepatitis-B-Infected Asian Americans
Nov 10 – Nearly 60 percent of infected Asian Americans fail to seek regular monitoring and treatment of hepatitis B. Grace Ma, professor and director of the Center for Asian Health in Temple University’s College of Public Health plans to conduct a study aimed at improving adherence to regular monitoring and treatment of the disease among infected Asian Americans. Read more.

Are US Veterans Being Appropriately Tested and Treated for Hepatitis B?
Nov 10 – The rates of serologic testing for HBV conducted by the VA were suboptimal as recommended by the AASLD practice guideline, according to an examination of the VA’s Corporate Data Warehouse. The study revealed that HBV infection is twice as common in the Veteran population as in the general population of the country. Read more.

Hepatitis B Relapse is Common After Stopping Antiviral Therapy
Nov 10 – Hepatitis B virus rebounded in nearly 80% of people treated with fully or partially suppressive antiviral therapy using adefovir (Hepsera), entecavir (Baraclude), lamivudine (Epivir), or tenofovir (Viread), indicating that long-term therapy is usually needed to control the virus, researchers reported. Read more.

Fighting Viral Hepatitis in the African Region
Nov 10 – Countries in the African Region should establish strong and well-resourced surveillance systems in order to detect viral hepatitis, a growing public health threat in Africa, suggests Dr. Luis Sambo, Regional Director for Africa, World Health Organization. Read more.

Barriers Remain in Educating People With Diabetes of Their Increased Hepatitis B Risk
Nov 10 - Diabetes educators cite a lack of time and competing priorities during counseling sessions with patients as key barriers to educating their adult patients with diabetes about vaccination against hepatitis B, according to a new survey by the American Association of Diabetes Educators (AADE) and GSK. Read more.

Daily Checkup: The Link Between Hepatitis B and Liver Cancer
Nov 3 – About 1 in 30 people worldwide has chronic hepatitis B, the main underlying cause of liver cancer. Dr. Steven Brower, a liver cancer specialist at Mount Sinai Beth Israel, speaks out in honor of Liver Cancer Awareness Month. Read more.

HBV Prevalent in Ugandan Pregnant Mothers and Increased Early Childhood Transmission
Nov 3 – Hepatitis B is highly prevalent in Uganda, with a national average of 10%, but with a much higher prevalence of 20% in Northern Uganda. In this Ugandan study, researchers looked at pregnant women and transmission to their babies.  Read more.

Scientists Pursue Novel Blood Tests for Cancer
Nov 3The inventor of a breakthrough DNA test for Down syndrome says the
technology can also be used to screen people for cancer, and is testing his technique following people infected with hepatitis B at risk for liver cancer. Read more.

Vaccinations 'Not Linked to Increased Risk of MS, Central Nervous System Disorders'
Oct 27 – Previous research has suggested that certain vaccinations may increase the risk of central nervous system disorders, including multiple sclerosis. But a new study published in JAMA Neurology finds no such association. Read more.

Maxwell Biotech Portfolio Company Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B
Oct 27 - Results from proof-of-concept clinical trials suggest Myrcludex B, a novel entry inhibitor, indicate positive results for the treatment of chronic HBV and may become an option for treating hepatitis delta. Read more.
Hepatitis B Virus Replication, E Antigen Secretion Reduced With Entecavir
Oct 27 – A combination of Entecavir plus turin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion making this a promising therapy for those with chronic HBV. Read more.

Judge Upholds Citations Issued for Bloodborne Pathogen and Lead Exposure
Oct 27 – Unfirst Corp. has been cited for violations of its Bloodborne Pathogens Standard, including failure to conduct proper training and provide Hepatitis B vaccinations to drivers and loading-dock workers exposing them to hazards. Read more.

9 Facts About Your Liver
Oct 20 – October is Liver Awareness and Liver Cancer Awareness Month! You might not think twice about your liver, but here’s why you should. Read more.

Tekmira Pharma Presents TKM-HBV Preclinical Study Data
Oct 20 – Tekmira Pharmaceuticals presented preclinical results showing potent and rapid reduction of hepatitis B surface antigen (HBsAg) demonstrated using TKM-HBV, their therapeutic agent targeting hepatitis B. Read more.

Liver Transplanted Second time in Hong Kong Man
Oct 20 - Hong Kong surgeons have performed a double world first with a transplant from one Hepatitis B sufferer to another with a liver that had already been transplanted once 11 years ago. Read more.

Obesity May Speed Aging of the Liver, Study Suggests
Oct 20 – Extra pounds cause the liver to age faster, potentially explaining why obesity is linked to diseases like liver cancer and insulin resistance, new research suggests. Read more.

Multimedia Information Drive for Hepatitis B Launched
Oct 13 - The World Health Organization, in tandem with the Hepatology Society of the Philippines, launched the B-Aware Campaign, an awareness campaign to spread information about hepatitis B and to alleviate discrimination in the Philippines.  Read more.

Liver Awareness Month: A Good Time to Clean Up Our Act
Oct 13 – October is Liver Awareness Month! What a great time to focus on the fabulous things that your liver does for your body and your health. Read more.

Drinking Decaf or Regular Coffee Maybe Good for the Liver, Study Suggests
Oct 13 – Higher coffee consumption, regardless of caffeine content, was linked to lower levels of abnormal liver enzymes, according the NCI researchers and published in Hepatology. This suggests that chemical compounds in coffee other than caffeine may help protect the liver. Read more.

Chicken, Fish Lower Liver Cancer Risk
 Oct 13 – The health benefits of upping your intake of poultry and fish are many and varied, but a new study has shown such consumption can significantly lower the risk of liver cancer. Read more.

People With Hepatitis B Who Have Cirrhosis Should Be Prioritized for Liver Cancer Screening
Oct 6 – Liver cancer screening for people with HBV infection should be targeted at those with cirrhosis. The risk of hepatocellular carcinoma (HCC) and death were 31- and 44- times higher, respectively, in people with liver cirrhosis compared to people who did not have cirrhosis. Read more.

The Hepatitis Scare (Philippines)
Oct 6 – One-out-of-eight Filipinos (equivalent to 16 million people) or 16% of the country is currently suffering from hepatitis B, especially among 20-39 year olds. HBV is also a root of discrimination, work restriction, and subsequent disqualification from employment. Read more.

“Gold of Pleasure” Oilseed Boosts Liver Detoxification Enzymes
 Oct. 6 - University of Illinois scientists have found compounds that boost liver detoxification enzymes nearly fivefold, and they've found them in a pretty unlikely place - the crushed seeds left after oil extraction from an oilseed crop used in jet fuel. Read more.

Lack of Political Will by Gov’t Hampering Fight Against Hepatitis
Sept 29 – The President of the Hepatitis B Foundation, Mr. Theobald Owusu-Ansah, has hinted that government is not doing enough in dealing with hepatitis B in Ghana. Read more.

Hope For People With Liver Failure — Artificial Livers Now Become a Reality
Sept 29 – A bio-artificial liver support system for patients suffering from acute liver failure is on its way, as investigations are done to assess its safety and effectiveness, according to new research. Read more.

Genetic Driver of Inflammation Uncovered, Used to Prevent and Treat Liver Cancer
Sept 29 – Blocking the expression of a gene known as astrocyte elevated gene-1 (AEG-1) halts the development and progression of liver cancer by regulating inflammation, demonstrated for the first time by scientists at Virginia Commonwealth University Massey Cancer Center. Read more.

Expert Calls For Enlightenment On Hepatitis B in Nigeria
Sept 22 - A gastroenterologist, Dr Olutoyin Asaolu, has called for enlightenment and collaboration among stakeholders in order to reduce the burden of Hepatitis B in the country of Nigeria. Read more.

Australian Govt Called to Act on Hepatitis Death Rate
Sept 22 – Hepatitis Australia, which represents the half a million Australians with viral hepatitis, has called for immediate government intervention to prevent a "tidal wave" of life-threatening liver disease. Read more.

Spreading Fast: Lack of Treatment Drug Leaves Patients Helpless Against Hepatitis
Sept 22 - Patients in Khyber-Pakhtunkhwa, Pakistan are suffering due to a shortage of quality interferon, a medicine used to treat viral hepatitis. Read more.

Involvement of the Host DNA-Repair Enzyme TDP2 in Formation of the Covalently Closed Circular DNA Persistence Reservoir of Hepatitis B Viruses
Sept 22 – Scientists from the recent 2014 international Meeting, Molecular Biology of Hepatitis B Viruses, published a new paper in PNAS, the official journal of the U.S. National Academy of Sciences!  Read more.

OnCore Biopharma Licenses 2nd Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection
Sept 15 – Located in the PA Biotech Center in Doylestown, OnCore secures exclusive rights to NVP018, which will complement their existing pipeline directed at achieving an all-oral cure for hepatitis B. Read more.

Recommendations to Improve Liver Health in Hepatitis B, Hepatitis C Patients
Sept 15 - Although it is widely understood that hepatitis B and hepatitis C are the leading causes of liver cirrhosis and liver cancer, a study published in Cancer Nursing reports an alarming number of HBV and HCV carriers have unhealthy habits that result in poor liver health. Read more.

Increase Seen in Liver Injury Caused by Herbals, Dietary Supplements
Sept 15 – New research shows that liver injury caused by herbals and dietary supplements increased from 7% to 20% in a U.S. study group over a ten-year period. Read more.

SAARC Experts Join Hands to Combat Liver Diseases
Sept 15 – With rising incidences of liver diseases in South Asian countries, experts from SAARC nations have come together to chalk out strategies to combat these diseases in the region and will include effective guidelines for the prevention and treatment. Read more.

Novira Completes Phase 1a Clinical Study of NVR-1221 for Treatment of HBV Infection
Sept 8 – Novira Therapeutics, a privately held biopharmaceutical company in the PA Biotech Center, developing novel therapies for curative treatment of chronic hepatitis B, announced successful completion of a Phase 1a clinical study that demonstrated NVR-1221 was safe and well-tolerated at all doses. Read more.

What You Need to Know About Hepatitis B
Sept 8 – A few days after World Hepatitis Day, Mandaluyong became the first city in the Philippines to initiate the B Positive movement, an advocacy initiative aimed at raising proactive awareness towards Hepatitis B. Read more.

A Potential Breakthrough On Liver Cancer
Sept 8 – An exciting breakthrough has occurred that might just reduce the burden of liver cancer through prevention, and possibly in a timelier manner. Read more.

Fight Brewing Over Liver Donation
Sept 8 – United Network for Organ Sharing (UNOS), the nonprofit that manages the nation's transplant system, will hold a public hearing to discuss ways to "increase equity" in how organs are assigned to patients across the country, particularly donated livers. Read more.

Could Your Dentist’s Office Give You HIV or Hepatitis B?
Sept 2 – Concerned about the increasing number of cases where patients undergoing dental treatments are detected with HIV and Hepatitis, medical experts caution that patients must ensure that the doctor open the examination instruments from a sterilized pouch in their presence. Read more.

Defectors’ Overall Health Lags Behind, Study Shows
Sept 2 – North Korean defectors are more susceptible to certain diseases, including hepatitis B, compared to their South Korean counterparts, according to a study by the Korea Centers for Disease Control and Prevention. Read more.

Carcinogenic Role of a Protein in Liver Decoded
Sept 2 – The human protein EGFR, which controls cell growth has served as a point of attack for target-oriented therapies, but a new discovery may lead to more effective treatment strategies to fight hepatocellular carcinoma.  Read more.

Campaign Focuses on Reducing HBV in Chinese City
Aug 25 – The Hepatitis B Foundation (HBF) joined forces with the Haimen City Center for Disease Control and Prevention for a 3-year campaign to educate clinicians, civic leaders and the city’s general population of 1 million residents on hepatitis B. Read the interview with HBF’s Chari Cohen in Healio Hepatology, and the BMC Public Health publication.

Immunization Program Protects Babies From Hepatitis B
Aug 25 – The transmission of hepatitis B from mother to child has been virtually eliminated in Kaiser Permanente’s Northern California region, thanks to a program, which ensures that babies receive all recommended shots on time. Read more.

Dentist Surrenders License Over HIV, Hepatitis Scare
Aug 25 – An Oklahoma oral surgeon whose filthy clinics led to the testing of thousands of patients for HIV and viral hepatitis permanently surrendered his professional license. Read more.

Doctors ID New Ways to Get More Kids Vaccinated
Aug 25 – Doctors are still struggling to find effective ways to convince wary parents of the importance of vaccinating their infant children, and have a new way to identify and approach parents that are hesitant to vaccinate infants. Read more.

Viral Hepatitis More Deadly than HIV, but Unfunded
Aug 18 – In what has become a cruel public health irony, not being HIV positive is a lethal disadvantage experienced by millions of people with chronic hepatitis and no access to life-saving drugs. Read more.

HKU Researchers’ New Liver Cancer System Helps Prolong Patients’ Lives
Aug 18 – Hong Kong researchers have developed Asia’s first system that classifies liver cancer patients into different stages to receive more targeted treatment, doubling patients’ median survival time and improving survival rates of those in more advanced stages. Read more.

Two Friends, a Big Heart and a Shared Liver
Aug 18 – A touching story involving two longtime friends and former roommates, and the gift of lifesaving living-donor transplantation. Read more.

Gateway to Care Campaign: A Public Health Initiative to Reduce the Burden of Hepatitis B in Haimen City, China
Aug 11 – Check out HBF’s first peer–reviewed publication from our 3-year Haimen City project, including a public health campaign targeting city residents, health care professionals, community leaders, and pregnant women. Haimen City has one of the highest incidences of liver cancer and mortality in China and the world. This city–wide education and awareness campaign reached almost 300,000 residents. Read more.

Model of Viral Lifecycle Could Help in Finding a Cure for Hepatitis B
Aug 11 – A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease. Read more.

Lack of Action Against Viral Hepatitis Causes Asia Pacific to Suffer
Aug 11 – In the Asia Pacific region, viral hepatitis kills over one million people every year, with a death rate three times higher than HIV/AIDS and nine times higher than malaria. Viral hepatitis causes 78% of all liver cancer globally, and liver cancer is the second most common cause of cancer death worldwide, yet only half of the countries surveyed in Asia Pacific have a national action plan to prevent and control the spread of viral hepatitis. Read more.

NICE Renews Efforts To Prevent Hepatitis
Aug 11 – The National Institute for Health and Care Excellence (NICE) announced new quality standards aimed at the preventing hepatitis B transmission and improving the lives of those living with the condition in the UK. Read more.

Gilead Allows India & China To Produce Generic HIV/HBV Drug
Aug 4 – Gilead Sciences announced it has reached a new agreement with the Medicines Patent Pool to expand access to their investigational drug tenofovir alafenamide (TAF) for HIV and hepatitis B, contingent on the medicine’s U.S. regulatory approval. Read more.

Hepatitis is Still the Silent Killer
Aug 4 – After rounding out a week of World Hepatitis Day events, Congressional Champions bring attention to the viral hepatitis epidemic and encourage other Congressional members to prioritize hepatitis. Read more.

‘Yellow Warriors’ Fight Not Just Virus but also Stigma of Hepa B
Aug 4 – Yellow is the color of courage for some people whose daily lives have been shaped by the physical and emotional challenges of battling Hepatitis B. The Yellow Warriors Society Philippines (YWSP) is a national organization of hepatitis B and C sufferers who have become advocates, particularly in the fight against HBV related discrimination. Read more.

Mouth Bacteria Invade the Gut in Liver Cirrhosis Patients
Aug 4 – Gut microbiota of individuals with liver cirrhosis differ notably from healthy individuals showing a high proportion of oral bacteria, and permitting the discovery of a non-invasive test for liver cirrhosis, accurate to over 90%. Read more.

Stephen Colbert Report Gives World Hepatitis Day Shout-Out Stephen Colbert Report Gives World Hepatitis Day Shout-Out
July 28 – Comedian Stephen Colbert on his daily show features World Hepatitis Day!




U.S. White House Live Webcast for World Hepatitis Day
July 28 – Tune in Wednesday, July 30 from 12:00-3:00pm EST, for a Live Webcast from the White House observance of World Hepatitis Day and to recognize hepatitis leaders that includes the Hepatitis B Foundation’s Executive Director! Tune in here.

WHO Welcomes Global Momentum On Viral Hepatitis
July 28 – Today on World Hepatitis Day, the World Health Organization welcomes new progress in tackling one of the world’s most serious diseases. Read more.

Viral Hepatitis Now Kills More People Than HIV/AIDS
July 28 – A major new analysis published in The Lancet highlights positive progress on the global burden of HIV/AIDS. Viral hepatitis, however, remains neglected and faces significant challenges to address the spiraling mortality rate. Read more.

Biochemist's Find is New Hope for Hep B Cure
July 21 – Dr. Adam Zlotnick at Indiana University has discovered a class of antiviral small molecules that target the viral DNA hidden in the infected livers of hepatitis B patients and could lead to a cure. Novel compounds based on these discoveries, known as Core Protein Allosteric Modulators, or CpAMs, are capable of altering the activities of a core hepatitis B protein that is essential for the virus’s continued survival. Read more.

New York City's Top Hospitals Fail to Vaccinate Newborns Against Hep B, Study Shows
July 21 – All babies should receive the hepatitis B vaccination as soon as they’re born, federal officials say, but advocates say some of the city’s top hospitals are not following recommendations, putting the babies at risk for infection. Two of the hospitals with the lowest vaccination rates in the city are Mount Sinai and Beth Israel, where fewer than 20 percent of babies received the HBV vaccine in 2012, according to Health Department data. And at Maimonides, Tisch and Roosevelt hospitals, just 20 to 40% of newborns got the vaccine that same year. Read more.

HBV Rebounds After Stopping Entecavir, Switching to Interferon May Help
July 21 – Most hepatitis B "e" antigen (HBeAg) negative chronic hepatitis B patients relapsed after stopping treatment with the antiviral drug entecavir (Baraclude), according to a report Gut. A related study found that switching from entecavir to pegylated interferon increased the likelihood of HBeAg seroconversion and hepatitis B surface antigen (HBsAg) loss in HBeAg positive patients. Read more.

Screening for Hepatitis B Virus Infection: A Public Health Imperative
July 7 – Annals of Internal Medicine editorial provides a clear rationale for the updated USPSTF recommendations, and reflects the HBF’s position on screening for hepatitis B. Read more.

Tenofovir Usually Suppresses Hepatitis B in HIV/HBV Coinfected People
July 7 – Tenofovir led to undetectable hepatitis B virus levels in 87% of HIV positive coinfected individuals, and a similar proportion maintained viral suppression over 6 years, according to a study described in Hepatology. Read more.

Super-Cooled Livers Could Bring New Flexibility to Organ Transplants
July 7 – In liver transplantation, one of the biggest inequities is geographic. A group of Harvard University researchers has come up with a preservation technique that could one day allow livers to be shared more easily around the world. Read more .

Drug Everolimus Fails to Improve Overall Survival in Advanced Liver Cancer Patients
July 7 – Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study in the July 2 issue of JAMA. Read more.

No Tenofovir Resistance Seen In 2 Years of Hepatitis B Treatment
June 30 – No cases of resistance to tenofovir (Viread) were detected among chronic hepatitis B patients with prior resistance to lamivudine (3TC or Epivir) through 96 weeks of treatment, according to a study described in Clinical Gastroenterology and Hepatology. Read more.

GAVI Alliance Addresses MSF Concerns on Infant Hepatitis B Vaccine
June 30 – Medecins Sans Frontieres recently expressed concern about the slow implementation of the World Health Organization’s recommendation that a dose of hepatitis B vaccine be delivered immediately after birth, and the GAVI alliance has resplied. Read more.

Fighting Hepatitis B and Liver Cancer in West Africa
June 30 – EU-funded researchers are identifying and treating patients with Hepatitis B in West Africa with the aim of reducing their risk of dying from liver cancer. The researchers are also developing a new test to identify those with liver cancer, so treatment can be given sooner – saving more lives. Read more.

Okyeame Kwame Fights Against Hepatitis B
June 30 – As part of activities to mark this year’s World Hepatitis B Day, Ghana’s award-winning hiplife artiste, Okyeame Kwame, will organize a free Hepatitis B screening event for 5000 people in Accra. Read more.

Screening Can Identify Early-Stage HCC But Benefits Unclear
June 23 – Chronic hepatic disease has been recognized as a risk factor for hepatocellular carcinoma, but does that mean that all patients should be screened? See what a recent study published in the Annals of Internal Medicine has to say. Read more.

WHO Calls for National Actions on Hepatitis
June 23 – Though home to about one quarter of the world population, the WHO Region for the Western Pacific accounts for nearly 50% of the 160 million chronic hepatitis B infections worldwide. Read more.

HIV infection Due to Unsafe Medical Injections May Have Fallen by Almost 90% Worldwide in Decade After 2000
June 23 – The number of HIV, hepatitis B and C infections in low and middle-income acquired due to unsafe medical injections fell by 87%, 83%, and 91% respectively between 2000 and 2010. "This is a remarkable public health achievement.” Read more.

Mayo Clinic Study Reverses Current Thought on Treatment of Cirrhosis
June 23 – Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. Read more.

Something to Celebrate: Improved Guidelines for Hepatitis B Screening
June 2 – The month of May gave us many reasons to celebrate. Reflecting on Asian American and Pacific Islander (AAPI) Heritage and Hepatitis Awareness Month, appreciating the rich AAPI history, and recognizing the importance of addressing viral hepatitis in AAPI populations. Read more.

Combating the Silent Epidemic of Hepatitis B in the AAPI Community
June 2 – Dr. Howard Koh, Assistant Secretary of Health, HHS, reminds us of the staggering impact of Hepatitis B in Asian American and Pacific Islanders, and how coordination and collaboration among federal partners works to reduce the burden of hepatitis B in these communities. Read more.

Outcomes in HBV/HCV Coinfected People Depend on Which Virus Dominates
June 2 – Among HBV/HCV coinfected people, about half have dominant hepatitis B virus while half have dominant hepatitis C, and those with active HBV replication are at higher risk of liver-related complications and death, according to study findings presented at Digestive Disease Week. Read more.

Hepatitis Warrior Hiking in China Shows Glaxo Hurdles
June 2 – Lei Chuang trekked almost 1,000 miles over 80 days from Shanghai to Beijing last summer, along riverbanks and highways, to deliver a petition beseeching China’s leaders to cut the prices of hepatitis B drugs. Read more.

Screening for Hepatitis B Virus Infection: A Public Health Imperative
May 26 – The U.S. Preventive Services Task Force, a national panel of health experts, advised that doctors should regularly screen people at high risk for contracting the hepatitis B virus. Read more.

World Health Assembly Approves Resolution on Viral Hepatitis and Noncommunicable Dieases
May 26 – The World Health Assembly has approved a resolution to improve the prevention, diagnosis, and treatment of viral hepatitis, as well as proposals to improve global coordination of efforts to address noncommunicable diseases. Read more.

Passing Hepatitis B From Mother to Child Halted With Vaccine
May 26 – The passing of the hepatitis B virus, a primary cause of liver cancer, from mother to child can be virtually eliminated by immunizing high-risk newborns within hours of birth and following up with vaccinations over the baby's first six months of life, according to a large, recently published, Northern California Kaiser study. Read more.

Talking About Hepatitis B and HIV: Working to End the Stigma
May 26 – Hepatitis B and HIV have stigmatizing effects within the Asian American and Pacific Islander communities. Read Mei’s personal account of how she copes. It’s time to diffuse the stigma. Read more.

Alnylam's Hepatitis B Therapy Shows Promise in Animal Studies
May 19 – RNAi specialist Alnylam is adding a hepatitis B therapy to its pipeline of candidates that employ its enhanced stabilization chemistry-GalNAc-conjugate technology enabling subcutaneous dosing. Read more.

Robust Hepatitis B Seroprotection in Adolescence After Immunization in Infancy
May 19 – The complete hepatitis B vaccine series given in childhood has been shown to provide protection against HBV into adulthood. However the duration of protection if administered in infancy was uncertain, raising the question, is a booster dose of the vaccine in adolescence necessary? Read more.

What Every Women Needs to Know about Hepatitis B and C
May 19 – In observance of National Women’s Health Week and Hepatitis Awareness Month, Health and Human Services (HHS) Viral Hepatitis Policy Advisor Corinna Dan, takes the opportunity to raise viral hepatitis awareness among women. Read more.

Treating Hepatitis B and C in HIV + People Reduces Liver Disease
May 19 – Effective antiviral treatment that suppresses hepatitis B virus replication or eradicates hepatitis C virus can lower the risk of developing advanced liver disease including cirrhosis, hepatocellular carcinoma, and decompensation in people with HIV and viral hepatitis coinfection, according to studies presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) and EASL. Read more.

Some Hepatitis B Patients Can Stop Antiviral Treatment Without Relapse
May 12 – Stopping antiviral therapy after several years appears generally safe for people with HBeAg negative chronic hepatitis B without liver cirrhosis, and a substantial proportion do not experience viral relapse or worsening liver inflammation while off treatment, according to a pair of posters presented at Digestive Disease Week. Read more.

HBV: Community-Based Programs May Improve Care
May 12 – Community outreach programs, helped along by funding from the Centers for Disease Control and Prevention, may be improving the screening, treatment, and care of patients with hepatitis B virus infection, according to an article published in the Morbidity and Mortality Weekly Report. Read more.

Novira Kicks Off Phase 1a Trial of Novel Hep B Drug
May 12 – Novira Therapeutics Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus infection, announced that it initiated a Phase 1a clinical study of NVR-1221. The Phase 1a clinical study is designed to assess the pharmacokinetic profile and dose-related safety and tolerability of NVR-1221 in healthy volunteers. Read more.

Screening May Help Boost Liver Cancer Survival Rates
May 12 – Increased screening for liver tumors in people with cirrhosis could help boost liver cancer survival rates, according to researchers, but unfortunately they found less than 20% of at-risk people are being tested. Read more.

May is Hepatitis Awareness Month
May 5 – Throughout May, during this year’s observance of Hepatitis Awareness Month, federal colleagues from across the U.S. Departments of Health and Human Services, Housing and Urban Development, Justice, and Veterans Affairs will be engaged in a variety of activities to increase awareness—among the public and healthcare providers—about viral hepatitis. Read more.

The B Positive Program as a model to reduce hepatitis B health disparities in high-risk communities in Australia
May 5 – The B Positive Program addresses the challenges in diagnosing and managing hepatitis B in culturally and linguistically diverse communities in high-risk communities in Australia. Read more.

Sci-B-Vac Bests Engerix-B for Preventing Mother-to-Child HBV Transmission
May 5 – An investigational vaccine known as Sci-B-Vac given to babies born to women with hepatitis B was more effective at preventing HBV infection than the widely used Engerix-B vaccine, according to a report at the 2014 EASL International Liver Congress. Read more.

Acetaminophen in Rx drugs: For Liver's Sake, Lower the Dose, Says FDA
May 5 – A Food and Drug Administration (FDA) warning was missed by many physicians, pharmacists and patients, so the FDA, in an unusual move, reminds us: Stop writing prescriptions for, stop dispensing prescriptions for, and stop taking prescription medications containing more than 325 milligrams of acetaminophen. Read more.

Some Immigrants In Columbus At Risk For Silent Killer
April 28 – Central Ohio is home to some 70,000 Asian immigrants, and advocates worry the silent deadly disease, hepatitis B, is hidden in the population. Read more.

Hepatitis B is Not Hindrance For Work
April 28 – Employers should neither isolate nor discriminate against workers who are Hepatitis B positive, the Hepatology Society of the Philippines (HSP) strongly voiced. HSP has written the Guidelines on the Evaluation of Hepatitis B Surface Antigen Positive Workers for Employment to dispel misconceptions and lack of knowledge about HBV in the Philippines. Read more.

Herbal Medicines and Supplements Carry Risk of Hepatoxicity
April 28 – Herbal medicines and other home remedies or supplements are a significant cause of hepatotoxicity experts warned recently during a symposium at the International Liver Congress. Read more and watch the videos.

Fiji Babies Covered
April 28 – This year’s immunization week celebrations in Fiji are focused on promoting vaccination against hepatitis B with the theme ‘Stop hepatitis B and liver cancer – Vaccinate at Birth’. Read more.

Prolonged Pegylated Interferon + Tenofovir Does Not Prevent Hepatitis Delta Relapse
April 21 – Treating hepatitis B patients with hepatitis delta virus (HDV) coinfection using pegylated interferon plus tenofovir for 96 weeks may reduce HDV viral load, but side effects are frequent and it did not significantly improve the likelihood of hepatitis B surface antigen (HBsAg) reduction, according to a report at the 49th EASL International Liver Congress last week in London. Read more.

Asia-Pacific Nations Prodded On Hepatitis Action Plans
April 21 – Health experts state that the Asia-Pacific region needs more cross-sector partnerships and funding to tackle viral hepatitis, and they are calling on countries in the Asia-Pacific to set national action plans to address the escalating impact of viral hepatitis. Read more.

Teen Makes Genetic Discovery of Her Own Rare Cancer
April 21 – Inspiring story of a teen with a rare from of liver cancer that not only recovered from her cancer, but embarked on a scientific journey using YouTube to reach out to other patients to collect tumor samples that would eventually lead to a cutting edge discovery. Read more and watch the videos.

Can Coffee Treat Liver Disease?
April 21 – Contemporary studies suggest that coffee is beneficial for chronic liver diseases and can positively impact liver function tests, viral hepatitis, and may even help prevent cirrhosis and liver cancer. Read more.

Three New Studies Help Clarify Optimal Use of Combination Therapy in Chronic Hepatitis B Patients
April 14 - Three new studies presented at the International Liver Congress 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues to achieve the best treatment outcomes in patients with chronic hepatitis B. Read more.

Viral Hepatitis More Deadly Than HIV in Europe
April 14 – Mortality from viral hepatitis is significantly higher than from HIV/AIDS across European Union (EU) countries, according to results from The Global Burden of Disease Study 2010, which was announced for the first time at the International Liver Congress 2014. Read more.

Small Cash Incentives Dramatically Improve Hepatitis B Vaccination Rates Among Injecting Drug Users
April 14 – Modest financial incentives significantly improve adherence to hepatitis B virus vaccination programs among patients receiving opioid dependence treatment, according to a study published in The Lancet. Read more.

New Marker to Predict Recurrence of Hepatocellular Carcinoma
April 14 – High preoperative levels of hepatitis B surface antigen (HBsAg) in patients with a low viral load predict an increased likelihood of hepatocellular carcinoma recurrence after resection, Chinese researchers report. Read more.

Updated Viral Hepatitis Action Plan Released
April 7 – An updated version of the nation’s first comprehensive cross-governmental action plan to combat chronic viral hepatitis, initially launched in 2011, has been released. The Action Plan for the Prevention, Care and Treatment of Viral hepatitis builds upon the progress accomplished over the past three years. Read more.

Screening for Liver Cancer in Patients With Cirrhosis
April 7 – Patients with cirrhosis who underwent surveillance via liver ultrasound for hepatocellular carcinoma had cancers detected at an earlier stage, and were more likely to receive curative instead of palliative treatment, and had longer survival. Read more.

High Hepatitis B Antigen Predicts Hepatic Cancer Recurrence
April 7 – The risk of hepatocellular carcinoma recurrence increased with high levels of hepatitis B surface antigen (HBsAg) , specifically at HBsAg above 1000 IU/mL. Read more.

Some of Us are Turning Our Livers Into 'Foie Gras'
April 7 – While most of us are more familiar with viral hepatitis, alcohol-related liver disease and liver cancer, there is another condition affecting the liver that is insidiously rising amongst the world population. Read more.

Hep B Cure Could Be Discovered in Bucks Co.
March 24 – When a hepatitis B cure is discovered, it might very well happen inside the walls of the Pennsylvania Biotechnology Center in Bucks County. Read more.

Entecavir Approved for Children 2 Years and Older for Hepatitis B virus Infection
March 24 – The U.S. Food and Drug Administration has approved the antiviral entecavir (brand name Baraclude) for use in children and teens age 2 and older. This robust antiviral is the first to be approved by the FDA for children in several years, and is considered one of the top two antivirals available to adults today. Read more.

Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in Chronic Hepatitis B Patients
March 24 – Arrowhead Research Corporation announced that patient dosing has begun in a Phase 2a clinical trial of ARC-520, its RNAi therapeutic for the treatment of chronic hepatitis B virus infection. The Company anticipates planned enrollment to be complete in the second quarter of 2014 and expects top line results to be released in the third quarter. Read more.

Isis Announces Antisense Targeting of HBV Produces Dose-Dependent Reductions in Hepatitis B Virus
March 24 – Isis Pharmaceuticals announced that treatment with an antisense compound targeting hepatitis B virus produced dose-dependent reductions in all measured liver and serum viral markers of HBV infection in animal models of HBV infection. These data will be presented at the 49th annual meeting of the European Association for the Study of the Liver (EASL). Read more.

Responding to the Escalating Impact of Viral Hepatitis in Asia Pacific
March 17 – Professor Ding-Shinn Chen, Chair of the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), addresses newly released data which CEVHAP will use to continue to raise awareness of the escalating impact of viral hepatitis in the Asia Pacific region. Read more.

HCC Risk Remains High With Hep B Antivirals
March 17 – Chronic hepatitis B patients who achieve complete response with oral antiviral therapy are still at much higher risk of developing hepatocellular cancer compared to patients with inactive chronic hepatitis B, Korean researchers find. Read more.

Vertical Transmission of Hep B On the Way Out
March 17 – Tenofovir in pregnant women with hepatitis B is extremely effective in preventing in utero infection and in combination with vaccination could eradicate the disease altogether, a New Zealand expert says. Read more.

Roadside Barbers: Main Cause of Communicable Diseases
March 17 – The use of unsterilized equipment by roadside barbers is the main cause of spreading communicable diseases, including Hepatitis B and C, in the twin cities of Pakistan. Read more.

Hepatera Completes Enrollment of Phase IIa Clinical Trial of Myrcludex B, for HBV
March 10 – A group of 48 patients infected with the hepatitis B virus have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd., with the aim to study safety, tolerability and efficacy. Read more.

Metabolic Profiling of Liver Cells Suggests New Treatments for Cirrhosis Patients
March 10 – In a new study that could help doctors extend the lives of patients awaiting liver transplants, a Rice University–led team of researchers examined the metabolic breakdown that takes place in liver cells during late–stage cirrhosis and found clues that suggest new treatments to delay liver failure. Read more.

Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug
March 10 – Biostar Pharmaceuticals, Inc., a China–based manufacturer and marketer of pharmaceutical and health supplement products, announced that it has signed a letter of intent with the Research Institute of Pharmaceuticals at Shaanxi University of Chinese Medicine to develop a new liver cancer drug based on Oleanolic Acid injection. Read more.

Hepatera Completes Enrollment of Phase IIa Clinical Trial of Myrcludex B, for HBV
March 10 – A group of 48 patients infected with the hepatitis B virus have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd., with the aim to study safety, tolerability and efficacy. Read more.

Metabolic Profiling of Liver Cells Suggests New Treatments for Cirrhosis Patients
March 10 – In a new study that could help doctors extend the lives of patients awaiting liver transplants, a Rice University–led team of researchers examined the metabolic breakdown that takes place in liver cells during late–stage cirrhosis and found clues that suggest new treatments to delay liver failure. Read more.

Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug
March 10 – Biostar Pharmaceuticals, Inc., a China–based manufacturer and marketer of pharmaceutical and health supplement products, announced that it has signed a letter of intent with the Research Institute of Pharmaceuticals at Shaanxi University of Chinese Medicine to develop a new liver cancer drug based on Oleanolic Acid injection. Read more.

Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520
March 3 – Arrowhead Research Corporation announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus infection. Read more.

Adult Immunization Retake: Lost Opportunities for Protection, Shared Responsibility
March 3 – According to Medscape, only 65% of healthcare professionals have been vaccinated to protect against hepatitis B in the U.S. Read more.

WHO Official Urges Hepatitis B Education in China
March 3 – While praising China’s efforts in reducing hepatitis B, Dr. Shin Young-soo, the World Health Organization (WHO) Western Pacific regional director, stressed more effort is needed to fight discrimination against hepatitis B virus carriers in China. Read more.

Small man, Great Power
March 3 – A chronic hepatitis B carrier in China shows the impact one, small man can have by empowering others with his sense of justice, and his courage to disclose his chronic HBV infection, and publicly raise awareness. Read more.

Degradation of Viral DNA in the Cell Nucleus Opens New Hepatitis B Treatment Possibilities
Feb 24 – New data reveals how the viral DNA of the hepatitis B virus can be degraded in the cell nucleus of liver cells, consequently allowing the virus to be eliminated, without damage to the liver cell, report scientists from the Helmholtz Zentrum München and the Technische Universität München in the journal, Science. Read more.

Hepatitis B Virus-Related Hepatocellular Carcinoma is Induced by MicroRNA-181a
Feb 24 – Researchers at Chongqing Medical University in China broke new ground on an association between microRNAs and hepatocellular carcinoma, the second leading cause of cancer-related deaths worldwide. Read more.

How to Turn Skin Cells Into Functioning, Mature Liver Cells
Feb 24 – Researchers have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish on their own, even after being transplanted into laboratory animals modified to mimic liver failure, raising the hopes for millions at risk for developing liver failure. Read more.

WHO: Liver Cancer Moves to the 2nd Leading Cause of Cancer Deaths in the World
Feb 17 – Based on the latest statistics from WHO on trends in cancer incidence and mortality worldwide, the cancer burden is growing, and liver cancer has moved from third to now the second leading cause of cancer death worldwide. Read more.

Are Doctors Screening Their Patients for Hepatitis B?
Feb 17 – Dr. Curtis T. Miyamoto, president of the Philadelphia County Medical Society, speaks with HBF’s own Chari Cohen and Daniel Chen about local efforts and encourages hepatitis B screening of at-risk patients. Read more.

Austrian Red Cross in Hot Water After ‘Rejecting’ Blood Donations From Muslims
Feb 17 – Austria's Red Cross has come under fire from the local Islamic community after one of its doctors reportedly refused to accept blood donations from Muslims or donors of Turkish origin due to the risk of Hepatitis B. Hopefully Nucleic-Acid Amplification testing (NAT) is standard for all Austrian blood donations. Read more.

Fighting Hepatitis B and Liver Cancer in West Africa
Feb 10 – European Union (EU) funded researchers are identifying and treating patients with Hepatitis B virus in West Africa with the aim of reducing their risk of dying from HBV and liver cancer through project PROLIFCIA. Read more.

China the Hardest Hit by Global Surge in Cancer, Says WHO Report
Feb 10 – China is bearing the brunt of new cancer cases and deaths amid an alarming global rise in the disease, with about 50% of new liver cancer cases recorded in China. Read more.

Hepatitis B and Kidney Transplantation
Feb 10 – Evaluating patients with hepatitis B serologies and HBV DNA viral load prior to kidney transplantation is essential to a successful kidney transplant for those with a current or prior hepatitis B infection. Read more.

CDC: Check Vaccines Before Attending Winter Olympics
Feb. 3 – Before attending the Winter Olympics in Sochi, Russia, U.S. health officials recommend travelers ensure their vaccinations are up to date, including hepatitis B. Read more.

Fish Spa May Spread HIV, Hepatitis B, Expert Warns
Feb. 3 – Fish spas are creating quite a splash in many areas, but health experts warn that the pedicures, where tiny fish nibble away the dead skin, may spread blood diseases such as HIV and hepatitis B. Read more.

British MPs Suggest Law to Ban Visas to Those Suffering From HIV and HBV
Feb 3 – Britain is mulling a draconian law that would ban foreigners with HIV and Hepatitis B from living or visiting the UK, which has caused uproar with civil society and activists urging rejection of the amendment. Read more.

B.C. Funds Hepatitis B Awareness Program for Asian Immigrants
Feb 3 – After years of lobbying, B.C.’s Ministry of Health is spending $400,000 on a hepatitis B education program aimed at Asian immigrants with Mandarin and Korean public information sessions scheduled first, to be followed with Punjabi, Tagalog and English. Read more.

NGMC Recognized for Protecting Newborns From Hepatitis B
Jan 27 – Northeast Georgia Medical Center (NGMC) has been recognized by the Immunization Action Coalition (IAC) and the Georgia Department of Public Health for achieving one of the highest reported rates in the state for its work to protect newborns from hepatitis B virus infection. Read more.

Children’s Patients May be at Risk of Infection After Colonoscopies
Jan 27 – More than 100 patients who had colonoscopies between 2011 and 2013 at Seattle Children’s have been advised to be tested for hepatitis B and C and HIV after the hospital discovered special equipment used in the procedures had not been properly cleaned. Read more.

Cooking Up Cancer?
Jan 27 – Grilling meats is an American tradition, but it’s not the healthiest thing to do. Research suggests that cooking meats over a flame is linked to liver and other cancers due to exposure to polycyclic aromatic hydrocarbons (PAHs). Read more.

Omega-3 Fatty Acids May Have Even More Health Benefits Than Thought
Jan 27 – Recent research shows that omega-3 fatty acids may offer protection against diet-induced nonalcoholic fatty liver disease (NAFLD), which can lead to nonalcoholic steatohepatitis (NASH), cirrhosis, hepatocellular carcinoma and liver failure. Read more.

Monitoring Inactive Hepatitis B Patients is a Cost-Effective Strategy
Jan 21 – A novel study determined that monitoring inactive chronic hepatitis B carriers is a cost-effective strategy for China. However, results published in Hepatology show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level. Read more.

Patients of Dentist at North Sydney Clinics, Australia, Informed of Possible Exposure to HIV, Hepatitis
Jan 21 – Almost 1000 patients treated by a Sydney dentist over the past decade may have been exposed to HIV and hepatitis B and C because medical equipment was not properly sterilized. Patient advocates say the case raises ''deeply concerning'' questions about patient safety in dental clinics and the quality of medical regulation. Read more.

Cigarettes More Dangerous Than Ever
Jan 21 - Smoking cigarettes can cause even more health problems than previously known, including liver and colon cancer, blindness, diabetes, and erectile dysfunction, said a major US government report on Friday. Read more.

Cost-effectiveness Analysis of the National Perinatal Hepatitis B Prevention Program
Jan 13 – The current CDC perinatal hepatitis B prevention program, is a cost-effective use of resources, but a program that reached all pregnant women would provide additional public health benefits, according to results of a recent analysis. Read more.

China Focus: Panic Leads to Drop in Hepatitis B Vaccination Rate
Jan 13 – Panic triggered by alleged vaccine-related deaths in China led to a 30 percent drop in the hepatitis B vaccination rate in December, with experts warning of rising incidence of HBV infection, despite conclusions by health authorities that the vaccine was not responsible for the deaths. Read more.

Nurse exposed 24 Buckeye inmates to hepatitis B and C
Jan 13 – For the second time in 17 months, inmates at the State Prison Complex-Lewis have been exposed to life-threatening disease by a health-care provider as a result of improper injection practices. Read more.

China Denies Hepatitis Vaccine Killed Nine Children
Jan 6 – Vaccines did not cause the deaths of nine children shortly after they were inoculated for hepatitis B as part of the Chinese government program, and no links have been found in eight other cases still being investigated by Chinese health authorities. Read more.

Hepatitis B and C Reduce Survival by More than 20 Years
Jan 6 – People with chronic hepatitis B or C lived about 2 decades less on average than those who did not have these infections, and chronic viral hepatitis was the 15th leading cause of death in the U.S. in 2010, CDC researchers reported in the January 1, 2014 Issue of Clinical Infectious Diseases. Read more.

Nigerian Federal Government Inaugurates Technical Group on Hepatitis Disease Control
Jan 6 – The Nigerian Federal Government has inaugurated a Technical Working Group on Viral Hepatitis Control in Nigeria, as a quick intervention on the increasing burden of viral hepatitis in a country where there is an 11% prevalence of HBV and 2.2% HCV prevalence. Read more.

Surgery Tied to Better Survival Outcomes in Huge Liver Tumors
Jan 6 – Surgical resection of huge hepatocellular carcinomas was linked with better survival outcomes versus transarterial chemoembolization (TACE), researchers found. Read more.

2013 News


December 30, 2013


Arrowhead Presents Data Suggesting ARC-520 Induces Therapeutic Flare in Chronic Hepatitis B


Joint Agency Letter to Health–related Schools Regarding Hepatitis B Discrimination


Hepatitis B Treatment with Entecavir or Tenofovir Lowers But Does Not Eliminate HCC Risk


Tenofovir Alafenamide Shows Similar Anti-HBV Activity with Less Kidney Toxicity


FDA Strengthens Hepatitis B Warning on 2 Cancer Drugs, Arzerra and Rituxan to Prevent HBV Reactivation


Hepatitis B Vaccination Cuts Deaths From Liver Disease, Cancer


Low Vitamin D Linked to Hepatitis B


Coffee Consumption Reduces Risk of Liver Cancer


Hepatitis B Vaccine Protection Lasts at Least 30 Years


Tenofovir May Help Mother-to-Child Hepatitis B Transmission


Diabetes Identified as Risk Factor for Liver Cancer Across Ethnic Groups
Dec 16 – Diabetes was associated with an increased risk for developing hepatocellular carcinoma, and this association was highest for Latinos, followed by Hawaiians, African-Americans, and Japanese-Americans. Read more.

Genetic Flaw in Males Triggers Onset of Liver Cancer, Diabetes
Dec 16 – Michigan State University researchers have uncovered a genetic deficiency in males that can trigger the development of one of the most common types of liver cancer and type 2 diabetes. Read more.

Universalization of Hepatitis B Vaccination Would be Taken Up with the Centre
Dec 16 – The Indian Society of Gastroenterology is appealing to the Union Health Ministry with the intent of universalizing the hepatitis B vaccine across all sections of the country. Read more.

About 2 Percent of Iranian Population Suffers from Hepatitis B
Dec 16 – About 1.4 million Iranians suffer from Hepatitis B, which indicates the average prevalence of the disease is about 2 percent. At the same time, the number of people infected with hepatitis B is declining. Read more.

Tenofovir for Hepatitis B Remains Safe and Effective Over 7 Years
Dec 9 – Chronic hepatitis B patients treated with tenofovir (Viread) for 7 years continued to maintain viral suppression and liver enzyme normalization, while serological response rates continued to increase, according to a poster presented at AASLD 2013. Read more.

China's Struggle With Hepatitis B Discrimination
Dec 9 – Despite a 2010 law banning hepatitis B screening in job and school admission applications, HBV discrimination abounds in China, and seeking justice remains a challenge. Read more.

Peru: Liver Cancer Like No Other
Dec 9 – Liver cancer is the sixth most common cancer worldwide, most often affecting men over 40, and those with cirrhosis or hepatitis B or C. But in Peru, it also uncharacteristically affects young people who do not have the identified related risk factors. Read more.

Warnings for Hepatitis B Reactivation in Cancer Patients Welcomed by the AASLD
Dec 2 – The FDA announced the requirement of a Boxed Warning for the anti-cancer immunosuppressive drugs Arzerra (ofatumumab) and Rituxan (rituximab), and is specific to the risk of reactivating hepatitis B in patients who were previously infected with the virus. Read more.

Arrowhead Submits Phase 2a Application for Hep B RNAi Candidate
Dec 2 – After announcing promising new data, Arrowhead has submitted its application to begin a phase II-a trial of ARC-520. Researchers will look to determine the effect of one intravenous dose of ARC-520, in combination with the oral antiviral entecavir, on hepatitis B surface antigen reduction. Read more.

Vaccine Implant Could Eliminate Painful Booster Shots
Dec 2 – Scientists in Europe have devised a novel new system that might one day replace booster shots. Patients would swallow a pill to trigger the release of vaccine doses from a gel implant placed beneath the skin. Read more.

Tenofovir Alafenamide Shows Similar Anti-HBV Activity with Less Kidney Toxicity
Nov 25 – A new formulation of tenofovir that can be taken at lower doses demonstrated potent activity against hepatitis B similar to that of the existing formulation in a 28-day study, but with less effect on kidney function, researchers reported at the 2013 AASLD Liver Meeting. Read more.

Hepatitis B and C Rates Higher Than Government Estimates
Nov 25 – A new federal government study provides the first estimates of the proportion of the population infected with the hepatitis B and C viruses, but experts say the figures significantly downplay the scale of the problem in Canada. Read more.

'Silent Epidemic' - Nearly Ten Percent of Filipinos Infected With Hepatitis
Nov 25 – Almost 10% of the Philippine population are infected with viral hepatitis, forcing experts to say that the situation is a "silent epidemic." 7.3 million are infected with chronic HBV and 1 million are infected with HCV. Read more.

B.C. Man Accused of Illegal Dentistry Turns Himself In
Nov 25 – A follow up on a British Columbia man, David Wu, accused of illegal dentistry, practicing out of his dirty, disorganized bedroom with unsterilized instruments. Most patients were young Chinese-Canadians now at risk for hepatitis B, C or HIV. Read more.

Entecavir + Tenofovir Works Well for Hepatitis B Patients with Prior Treatment Failure
Nov 18 – A dual regimen of entecavir (baraclude) plus tenofovir (Viread) for 48 weeks led to virological response and was generally well-tolerated as second-line therapy for chronic hepatitis B patients who had failed previous nucleoside/nucleotide treatment, according to data presented at the 2013 AASLD Liver Meeting. Read more.

Hepatitis B Vaccine Protection Lasts at Least 30 Years
Nov 18 – Hepatitis B vaccination provides long-term protection through 30 years for a majority of recipients, and more than 90% were protected with either initial immunization or a booster, according to a presentation at the 2013 AASLD Liver Meeting. Read more.

Genovate and ScinoPharm Co-Develop Hepatitis B Drug "Livepro"
Nov 18 – Generic drug Livepro, (Entecavir) will be commercially available in Taiwan at the end of the year and is a joint development product of Genovate and ScinoPharm. Read more.

HBV Response to Tenofovir Similar in People With and Without HIV
Nov 18 – Nearly 90% of people with chronic hepatitis B virus in a Spanish group attained an undetectable HBV load after 96 weeks of tenofovir. Response rates did not differ between people with and without HIV infection. Read more.

Hepatitis B Treatment with Entecavir or Tenofovir Lowers But Does Not Eliminiate HCC Risk
Nov 11 – While entecavir or tenofovir can reduce the risk of hepatocellular carcinoma, people with chronic hepatitis B should continue to undergo regular monitoring for liver cancer. Better predictive models may also be needed for Caucasian patients. Read more.

Early Treatment With Nucleotide/Nucleoside Analogues Safe, Effective for HBV-Induced Liver Failure
Nov 11 – Immediate treatment of hepatitis B virus induced acute liver failure with nucleotide/nucleoside analogues is well tolerated and avoids liver transplantation, researchers reported at the 2013 AASLD Liver Meeting. Read more.

Viral Hepatitis is a Leading Cause of Death Worldwide
Nov 11 – Chronic viral hepatitis was identified as one of the leading causes of mortality worldwide, according to the 2010 Global Burden of Disease Study presented at the 2013 AASLD Liver Meeting. Read more.

The Prevalence of Fibromyalgia Among Patients with Hepatitis B Virus Infection
Nov 11 – Fibromyalgia, characterized by widespread and chronic musculoskeletal pain and fatigue, appears to be more prevalent among patients with hepatitis B, according to a recent study. Read more.

Arrowhead Presents Data Suggesting ARC-520 Induces Therapeutic Flare in Chronic Hepatitis B
Nov 4 – Data presented at the AASLD Liver Meeting demonstrated a reduction of key HBV antigens and DNA and a therapeutic immunological flare, which could lead to HBsAg seroconversion and a functional cure for HBV. Read more.

Fast, Painless Alternative to Liver Biopsies for Hepatitis Patients Proves Accurate and Reliable
Nov 4 – FibroScan, a non–invasive alternative to liver biopsy, the current standard method of diagnosing cirrhosis in hepatitis patients, proves very reliable in a national multi–center. Read more.

Barber with Hepatitis B Jailed in Dubai for Offering Bribe Over Blood Test
Nov 4 – A barber with Hepatitis B and two coworkers who tried to bribe a municipality health worker into falsifying blood test results have been sentenced to one year in prison. Workers seeking work permits in the UAE are screened and deported if they are found HBV positive and intend to work with the public, including barbers and salon workers. Read more.

Researchers Recently Launched Collaborative Hepatitis Network in Africa
Nov 4 – Physicians and researchers from Africa, the United States and Europe recently launched the Africa Collaborative Hepatitis Network, known as HepNet to study how to better prevent and control viral hepatitis. Read more.

Asian Americans Comprise Half of All People with Hepatitis B in the U.S.
Oct 28 – Local hepatitis B advocates in Seattle debunk HBV myths and state we need more education to overcome stigma affecting Asian and Pacific Islanders (APIs). While APIs account for less than 5 percent of the U.S. population, they comprise half of the estimated 1.2 million people living in the United States with chronic hepatitis B. Read more.

Coffee Consumption Reduces Risk of Liver Cancer
Oct 28 – A meta-analysis of 16 studies consistently showed that a moderate amount of coffee consumption, particularly three cups a day, could possibly reduce the risk of liver cancer by 50 percent. Read more.

Scientists Find that Activating Family of Small Proteins Could Suppress Liver Malignancies
Oct 28 – Signaling crosstalk between different protein switches has an influence on the development of cancer and paves the way for the development and application of therapeutics targeted at liver cancer, according to research from the National University of Singapore. Read more.

Son Gives Dad a Liver and a New Life
Oct 28 – A son gives his father the gift of life by donating part of his liver to his father, diagnosed with liver cancer due to chronic hepatitis B diagnosed 30 years ago. Read more.

Hepatitis B Mutation Seen in Only Men, Increased Risk of Liver Cancer
Oct 21 – A team of researchers identified a mutation from the hepatitis B virus that seems to appear only in men and may explain why HBV-infected males are roughly five times more likely than HBV–infected women to develop certain types of liver cancer. Read more.

Entecavir and Tenofovir Both Work Well Against Hepatitis B in Clinical Practice
Oct 21 – Entecavir (Baraclude) and tenofovir (Viread) both demonstrated potent activity against hepatitis B virus in a Turkish study presented at the second IDWeek conference. Read more.

Hepatitis B Treatment in Real Life: Common & Uncommon Patient Profiles
Oct 21 – The Asian Health Foundation is hosting a CME/CE certified educational dinner meeting series in 6 cities across the U.S., and will provide Health Care Professionals with an understanding of treatment strategies for hepatitis B. Read more.

Arrowhead to Present at Upcoming Conferences Oct 21   Arrowhead Research Corporation will present data on ARC-520, its hepatitis B drug candidate, at two scientific conferences including the 2013 International Meeting on Molecular Biology of Hepatitis B Viruses in Shanghai, coordinated by the Hepatitis B Foundation, and the AASLD Liver Meeting in Washington, DC.Read more.

Vaccination Campaign Doubles HBV Mutations
Oct 14 – A universal infant vaccination campaign in China has led the Hepatitis B virus to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies. Read more.

Tenofovir May Help Mother-to-Child Hepatitis B Transmission
Oct 14 – Taking tenofovir during the final months of pregnancy may provide extra protection against perinatal transmission of hepatitis B virus, along with immunization of the infant, according to a presentation at the IDWeek conference. Read more.

Arrowhead Initiates Phase 1 Study of ARC-520 for Treatment Against Chronic HBV Infection
Oct 14 – Arrowhead announced that it completed enrollment in a phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B. Initial data indicate that ARC-520 is generally safe and well tolerated at all six dose levels studied. Read more.

Researchers Identify Liver Cancer Progenitor Cells Before Tumors Become Visible
Oct 14 – Researchers have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma (HCC) tumors, according to researchers at the University of California, San Diego School of Medicine. Read more.

Hepatitis B Foundation’s Research Institute Renamed for Nobel Prize Winner Dr. Baruch S. Blumberg
Oct. 7 - The Hepatitis B Foundation officially renamed its research institute the "Baruch S. Blumberg Institute" in a grand re-opening ceremony today to honor the scientific legacy of the Foundation’s co-founder, Dr. Baruch Blumberg who won the Nobel Prize for his discovery of the hepatitis B virus. Featured guest speaker was Mr. Mark Thompson, President and CEO of The New York Times, who is also the son-in-law of the late Dr. Blumberg. Read more.

Entecavir, Tenofovir Comparable in Patients with Treatment-Naïve Chronic Hepatitis B
Oct 7 – Third-year results of a “real-world” cohort study found the antivirals entecavir and tenofovir provided comparable efficacy for treatment–naïve patients with chronic hepatitis B and high genetic barriers against resistance, a study concluded at IDWeek 2013. Read more.

High HBV Viral Load Raises Risk of Progression to Liver Cancer
Oct 7 – Hepatitis B patients with high HBV DNA levels, indicating active viral replication, are more likely to experience progression of abnormal liver nodules to hepatocellular carcinoma, researchers reported at the 7th International Liver Cancer Association Annual Conference (ILCA 2013). Read more.

HBV Vaccine Response Status Not Associated with cART CD4 Gains at 1-Year
Oct 7 – Hepatitis B virus vaccine response status was not associated with post–combination antiretroviral therapy (cART) CD4 gains at 1-year among those with virologic suppression, a study concluded at IDWeek 2013. Read more.

Drug Use Blamed for Rise in Hepatitis B Cases
Oct 7 – At a recent Harrison-Clarksburg Health Department meeting in West Virginia, hepatitis B rates were a notable topic of discussion. Read more.

FDA Strengthens Hepatitis B Warning on 2 Cancer Drugs
Sept 30 – U.S. health regulators have strengthened the warnings on two blood cancer drugs to reflect the risk that they may reactivate the hepatitis B virus in patients previously infected with the disease. Read more.

Preventing Mother-to-Child Transmission of HBV
Sept 30 – Pregnant women with hepatitis B are less likely to pass the virus on to babies delivered by elective cesarean section, compared to those delivered naturally or by urgent cesarean section, according to researchers. Read more.

Published Phase 3 Data on HEPLISAV Shows Safety and Effectiveness
Sept 30 – Dynavax announced results of two Phase 3 trials of HEPLISAV published in J. Vaccine, which concluded that HEPLISAV induced significantly higher seroprotection rates in all groups (including hypo-responsive populations) than the approved HBV vaccine in a shorter 2-dose schedule over one month while maintaining a similar safety profile. Read more.

New Test Enables Early Diagnosis of Liver Cancer
Sept 23 – Researchers have found a way to make early liver cancer show its true colors. They have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue. Read more.

Patient, Heal Thyself: Solution to Personalized treatment for Chronic Infections Could Lie in Patient's Own Blood
Sept 23 – There’s hope for a new personalized treatment strategy that could use a patient's own blood to treat chronic hepatitis B and C infections using vaccine therapies. Read more.

Army Recruits Dropped Over Hepatitis B, HIV/AIDS
Sept 23 - Hundreds of youth who turned up for the three-day Uganda People’s Defense Forces (UPDF) recruitment exercise in Kampala were disqualified after they tested positive for Hepatitis B or HIV/AIDS. Read more.

Age is No Deterrent in Dream to Save Lives
Sept 23 – 91-year-old Wu Mengchao is among China’s most renowned doctors in the field of liver cancer treatment and research. His drive and accomplishments are admirable. Read more.

114 Children Hospitalized After Being Given Hepatitis B Vaccine Instead of Pulse Polio Drops
Sept 16 – In a major medical goof up, as many as 114 children were hospitalized in West Bengal after they were mistakenly given Hepatitis B vaccine orally instead of Pulse Polio drops on Sunday. Read more

High Rate of New Hepatitis B Among African-Americans
Sept 16 – Black Americans have a higher incidence of hepatitis B virus infection (new infections) than any other racial/ethnic group according to a review article of Clinical Gastroenterology and Hepatology. Read more

HIV and Hepatitis Risk for Steroid Users
Sept 16 - People who inject anabolic steroids and tanning drugs are at a higher risk of HIV and viral hepatitis, a study from Public Health England (PHE) has revealed. Read more.

OSHA Fines Atlanta Health Careers Institute
Sept 16 – OSHA fined Atlanta Health Careers Institute LLC $62,000 for allegedly not training properly employees in a bloodborne pathogen program and not making available the Hepatitis B vaccine to workers exposed to potential bloodborne pathogen hazards. Read more.

Hep B Vaccination May Cut Deaths From Liver Disease
Sept 9 – Taiwanese researchers report a 90 percent reduction in deaths from complications of hepatitis B and a decrease in the spread of hepatitis B since the country began its infant vaccination program in 1984. Read more

Tenofovir is Highly Effective for HIV/HBV Co-infection, Meta-Analysis Shows
Sept 9 – Tenofovir, which has potent activity against both HIV and hepatitis B virus, is the most effective hepatitis B treatment for people with HIV and HBV co-infection, according to a 23-study meta-analysis. Read more

Cancer Experts Detail New Approaches to Liver Cancer Treatment with Stereotactic Ablative Radiotherapy
Sept 9 – Clinical experts outlined promising new approaches to treating liver cancer using radiosurgery with advanced imaging and motion management technology, since many patients are not eligible for a liver transplant or surgery. Read more.

Redistricting Might Shorten Wait for Liver Transplants
Sept 3 – Where you live can affect your chances of getting a liver transplant and your risk of dying while waiting. William Sherbert learned this lesson when liver failure from hepatitis B put him on the transplant list. Read more

Ramon Magsaysay Awards: Pinoy Doc Champions Health Care for All
Sept 3 - Filipino hepatologist and Ramon Magsaysay awardee, Dr. Enesto Domingo, discusses the challenges in addressing hepatitis B and liver cancer in the Philippines, and the need for universal HBV vaccination and health care for all. Read more

Western Australia (WA) Research Circumvents Stem Cell Cancer Risk
Sept 3 – The clinical use of multipotent stem cells to regenerate new tissue and organs may be perceived by some as the solution of the future, but is this evidence conclusive? Read more.

Smart Syringe Turns Red to Tell You It's Been Used
Sept 3 – An innovative solution to the global problem of unsterilized second-hand syringes may save thousands of lives each year by reducing the transmission of blood-borne diseases such as hepatitis B, hepatitis C, and HIV. Read more

Novel Biomarker Could Potentially Lead to Early Detection of Liver Fibrosis
August 26 – A study reveals the central role of the immune molecule interleukin 33 (IL-33) in the formation of liver fibrosis, suggesting its use as a biomarker to potentially lead to early detection of fibrosis in patients. Read more

German Surgeons Perform Liver Cancer Operation Using Tablet
August 26 – The first of its kind liver cancer operation was conducted with the help of a tablet and a new app, promising support for surgeons in reducing the rate of complications during operations. Read more.

Galectin Therapeutics Targets Silent Epidemic in Liver Fibrosis
August 26 – Galectin Therapeutics, focusing on diseases such as fatty liver disease where galectin proteins play a major role in the disease process, has developed 2 classes of galectin inhibitors. The company is currently enrolling NASH patients with advanced fibrosis in a dose escalated Phase 1 study. Read more

Call for Coalition Hep B Commitment
August 26 – Peak health bodies are calling on the Coalition to commit to funding what they say are urgently needed hepatitis B treatment and awareness programs. Read more

GAVI Alliance Bridges China-Africa Immunization Cooperation
August 19 – The GAVI Alliance held an event to share the Chinese experience of immunization with African health ministers at the China-Africa health forum, which focused on the lessons learned from China's hepatitis B vaccination program. Read more

When Vaccinations Fail to Cause Response: Causes Vary with Vaccine and Person
August 19 – Most people react very well to vaccinations and have an adequate immune response against the pathogens. However, reasons for a non-response may vary. Read why some are hepatitis B vaccine non-responders. Read more.

Increased Caffeine Intake May Reduce Fatty Liver in People With NAFLD
August 19 – Surprise! Your morning cup of tea or coffee may be doing more than just perking you up before work, suggests an international team of researchers led by Duke-NUS Graduate Medical School and the Duke University School of Medicine. Read more

Hepatitis C Outbreak: In Wake Of Kwiatkowski Guilty Plea, Patients Seek Accountability
August 19 – Patients at a New Hampshire hospital who were infected with hepatitis C by a traveling medical technician with a drug problem are pleased with his guilty plea but are still pushing to hold others accountable. Read more

New Gene Therapy Advance Holds Promise for the Treatment of the Global Killer HBV
August 12 – A new gene therapy approach based on the engineering of a new class of proteins called TALENs recognizes and may disable the DNA of HBV. Read more

End This Neglect of Viral Hepatitis
August 12 – With mortality rates comparable to HIV/Aids, TB and malaria, is it time the global health community addressed viral hepatitis with the urgency it needs? Read more.

Urgent Call to Avert Hepatitis B Crisis
August 12 – Migrant communities in Melbourne’s west are being urged to protect against hepatitis infection as experts warn that Australia faces a hepatitis B crisis. Read more

Learn From My Friend’s Death: Love Your Liver
August 12 – Reflecting on the tragic loss of a friend, this author and co-founder of the Al D. Rodriguez Liver Foundation raises viral hepatitis awareness. Screen. Vaccinate. Don't Hesitate. Read more

China Nixes Patent for Gilead HIV, Hepatitis Drug Viread
August 5 – China officials have revoked the patent protecting Gilead Sciences Inc.'s HIV and hepatitis B drug, Viread. What does this mean for those living with chronic hepatitis B? Read more

Hepatitis B Treatment with Entecavir Lowers Risk of Liver Cancer
August 5 – Long-term treatment with entecavir significantly reduces the chances of developing hepatocellular carcinoma compared with no treatment, and appears to lower the risk more than an older drug, especially for the most at-risk patients, according to a report in the July 2013 issue of Hepatology. Read more.

Boston Patients Exposed to Virus Due to Lack of EHR Training
August 5 – Thirteen dialysis patients at Boston Medical Center were exposed to hepatitis B earlier this year when two nurses from an outside dialysis contractor failed to receive access to the hospital’s EHR system, which would have let them know that an infected patient had used equipment that was then shared with the victims. Read more

'Two-Thirds of Injections in India Unsafe’
August 5 – Two-thirds of injections being used in India are unsafe, posing health hazards such as hepatitis B, hepatitis C, and HIV. According to WHO, up to 40% of injections worldwide are given with syringes and needles reused without sterilization. Read more

WHO Urges Governments to Act on Hepatitis Threat
July 29 - WHO is urging governments to act against the five hepatitis viruses that can cause severe liver infections and leads to 1.4 million deaths every year. WHO also released its first-ever country hepatitis survey, covering 126 countries. Read more

Group Wants Law for Workers With Hepa B – Philippines
July 29 – A group of doctors called on lawmakers to pass a bill that will set clear-cut policies to protect workers who test positive with hepatitis B in the workplace in the Philippines. Read more.

Israel's SciVac Eyes Global Expansion of 3G Hepatitis B Vaccine
July 29 - Israeli drug company SciVac is seeking U.S. approval for a widely used hepatitis B vaccine as part of a push for increased global sales of a product, which it says could stem global growth in the disease. Read more

Film Fights the Scourge of Hep B
July 29 – An Australian-Vietnamese soap-opera drama uses comedy and drama to tackle hepatitis B taboos, debuted at Hoyts Wetherill Park, Australia. Read more

In Asia Pacific, One Death Every 30 Seconds From Viral Hepatitis
July 22 – The number of people dying from viral hepatitis has reached one million every year in the Asia Pacific Region, a death rate that is three times higher than HIV/AIDS. Read more

Many People Need Hepatitis B Treatment in Gambia
July 22 - About 8% of people tested through a community-based screening program in Gambia have hepatitis B, and about 8% of these have advanced liver disease and meet European criteria for antiviral therapy based on findings from PROLIFICA - Prevention of Liver Fibrosis and Liver Cancer in Africa, the first program aimed at testing, assessing, and treating chronic hepatitis B in West Africa. Read more.

Inequalities in the Treatment of Hepatitis Require EU Intervention
July 22 – Differences in prevention, detection and access to treatment of viral Hepatitis in different European Union member states are alarming. Read more

Hundreds Call Hepatitis Helpline
July 22 – Hundreds of people have been calling The Hepatitis Foundation of New Zealand following the launch of their “Can You Say Yes” hepatitis B campaign aimed at encouraging those at risk to be tested for hepatitis B. Read more

Cancer Among Asian Americans
July 15 – Liver cancer is a leading cause of death for Asian Americans, but few know chronic HBV is a risk factor. A new campaign, “Know Hepatitis B”, launched by the CDC and Hep B United aims to improve awareness, advocate for testing, and improve care, treatment and health outcomes by educating AAPI communities. Read more

Family Promise: Get Tested for Hepatitis B
July 15 – One in 12 Asian Americans has hepatitis B, but 2 in 3 don’t know they have it. Protect your family and get tested for hepatitis B. View the new CDC PSA.

Govt Steps Up Efforts in Fight Against Spread of Hepatitis
July 15 - Concerned about the high prevalence of hepatitis B, the Health Ministry will carry out nationwide screening tests for pregnant women this year to prevent further spread of the HBV, beginning in Jakarta. Read more

GLOMEF Intensifies Public Education on Hepatitis B
July 15 – The Global Media Foundation (GLOMEF), a human rights and anti-corruption media advocacy organization in Ghana has intensified public education on HBV, especially among the rural folk with much focus on market women and farmers. Read more

Recall of Possibly Tainted Hepatitis B Vaccine
July 8 – Pharmaceutical giant Merck & Co. voluntarily recalled a single lot of its hepatitis B vaccine due to the possibility of cracked vials, which may compromise sterility. Read more

Ancient Origin of Hepatitis B Viruses Revealed by DNA Fossils in Bird Genomes
July 8 – The hepatitis B virus originally infected birds back when the dinosaurs still roamed the planet, according to a newly published study of genomic bird DNA, a finding that may help improve human health outcomes. Read more

Intestine Bugs Could Be Key To Obesity-Cancer Link
July 8 – Researchers in Japan report that obese mice carry an altered gut flora, which is linked to an increase in the production of DNA-damaging acid that causes liver inflammation and cancer. Read more

Scientists Create ‘Human Liver’ From Stem Cells
July 8 – Scientists in Japan said they had grown human liver tissue from stem cells in a first that holds promise for alleviating the critical shortage of donor organs. Read more

New USPSTF Hepatitis C Testing Recommendation Hailed by NVHR
July 1 - U.S. Preventive Services Task Force (USPSTF) has released updated hepatitis C screening recommendations to test all people born from 1945 to 1965. Individuals born between these years have the highest rates of chronic infection and represent 75% of the more than 4 million cases of HCV in the U.S. Read more

Experts Warn of a Liver Cancer Time Bomb
July 1 - Increased diagnosis and treatment of people with hepatitis B is vital to prevent a liver cancer time bomb, experts warn. A liver cancer prevention policy launched by the Cancer Council on Monday calls for increased testing of groups at risk of hepatitis B, and notes that less than half of Australians affected are aware they carry the disease. Read more

Adherence To and Initiation of HBV Therapy Prove Problematic In Real-World Settings
July 1 - Mindie H. Nguyen, MD, of Stanford University School of Medicine presented two studies at DDW that found medical non-adherence can be a larger issue than antiviral resistance, and that many factors beyond patient noncompliance can contribute to this problem and lead to virologic breakthrough. Read more

Hepatitis B Total Rises to 18 in Investigation of North Charleston Center
July 1 – A total of 18 people have tested positive for HBV since the state health department launched an investigation into a North Charleston medical clinic since May. All the people involved received at least one injection from Tri-County Spinal Care Center, the health department said, because “several lapses in infection control procedures” were identified at the facility. Read more

Anti-HBV Vaccine Fails Against Chronic Hepatitis B
June 24 – A therapeutic vaccine candidate, aimed at breaking immune tolerance to the hepatitis B virus, failed in a recent trial, but the researchers believe the problem is that the adjuvant itself was too potent. Read more

Does HBV Suppression Prevent Liver Disease Progression?
June 24 – Chronic hepatitis B patients with cirrhosis may still experience liver disease progression even if they undergo antiviral treatment and achieve good virological response, according to a poster presented at the Digestive Disease Week 2013 meeting. Read more

More Patients Test Positive for Hepatitis in North Charleston Clinic Investigation
June 24 - Twelve patients of Tri-County Spinal Care Center have tested positive for hepatitis B, and the S.C. Department of Health and Environmental Control cannot determine when those individuals were infected. On May 17, DHEC notified the clinic of three patients who tested positive for hepatitis B after receiving invasive injections. Read more

Hep B United Partners with CDC on First-Ever Multilingual Hepatitis B Testing Campaign for AAPIs
June 17 – Hep B United joins the Centers for Disease Control and Prevention (CDC) in announcing the first-ever multilingual campaign for Asian Americans and Pacific Islanders (AAPIs), to increase testing for hepatitis B among this population across the United States. Read more

Scientists ID Gene Linked to Aggressive Liver Cancer
June 17 – Researchers have found a gene they say can help identify patients facing aggressive liver cancer, and may prove key to their future treatment. Read more

Bananas as Hepatitis B Oral Vaccine?
June 17 – Cornell researchers are currently considering bananas as a potential oral vaccine against the HBV virus in developing countries. Read more

Supreme Court's Human Gene Ruling Draws Local Interest
June 17 – HBF’s Dr. Timothy block weighs in on the recent Supreme Court ruling that human genes cannot be patented, and the impact on future research. Read more

Joint Agency Letter to Health–related Schools Regarding Hepatitis B Discrimination
June 13 - A historic letter on behalf of the Department of Justice, the Department of Health and Human Services, and the Department of Education has been issued regarding the participation of students with hepatitis B in health-related schools and programs. This letter emphasizes the importance of the updated CDC Recommendations and is a reminder of the institution's nondiscrimination obligations under the Americans with Disabilities Act. Read more

Eradication of Hepatitis B: A Nationwide Community Coalition Approach to Improving Vaccination, Screening, and Linkage to Care
June 10 - Hep B United, a national campaign to support and leverage the success of community-based HBV coalitions provides a strategic response to the HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Read more

Low Vitamin D Linked to Hepatitis B
June 10 – Vitamin D deficiency might be a key player in hepatitis B replication, researchers reported. Read more

Tenofovir and Entecavir Effectively Suppress Hepatitis B Virus
June 10 – The newer antivirals tenofovir and entecavir inhibit HBV replication more effectively than older agents, but good adherence is needed to maintain long-term viral suppression, according to a set of studies presented at the Digestive Disease Week meeting. Read more

160,000 Singaporeans Suffer From Hepatitis B, Chronic Hepatitis B
June 10 – Some 160,000 or 2.7% of Singapore’s population suffer from hepatitis B, where HBV is the most common cause of liver diseases and liver cancer as revealed at the Asian Pacific Association for the Study of Liver Week (APASL). Read more

Community Health Workers Help Increase Hepatitis B Screenings in the Asian American Population, Experts Say
June 3 – Great way to end Hepatitis Awareness Month with an update on community events that are getting more Asian Americans screened for hepatitis B. Read more

DHEC Digs Into 2 Years of Records in Hepatitis B Investigation
June 3 – The Department of Health and Environmental Control is now seeking to test as many as 500 people who visited a North Charleston spine clinic and received injections. Read more

Liver Cancer Rates a Wake-Up Call That It's Time to Address Liver Disease Epidemic
June 3 – New Canadian Cancer Statistics show that liver cancer is one of the fastest rising forms of cancer in Canada, and is a direct result of contributing liver diseases like hepatitis B and C and fatty liver disease not being identified and treated early enough. Read more

Cedar Rapids Man Gets Prison in False Hepatitis B Claim
June 3 – A Cedar Rapids man has been given prison time for posting false information on Facebook about a consumer product being tainted with Hepatitis B. Read more

AASLD Members at Forefront to Raise Awareness of Hepatitis B and C
May 28 – Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. The AASLD, NVHR, and other partners were pleased to participate with the Congressional Hepatitis Caucus to provide testing for hepatitis B and C and raise awareness at the US House of Representatives. Read more

Got a Fatty Liver? Here’s How to Beat the Flab
May 28 – Fatty liver, one of the causes of liver cancer, can be a scary diagnosis, but gastroenterologists say that with dietary changes and regular exercise, progression of liver damage can be prevented. Read more

Clinic 'Shocked' After 3 Patients Diagnosed With Hepatitis B
May 28 – A Charleston spinal care center is working with the S.C. Department of Health and Environmental Control after receiving the "shocking" news that 3 of its patients contracted hepatitis B after getting injections there. Read more

HHS Viral Hepatitis Action Plan Will Be Renewed
May 20 - The U.S. HHS National Viral Hepatitis Action Plan is celebrating its 2nd anniversary this year and Dr. Howard Koh, Assistant Secretary for Health of HSS, has announced that the partner agencies are committed and dedicated to renewing the Action Plan for another three years. The federal partners are currently working on their vision and priorities for 2014–2016. Read more

Hepatitis B Virus Linked with Non-Hodgkin’s Lymphoma
May 20 – Individuals with chronic hepatitis B virus infection may have an increased risk of developing non-Hodgkin’s lymphoma, according to findings recently published in The Lancet Oncology. Read more

NJ Recognizes May As National Hepatitis Awareness Month
May 20 – The New Jersey Department of Health, leader of an active HBV coalitions and Hep B United member, recognizes May as National Hepatitis Awareness Month. Read more

Bayer Begins Phase III Trial of Regorafenib in Patients with Hepatocellular Carcinoma
May 20 – Bayer HealthCare has started to enroll patients in an international phase III trial to evaluate the efficacy and safety of regorafenib for the treatment of patients with hepatocellular carcinoma who have progressed on sorafenib treatment. Read more

Eliminating Perinatal Transmission of Hepatitis B: More Than Just A Test
May 13 – Tackling and eliminating perinatal hepatitis B in the United States through the Viral Hepatitis Action Plan initiatives, vital partners and the implementation of provisions of the Affordable Care Act. Read more

Do Asian Patients Respond Better to Pegylated Interferon for Hepatitis B?
May 13 – Some Asian people with chronic hepatitis B treated with pegylated interferon may experience better outcomes on certain measures than Caucasians, though overall response rates are similar, according to a comparative analysis presented at the EASL International Liver Congress last month. Read more

Jennerex Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC)
May 13 – Jennerex's Pexa-Vec, an oncolytic immunotherapy designed to treat advanced HCC patients who have failed sorafenib, has received FDA orphan drug designation. Read more

Novel Tests Improve Diagnosis of Two Types of Liver Cancer
May 13 – New data from two clinical trials that were presented at the International Liver Congress 2013, demonstrated substantial improvements in the detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma using diagnostic urine tests. Read more

Health Providers With Hepatitis B Are No Threat to Patients, Covered By Disability Law
May 6 – New guidelines and the recent Department of Justice settlement are powerful tools to combat hepatitis B discrimination of medical professionals and students who are HBV carriers. Read more

May is Hepatitis Awareness Month
May 6 – May 1 marked the start of the month-long observance of Hepatitis Awareness Month. The observance is an important element of government-wide efforts to raise awareness about viral hepatitis and decrease health disparities by educating communities about the benefits of viral hepatitis prevention, testing, care, and treatment. Read more

Combo of 2 HIV Drugs Can Control Hepatitis B
May 6 – The HIV antiretrovirals Viread (tenofovir) and Emtriva (emtricitabine), which are typically combined as Truvada, can suppress the hepatitis B virus in three-quarters of those with “immune-tolerant” infection. Read more

Genetic Fossils Betray Hepatitis B's Ancient Roots
May 6 – A virus that causes liver diseases in people may have infected birds that shared the planet with dinosaurs. Read more

Five Reasons Asian Americans Should Get Tested for Hepatitis B
April 29 – More than 1 million Americans have a lifelong, or chronic, infection of hepatitis B. This includes one out of every 12 Asian Americans. If you or your parents were born in Asia or the Pacific Islands, the Centers for Disease Control and Prevention (CDC) recommends that you get tested for hepatitis B. Read more.

Health-Care Worker Visits Increase Hepatitis B Screening Rates for Hmong Americans
April 29 – Lay health workers increased screening rates for the hepatitis B virus and knowledge about the disease among a group of Asian Americans, known as the Hmong, UC Davis researchers have found in the first study of its kind. Read more.

Novel Therapeutic Approaches to Cure Chronic HBV Infection
April 29 – Exciting new data presented at the International Liver Congress 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for chronic hepatitis B virus infection. Read more.

New Drug Stimulates Immune System to Kill Infected Cells in Animal Model of Hepatitis B Infection
April 29 – A novel drug, GS–9620, developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells. Read more.

Dozens of Oklahoma Dentist’s Patients Positive for Hepatitis
April 22 - Dozens of patients of an Oklahoma dental clinic shuttered for unsanitary conditions have tested positive for hepatitis, according to a joint statement issued by Oklahoma State Department of Health and the Tulsa Health Department. Read more.

FDA Approves FibroScan® for Non-invasive Liver Diagnosis
April 22 - Echosens™ announces its FibroScan® device received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on April 5th, 2013 and is now ready to market its pioneering technology in the United States. Read more.

Liver Disease a Major Cause of Illness and Death Across the European Union: Action Needed to Save Lives
April 22 – Liver disease is the cause of a considerable burden of illness across the European Union (EU), investigators report in The Journal of Hepatology as a result of viral hepatitis, consumption of alcohol and fatty liver disease. Read more.

Interferon Induces Persistent Viral Infection, Suggests A New Approach To Clearing Infections From AIDS To Hepatitis
April 22 – Scientists at The Scripps Research Institute (TSRI) have made a counterintuitive finding that may lead to new ways to clear persistent infection that is the hallmark of such diseases as AIDS, hepatitis B and hepatitis C. Read more.

Public Health Response to Improper Infection Control at Tulsa Dentist Office
April 15 – As of April 11, there were 2,432 people who visited the Tulsa Health Department clinic to be screened for hepatitis B, hepatitis C and HIV following the recent announcement regarding the public health response to the improper infection control practices of Tulsa oral surgeon W. Scott Harrington. Read more.

Scientists Test Smallpox Vaccine as Cancer Killer
April 15 - Scientists at the University of California San Diego are conducting a multicenter clinical trial to see if genetically engineered smallpox virus can be used to fight liver cancer. Read more.

Australian Medical Association Calls for Mandatory Proof of Vaccination
April 15 – Parents who fail to vaccinate their children should face barriers to enrolling them in school and childcare centers, the Australian Medical Association says. Read more.

Tenofovir and 3TC Prevent New Hepatitis B Infections in Gay Men Living With HIV
April 8 – The inclusion of 3TC or tenofovir in antiretroviral treatment regimens reduces the risk of infection with hepatitis B virus (HBV) for gay men living with HIV who have not been vaccinated against HBV. Read more.

Liver Diseases Pose Major Problem in Future for Health Care Professionals: Report
April 8 – British Columbia (B.C.) needs more resources dedicated to the awareness, prevention and treatment of liver disease if it is to head off a brewing public health crisis, says one of the province’s leading liver specialists. B.C. has the third-highest rate of chronic hepatitis B infection in Canada. Read more.

He Battled Liver Cancer Thrice, and Won
April 8 – An amazing 52 year-old man is the recipient of a liver transplant, and has battled liver cancer three times in ten years as a result of a hepatitis B infection passed to him at birth from his mother. Read more.

Oklahoma Dental Patients May Have Been Exposed to HIV, Hepatitis B, Hepatitis C
April 1 – Health officials are urging 7,000 patients of an Oklahoma dentist to be tested for potential exposure to HIV, hepatitis B and hepatitis C. Read more.

New NIH Award Aims to Reduce Asian American Hepatitis B Disparities Through Health Information Technology
April 1 – A new grant award by the National Institute on Minority Health and Health Disparities of the NIH will support the development of new Health Information Technology (HIT) strategies by AAPCHO to increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander (AAPI) populations. Read more.

Drug 'May Reverse Liver Disease'
April 1 – A cheap and readily available drug could reverse severe liver disease, even in patients who find it impossible to give up alcohol, research suggests, and may provide an alternative to a liver transplant. Read more.

Chinese Airline Sued for Hepatitis B Discrimination During Recruitment
April 1 – In what is believed to be the first court case involving hepatitis B discrimination in China’s airline industry, charter flight operator, Capitol Airlines is being sued for refusing to employ a pilot because he had HBV. Read more.

Responding to Viral Hepatitis Through Health Reform
March 25 – NASTAD releases the primer on viral hepatitis and the Affordable Care Act (ACA) in light of the ACA’s anniversary. The ACA provides an opportunity to not only improve access to essential care and treatment for people living with viral hepatitis, but to diagnose viral hepatitis earlier and prevent new infections. Read more.

Hep B Poorly Managed in Kids, Pregnant Women
March 25 – Mother-to-child hepatitis B transmission continues despite vaccination and immunoglobulin administration and there is “scope for considerable improvement”, say Victorian experts. Read more.

Hepatitis B Treatment Named as Top-Selling Drug for Last Year
March 25 – A pharmaceutical for the treatment of chronic hepatitis B was the top-selling drug in Taiwan last year, taking the top by replacing a drug tackling high blood pressure. Read more.

Soybean Meal Peptides Could Stop Colon, Liver and Lung Cancer Growth
March 25 – The bean used to make tofu could also have powerful anti-cancer properties, according to a new study published in the Journal Food Research International. Read more.

Listen to Hepatitis B and Liver Cancer by Dr. Robert G. Gish
Download March 6th Webinar

School Cheers as Student Donates Liver to His Dad
March 18 – A Taipei high school student puts his education on hold so he can donate part of his liver to his father, a hepatitis B carrier with cirrhosis. Read more.

Arrowhead RNAi Candidate ARC-520 Induces Greater than 90% Reduction in Circulating HBV DNA in Chimpanzee with Chronic Hepatitis B
March 18 – Arrowhead Research Corporation, a targeted therapeutics company, announced that a study of its RNAi-based candidate ARC-520 in a chimpanzee chronically infected with the human hepatitis B virus supports findings from rodent models indicating that it can knock down HBV DNA and key viral antigens. Read more.

PEG-IFN May Improve Response to Entecavir for HBV
March 11 – Adding pegylated interferon alfa-2a to entecavir increases treatment response in patients with chronic hepatitis B virus infection who are HBeAg positive, according to preliminary results from an international clinical trial. Read more.

Pennsylvania Biotech Center, Created by Hepatitis B Foundation Has Huge Economic Impact
March 8, 2013 - The PA Biotechnology Center, created by the Hepatitis B Foundation, has generated $579 million for the region and state, and 573 jobs over the past 4 years, according to the Economic Impact Study 2013, released by Byler Associates. View Video.

Justice Department Settles with the University of Medicine and Dentistry of New Jersey Over Discrimination Against People with Hepatitis B
March 5 – The U.S. Justice Department has reached a settlement with the University of Medicine and Dentistry of New Jersey that resolves complaints that some applicants were unlawfully excluded because they have hepatitis B. Under the settlement, UMDNJ will adopt a disability rights policy and allow the applicants to enroll. The Hepatitis B Foundation is proud to have played a role in successfully advocating for these students. Read more.

Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus
March 4 – Drug developer Arrowhead Research Corp. released data demonstrating its RNAi-based candidate ARC-520 has the potential to treat chronic hepatitis B in a fundamentally different manner, with the goal of finding a functional cure. Read more.

Exposure to Hepatitis B Virus Activates Immunity in Young People, Suggesting Benefits for Earlier Treatment
March 4 – New research indicates therapeutic interventions currently withheld from younger patients with so-called ‘immune tolerance’ to hepatitis B, may in fact benefit from earlier treatment. Read more.

Tenofovir Plus Emtricitabine or Lamivudine Does Not Always Suppress Hepatitis B in HIV/HBV Coinfected
March 4 – HIV/HBV coinfected people with high hepatitis B virus levels and those who are HBeAg positive are at greater risk of not achieving HBV suppression after a year on tenofovir plus emtricitabine or lamivudine, but most did so eventually, as reported in AIDS. Read more.

Antioxidant N-acetlycystein Improves Survival of Transplanted Liver
March 4 – N-acetylcysteine (NAC) administered during recovery of a liver from a deceased donor can help reduce damage during transplantation and increase survival of the liver graft in the recipient, according to a study published in Liver Transplantation. Read more.

Considerable Proportion of HBV/HCV Cases Go Unreported
Feb 25 – Reporting of chronic hepatitis B virus and hepatitis C virus infections is improving, but is still incomplete, according to research published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. Read more.

Dynavax Slides as FDA Rejects Adult Hepatitis B Vaccine
Feb 25 – U.S. health regulators denied approval for Dynavax Technologies Inc's adult hepatitis B vaccine and sought additional data to evaluate its safety, delaying the market entry of a faster-acting and less frequently needed vaccine for the liver-attacking infection. Read more.

Combining Tenofovir With FTC or 3TC Boosts Chances of HBV Suppression for People Co-Infected with HIV
Feb 25 – A study involving people co-infected with HIV and hepatitis B virus shows that antiretroviral therapy that combines tenofovir with FTC or 3TC has the best chance of suppressing HBV replication to undetectable level. Read more.

Publication of First Comprehensive Literature Review on the Burden of Liver Disease in Europe
Feb 25 – The European Association for the Study of the Liver (EASL) has unveiled its new publication “The burden of liver disease in Europe” a review of available epidemiological data, which suggests the leading causes of cirrhosis and primary liver cancer. Read more.

Chronic hepatitis B: What Should Be the Goal for New Therapies?
Feb 17 – Chronic hepatitis B can be medically managed with current therapies, but not reliably “cured”. Should the goals for new therapies and potential cures be redefined? Dr. Timothy Block, HBF President and Drexel University Professor, and co-authors offer clarification in Antiviral Research. Read more.

Chronic Viral Hepatitis in Cancer Patients Requires Personalized Management
Feb 17 – The likelihood of HBV reactivation during cancer treatment has led some oncologists to advocate for more thorough and standardized HBV screening guidelines. What decisions are being made regarding a patient’s need for antiviral therapy and the duration of such therapy? Read more.

Sounding the Alarm on a Silent Epidemic: Federal HIV/STD Advisory Group Adopts Viral Hepatitis as Priority
Feb 18 – In support of enhanced cross-government efforts to address the prevention, care and treatment of viral hepatitis, a federal advisory body on HIV and STDs recently expanded its scope and title to include viral hepatitis. Read more.

U.S. Court Invalidates Patent on Bristol Hepatitis B Drug
Feb 18 – A U.S. federal court has invalidated the U.S. patent on Bristol-Myers Squibb Company’s Baraclude treatment for hepatitis B after a challenge from generic drug maker Teva Pharmaceutical Industries. Read more.

Saint Louis University Research Aims Knockout Punch at Hepatitis B
Feb 11 – Saint Louis University investigators together with collaborators from the University of Missouri and the University of Pittsburgh report a breakthrough in the pursuit of new hepatitis B drugs that could help cure the virus. Researchers were able to measure and then block a previously unstudied enzyme to stop the virus from replicating. Read more.

Modified Smallpox Vaccine Stymies Liver Cancer in Study
Feb 11 – A genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival more than a year, a study found. Read more.

HIV Associated With Nonresponse to HBV Vaccine
Feb 11 – The response of adults with HIV to hepatitis B virus vaccination was investigated by researchers from the University of Washington and Kenyatta National Hospital in Kenya, and may provide best practices for re-vaccination of those with HIV infection that do not respond to the HBV vaccine. Read more.

One-Third Cases of Hepatitis B, C Preventable
Feb 11 – A recent study shows about one-third of the hepatitis B and C cases in Pakistan can be prevented by interventions directed towards a few selected and modifiable risk factors. Read more.

Chronic Hepatitis Cohort Study Sheds Light on Burden of Hepatitis B and C in U.S.
Feb 4 – People born between 1945 and 1964 account for the highest proportion of hepatitis B and C cases, and these viruses are a significant cause of illness and death, according to an analysis described in Clinical Infectious Diseases. Read more.

Medgenics Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment
Feb 4 – The first phase I/II study of INFRADURE, a subcutaneous autologous skin tissue implant for continuous production and delivery of interferon to treat HBV, HCV and HDV is underway, with the aim to replace months of weekly injections of interferon and associated serious side effects. Read more.

Celsion's Experimental Liver Cancer Treatment Fails in Late-Stage Trial
Feb 4 – Celsion Corporation announced its experimental liver cancer treatment, Thermo-Dox in combination with radio frequency ablation, failed to demonstrate significant progression free survival for patients with hepatocelluar carcinoma. Read more.

Government Commissions Research on Hepatitis B In Rwanda
Feb 4 – Rwanda’s Ministry of Health is conducting research to establish the prevalence of hepatitis B in the country. Read more.

NIH Awards AAPCHO Over $700,000 to Study Impact of Health Information Technology on Asian Americans Living With Viral Hepatitis
Jan 28 – The Association of Asian Pacific Community Health Organizations (AAPCHO) received a 3-year grant totaling over $700,000 from the NIH to develop new Health Information Technology strategies that increase screening for chronic hepatitis B and reduce the impact of HBV among high-risk Asian American and Pacific Islander populations. Read more.

Hepatitis B Genotype C Linked to Increased Hepatoma Risk
Jan 28 – Of all the major hepatitis B virus genotypes, genotype C carries the highest risk for hepatocellular carcinoma, Chinese researchers say. Read more.

Heavy Alcohol Use Increases Liver Cancer Risk for People With Hepatitis B
Jan 28 – Hepatitis B patients with liver cirrhosis who consumed large amounts of alcohol were more likely to develop hepatocellular carcinoma (HCC) than people who drank less, according to a report in the December edition of Hepatology. Read more.

Co-Infection With Hepatitis B or C is a Risk Factor for Reduced Bone Mineral Density Among Women With HIV
Jan 28 – After comparing bone mineral density between people with HIV infection alone and people with chronic viral hepatitis co-infection, a study published in the Journal of Acquired Immune Deficiency Syndromes found woman coinfected with hepatitis B or C and HIV had reduced bone mineral density. Read more.

Liver Disease Is Leading Cause of Death for People with Chronic Hepatitis B
Jan 21 – Advanced liver disease caused by hepatitis B virus, – including hepatocellular carcinoma and decompensated cirrhosis – accounted for more than 40% of deaths of people with chronic HBV in a large health maintenance organization, researchers reported in Hepatology. Read more.

Health Care-Related Exposure Linked to HCV, HBV Infection in Older Adults
Jan 21 – Older patients who received healthcare had increased risk of becoming infected with hepatitis B or hepatitis C. Patients' behavioral risks — being in jail, using "non-injected illicit drugs," or having sex with hepatitis-infected partners or with multiple partners — had no relation to this increased risk. Read more.

Mercer Counters High Hep B Numbers With Free Vaccinations
Jan 21 – West Virginia has the highest rate of Hepatitis B in the U.S., with Mercer County rates higher than both the state and national rates. Read more.

Viruses Prompt Oncogenic Transformation By Genetically Altering Infected Cells As Seen In Hepatitis B
Jan 21 – MiR–148a is repressed by hepatitis B virus X protein (HBx) to promote the growth and metastasis of liver cancer, as reported in the Journal of Clinical Investigation. Read more.

NIH Scientists Shed Light on Mystery Surrounding Hepatitis B Virus
Jan 14 – Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing enigma about the structure of a protein related to the Hepatitis B virus were reported in Structure, and may lead to new therapeutic strategies for chronic liver disease. Read more.

Adolescents May Lose Hepatitis B Virus Protection Despite Vaccination as Infants
Jan 14 – New research presented in Hepatology reveals that a significant number of adolescents lose their protection from hepatitis B virus infection despite having received a complete vaccination series as infants. Read more.

716 Patients at VA May Have Been Exposed to HIV, Hepatitis
Jan 14 – More than 700 patients at the Buffalo VA Medical Center may have been exposed to HIV, hepatitis B or hepatitis C because of the inadvertent reuse of insulin pens intended to be used only once. Read more.

Hepatitis B treatment and Care in the UK Need to Evolve to Keep Pace With the Global Epidemic
Jan 14 – “Persistent HBV infection has changed its face in the UK,” research published in the online edition of Clinical Infectious Diseases shows. The study found considerable diversity in viral genotype and patient ethnicity, and that only one in three patients were taking therapy. Read more.

Most Hepatitis B Patients Who Respond to Tenofovir Show Improved Liver Health at 5 Years
Jan 7 – Treatment with tenofovir remains safe and effective over 5 years, and people who achieve sustained viral load suppression experience improvement in liver histology, including regression of fibrosis and cirrhosis, according to study findings described in The Lancet. Read more.

Treatment of HBeAg Positive Chronic Hepatitis B: Interferon or Nucleoside Analogues
Jan 7 – A review of clinical aspects of the management of chronic HBV with either interferon or nucleoside analogues are featured in Liver International, proceedings of 6th Paris Hepatitis Conference, International Conference on the Management of Patients with Viral Hepatitis. Read more.

Hepatitis B Vaccine 95% Effective in Reducing Cancer, Other Ailments
Jan 7 – A medical practitioner based in Abuja, Abiodun Ajayi, has called on Nigerians to adhere to WHO’s recommendation of Hepatitis B vaccination to prevent acute and chronic HBV and liver cancer cases. Read more.

2012 News

Long Term Antiviral Hepatitis B Treatment Advocated
Dec 24 – Study results published in TheLancet support the long-term use of tenofovir for chronic hepatitis B virus, showing that it can suppress the virus and lead to regression of fibrosis and cirrhosis in patients after 5 years' treatment. Read more.

Entecavir Shows Good Efficacy for Black and Hispanic Hepatitis B Patients
Dec 24 – The nucleoside analog entecavir worked as well for previously untreated African-American and Hispanic/Latino hepatitis B patients as it did for the majority white and Asian study populations in prior clinical trials, according to a poster presented at the AASLD Meeting last month. Read more.

Doc Infects Patients With Hepatitis B During Surgery
Dec 24 - A doctor with hepatitis B who preformed joint replacement surgeries unknowingly passed the virus on to at least two of his patients, according to a new report. Read more.

Adding Pegylated Interferon to Entecavir Improves HBV Treatment Response
Dec 17 - Intensifying entecavir treatment for hepatitis B by adding pegylated interferon lowers HBV viral load and increases the likelihood of hepatitis B "e" antigen loss, according to a report at the 2012 American Association for the Study of Liver Meeting. Read more.

HBV Screening Hit or Miss in Rituximab Users
Dec 17 – At least in one academic medical center, half of cancer patients on rituximab (Rituxan) were not screened for hepatitis B virus infection as recommended. Read more.

Doctor Making a Difference in the Fight Against Hepatitis B
Dec 17 – Inspiring story of Dr. Loc T. Le who overcame tremendous odds to become a successful medical doctor and teacher. Dr. Le is a passionate HBV expert and advocate and is now the chairman of the National Task Force on Hepatitis B. Read more. Read more.

Focus on Hepatitis in Togo
Dec 17 – The spread of viral hepatitis in Togo, where there is little awareness of the disease and most people discover by chance that they are infected, is causing concern, says the Save Africa from Hepatitis Society (ASADH), which is working with the Health Ministry to combat the disease. Read more.

Adult Antiviral Drug Effective in Suppressing Hepatitis B in Teens
Dec 10 – A recent clinical trial found that the adult antiviral drug, tenofovir, is safe and effective in treating adolescents with hepatitis B virus. Trial results published in the December issue of Hepatology, show that tenofovir DF suppressed HBV in 89% of pediatric participants. Read more.

A Killer on the Rise: FGM Blamed for Hepatitis B ‘Yellow Jaundice’ Deaths in Liberia
Dec 10 – The practice of Female Genital Mutilation (FGM), practiced prior to civil war in 1989, is one of the major factors responsible for the transmission of hepatitis B in the women of Liberia. Read more.

China Labor Force Issues: Hepatitis B Virus and Infectious Diseases
Dec 10 – An interesting look at hepatitis B discrimination in the Chinese work force, where “legally speaking it is not proper to discriminate against HBV carrier applicants for employment”. Read more.

Do Not Mix Hepatitis B Drug Adefovir With Stribild HIV Combo Pill
Dec 10 – The FDA has announced an update to the label information for adefovir (Hepsera), adding the 4-in-1 antiretroviral combination pill Stribild (elvitegravir/cobicistat/tenofovir/emtricitabine) to the list of other products that should not be co-administered with adefovir. Read more.

Painkillers May Protect Liver
Dec 3 – Non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin, may help prevent liver cancer, a large observational study suggested, though there is a concern with the risk for bleeding. Read more.

Nucleoside Analogs Reduce Hepatitis B Liver Cancer Risk, Cirrhosis Remains a Concern
Dec 3 - Treatment of chronic hepatitis B with nucleoside/nucleotide analogs can reduce the risk of developing hepatocellular carcinoma, but there are caveats according to studies presented at AASLD 2012. Read more.

European Commission Approves Viread for Hepatitis B in Adolescents and for HIV-1 in Children and Adolescents
Dec 3 – Viread (tenofovir) is now approved for the treatment of chronic hepatitis B virus infection in adolescent patients aged 12 to less than 18 years with compensated liver disease and evidence of immune active disease in Europe. Read more.

Gene May Hold Key to Controlling Hepatitis, HIV and Tuberculosis
Dec 3 – The gene Arih2, fundamental to the function of the immune system, may hold the key to treating and potentially controlling chronic infections such as hepatitis B, HIV and TB, according to authors of a new study published in the journal Nature Immunology. Read more.

Tenofovir Safe for Long-term Hepatitis B Treatment with Little Bone Loss
Nov 26 - Two studies show that tenofovir continues to be safe and highly effective for treating chronic HBV through 8 years of follow-up and that there is minimal bone loss among tenofovir–treated patients using the FRAX method. Read more.

Hepatitis B Vaccination Campaign For Newborns Shows Promise
Nov 26 – A hepatitis B vaccination program in Australia for Aboriginal newborns in the country’s Northern Territory significantly reduced the infection rate of the deadly disease, according to researchers at the University of New South Wales. Read more.

Smallpox Vaccine Kills Liver Cancer
Nov 26 – A global team of scientists led by Bay Area doctors is studying an unusual new technique - involving, in part, injecting a genetically engineered smallpox vaccine directly into tumors - that they hope will prolong the lives of patients with untreatable liver cancer. Read more.

FDA Panel Backs Dynavax’s Hep B Vaccine Efficacy, But Not Safety
Nov 19 – A U.S. Food and Drug Administration panel voted unanimously to recommend the effectiveness of Dynavax Inc's hepatitis B vaccine Heplisav, but raised concerns about its safety, asking for more data from studies on a wider population. Read more.

International Liver Research Community United Behind World Gastroenterology Organisation Action
Nov 19 – The World Gastroenterology Organisation declared hepatocellular carcinoma to be the major health issue on which it will focus in 2013. HCC is the number five cause of death worldwide and the number three cause of cancer deaths worldwide. Read more.

Scientists Determine How Hepatitis B&D Enter Liver Cell
Nov 19 – Scientists have filled a major gap in our understanding of hepatitis B and D by identifying the receptor that allows HBV and HDV to enter human liver cells, which may aid in the development of new therapies and treatments. Read more.

Antiviral Therapy May Cut Recurrence of Hepatitis B-Linked Liver Cancer
Nov 19 – People with liver cancer tied to infection with the hepatitis B virus who got antiviral therapy after cancer surgery had a lower risk of tumor recurrence than those who did not get it, according to a new study. Read more.

GI-13020 TarmogenR for the Treatment of Chronic Hepatitis B Generates Antigen Specific T Cell Responses
Nov 12 – GI-13020, an investigational therapeutic vaccine for the treatment of chronic HBV demonstrated immunogenicity in two key preclinical studies. Does the opportunity exist to increase HBV surface antigen serconversion rates with the use of this vaccine? Read more.

Antiviral Therapy Safe and Effective for Hep B Patients With Advanced Cirrhosis
Nov 12 - Antiviral drugs including entecavir, lamivudine, telbivudine, and tenofovir are generally well-tolerated and effective against hepatitis B virus in people with liver cirrhosis, and may lower mortality even among patients with severe decompensated cirrhosis, according to two recently published studies. Read more.

Inovio Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV
Nov 12 – Invovio’s synthetic therapeutic HBV vaccine generated strong T cell responses that eliminated targeted liver cells in mice. Will this new therapeutic HBV vaccine have the potential to clear hepatitis B in the liver and prevent liver cancer in humans? Read more.

New Cohort Shows the Impact of Hepatitis B and Hepatitis C on the ‘Baby Boom’ Generation
Nov 12 - A new US study provides more evidence of the disproportionate impact of viral hepatitis infections on the 'baby boom' generation, with more than half of HBV infections among patients born between 1945 and 1964. Read more.

Registry Data Shows Hepatitis B Medications Appear Safe During Pregnancy
Nov 5 – An analysis of data from the Antiretroviral Pregnancy Registry found no evidence that pregnant women's use of drugs to treat chronic hepatitis B, including lamivudine and tenofovir, is associated with birth defects. Read more.

Human-Like Mice Livers Enhance Drug Development
Nov 5 – A new bioengineering technique that substitutes human liver cells in place of mice liver cells may allow researchers to develop more effective drugs prior to clinical trials. Read more.

Cancer Breath Test: Medicine’s Next Big Thing
Nov 5 – “Each breath you take says a lot about your health”, and may be used to diagnose and stage liver and other cancers in the future. Read more and view the video.

Hepatitis E Vaccine Debuts
Nov 5 – Batches of the world’s first vaccine against the hepatitis E virus began rolling out of a Chinese factory last week, promising to stem a disease that every year infects about 20 million people and claims 70,000 lives. Read more.

Hepatitis B Patients With HBeAg Seroconversion on Treatment May Not Have Durable Response
Oct 29 – People with chronic hepatitis B virus who achieve hepatitis B "e" antigen (HBeAg) seroconversion when treated with nucleoside/nucleotide analogs are more likely to experience HBeAg seroreversion and HBV reactivation than those with natural clearance, according to a study described in the Journal of Infectious Diseases. Read more.

Mongolia Reached Regional Goal on Hepatitis B Control
Oct 29 – Despite alarming statistics estimating hepatitis B infection of more than 77% of the population at some time in their life, Mongolia has achieved the Regional goal for hepatitis B control, verified by the WHO Regional Verification Committee. Read more.

Few HCV/HBV Infections Identified in Adults With Access to Care
Oct 29 – Despite improved access to care through health care organizations, more aggressive policies for hepatitis B and C testing are needed to identify those infected, according to recent data. Read more.

Primary Care Physicians Miss Hepatitis Vaccine Targets
Oct 29 – Primary care physicians are failing to meet guidelines for hepatitis A and hepatitis B vaccination in patients with chronic hepatitis C infection, according to US research, which suggests there are substantial gaps in knowledge about the need for vaccination. Read more.

CU-Bolder Discoveries Hold Promise for Treatment of Hepatitis B Virus
Oct 23 – After three decades of searching, a University of Colorado Boulder-led team has discovered two prime targets of the hepatitis B virus, which may lead to new drug treatments for those infected with HBV. Read more.

Common Medical Screen Predicts Liver Cancer in General Population
Oct 23 – ALT and AST enzyme levels in the blood routinely monitored by physicians are also the best predictor of liver cancer risk for the general population, a team of scientists in Taiwan and The University of Texas MD Anderson Cancer Center reported in the Journal of the National Cancer Institute. Read more.

New Hepatitis B Vaccine Induces Higher Seroprotection Rates Than Engerix-B
Oct 23 – Two doses of the investigational hepatitis B vaccine, Hepislav, administered over 4 weeks induced significantly higher rates of and earlier seroprotection than Engerix-B given as 3 doses over 24 weeks based on results of two pivotal Phase 3 trials. Read more.

Vietnam, US Cooperate in Preventing Viral Hepatitis
Oct 23 – The San Francisco-Ho Chi Minh City Sister City Committee and HCMC University of Medicine and Pharmacy signed a memorandum of understanding (MoU) on cooperation to foster activities for prevention and control of liver diseases in Vietnam, where as many as 8 million people among a population of 85 million are believed to be infected with hepatitis B and C. Read more.

Statins Could be First Preventive Treatment for Liver Cancer
Oct 15 – Statins may reduce the risk for hepatocellular carcinoma, particularly in Asian versus Western patients, shows the results of a meta-analysis. Read more.

Study Reveals Prehistoric Journey of Hepatitis B
Oct 15 – A new study has revealed how the spread of hepatitis B coincides with dates of human migration throughout history, and how it could provide a framework for studying the ongoing burden and evolution of the hepatitis B virus. Read more.

Indonesia in Bold Move to Obtain Cheap Drugs for HIV and Hepatitis B
Oct 15 – The Indonesian government has quietly made an order that overrides Big Pharma's patents on seven important drugs for HIV and hepatitis B, allowing local drug companies to make cheap and affordable versions for its citizens. Read more.

Early Results Show Promise for Stem Cells in Treating Chronic Liver Failure
Oct 15 – Stem cell transfusions may someday replace the need for transplants in patients who suffer from liver failure caused by hepatitis B, according to a new study out of Beijing. Read more.

Adefovir Resistant Hepatitis B Virus Can Remain Susceptible to Tenofovir
Oct 8 – Tenofovir continues to be effective for treating chronic hepatitis B patients who have developed resistance to the related drug adefovir according to a report in the August 14, 2012 online edition of Antiviral Therapy. Read more.

26 And Already Had Two Liver Transplants
Oct 8 – An inspiring story of a 26 year-old Hispanic man, who fought for his second liver transplant after years in-and-out of hospitals due to his hepatitis B infection contracted at birth. Read more.

Life Depends on the Liver
Oct 8 – Although it is estimated that 1 in 10 in Hong Kong carry the hepatitis B virus, and liver cancer is one of the top three killers, many fail to understand the gravity of the situation, a recent survey found. Read more.

Follow-Up Lacking for Babies After Hepatitis B Vaccination: CDC
Oct 1 – Many U.S. babies born to mothers infected with hepatitis B do not receive recommended follow-up testing after vaccination, to ensure the vaccine blocked mother-to-child transmission, a new study finds. Read more.

Positive Hepatitis B Surface Antigen Tests Due to Recent Vaccination: A Persistent Problem
Oct 1 – Vaccination for HBV can produce transiently detectable levels of HBsAg in patients, though it appears unlikely to persist beyond 14 days post-vaccination. Read more.

Tenofovir is Safe and Effective For Treating Adolescents with Hepatitis B
Oct 1 – Teenagers with chronic hepatitis B virus infection responded well to 2 years of treatment with tenofovir in the first study of the drug in this population. Read more.

Countries in Western Pacific Region to Meet Hepatitis B Control Target
Oct 1 – The World Health Organization (WHO) Regional Director for the Western Pacific Shin Young-soo said that at least 30 countries and areas in the region will likely reach the target of reducing the prevalence of hepatitis B infection to less than 2 percent among children of at least 5 years old by 2012. Read more.

The Faces of HBV in America
Sept 24 – “With the number of new [HBV] infections remaining steady despite the availability of a vaccine, and the significant rise of primary liver cancer in the USA, it is imperative that hepatitis B be prioritized as an important public health concern,” according to a published statement from the Hepatitis B Foundation. The opportunity exists to reduce the prevalence of chronic HBV in the US with more rigorous screening and vaccination, particularly in certain groups that are well defined. Read more.

First Low-Cost, Paper-Based, Point Of Care Liver Function Test
Sept 24 – A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics For All (DFA), a vital diagnostic for developing countries. Read more.

Switching to Tenofovir Suppresses Hepatitis B in HIV/HBV Co-infected People
Sept 24 – People with HIV and hepatitis B virus co-infection, who substituted tenofovir for zidovudine (Retrovir) or abacavir (Ziagen) in their antiretroviral regimen, saw a reduction in hepatitis B viral load despite HBV being resistant to lamivudine, according to a poster presented at ICAAC 2012. Read more.

Sydney’s Hep B Hotspot Reveals Cancer Secret
Sept 24 – Liver cancer is estimated to soar in the next decade, particularly in migrant populations living in Sydney. Meet Oliver, a Chinese–Australian, and a lucky liver transplant recipient and liver cancer survivor. Read more.

ICAAC 2012: Hepatitis B Vaccine Effective Long-term, but Some Lose Protection After 15 Years
Sept 17 – Nearly all children who received 3 doses of the Engerix-B hepatitis B vaccine achieved protective immunity, but about 20% fell below the protective antibody threshold by year 15 and could benefit from a booster shot, Canadian researchers reported at ICAAC 2012. Read more.

China Ready to Expand Collaboration With GAVI
Sept 17 –The expansion of China’s collaborative efforts with the GAVI Alliance by sponsoring and engaging in multilateral aid efforts in the public health sector were discussed in meetings between GAVI CEO Dr. Seth Berkley, and China’s Health Minster. China has had a successful hepatitis B vaccination campaign, and it is hoped they will be able to produce and distribute affordable, life-saving vaccine in sufficient quantities so children throughout Africa and Asia may benefit. Read more.

Report: Exercise is Good For Your Liver
Sept 17 – Regular exercise and eating a nutritious, balanced diet is extremely important to the health of your liver, and now a study indicates it is important in terms of the progression of liver cancer. Read more.

Earlier Treatment for Young Patients with Chronic Hepatitis B More Effective in Clearing Virus
Sept 10 – Contrary to current belief, children and young patients with chronic hepatitis B, do have a protective immune response and may be more suitable candidates for treatment than previously considered. Read more.

Hepatitis B Rates Higher Than Expected Among Gay Men, Drug Users, Vaccinated Babies
Sept 10 – An unexpectedly high proportion of gay/bisexual men and injection drug users develop chronic hepatitis B rather than clearing the infection, reported in the Journal of Hepatology. Other recent studies found that more than one-quarter of children born to mothers with hepatitis B showed evidence of "occult" HBV infection despite vaccination at birth, and that some individuals vaccinated as children may still show evidence of infection as adults. Read more.

Hepatitis Epidemic Must be Tackled to Stop Liver Cancer Cases Doubling
Sept 10 – Liver cancer experts at the Australasian Viral Hepatitis Conference in New Zealand are urging Australian and New Zealand governments and health professionals to set new targets for the number of people receiving treatment for hepatitis B and C, which are largely responsible for the soaring liver cancer rates in both countries. Read more.

Entecavir/Tenofovir May Benefit Chronic HBV Patients With Higher DNA Levels
Sept 10 – Therapy with entecavir and tenofovir was similarly as effective as entecavir alone in patients with chronic HBV, but improved response among hepatitis B e antigen-positive patients with higher baseline HBV DNA levels. Read more.

Hepatitis B: Deadlier Than Ever
Sept 4 – Hepatitis B is “on a silent rampage in the Philippines” where 60% of the population has been infected with HBV and 10% are chronically infected. The Hepatitis B Foundation was cited as an expert resource addressing global hepatitis B. Read more.

Tenofovir Hepatitis B Label Update Adds Info on Kids, Longer-term Data for Adults
Sept 4 – The U.S. Food and Drug Administration announced that product label information for tenofovir (Viread) has been revised to include further information about treatment of chronic hepatitis B in teenagers and 240-week data for adult patients. Read more.

Kindergartens Refuse Hepatitis B Carriers
Sept 4 - More than 30 percent of China's kindergartens refuse to enroll children who are infected with the hepatitis B virus, according to Beijing Yirenping Center report released last week. Read more.

R. Palmer Beasley, Expert on Hepatitis B, Dies at 76
Aug 27 – Dr. R. Palmer Beasley, an epidemiologist who discovered hepatitis B is easily transmitted from infected mother to baby during childbirth, confirmed the role of HBV in causing liver cancer, and who saved millions by helping to persuade WHO to include the hepatitis B vaccine in its global recommendations for immunizations, has passed away. Read more.

Novel Treatment for Hepatitis B, HIV Raises $23M
Aug 27 – Novira Therapeutics, a biotechnology company with a novel drug treatment for hepatitis B and HIV patients, could change the way drugs combat viruses, and potentially lead to better cure rates through the development of capsid–targeting antivirals. Read more.

AIDS 2012: HIV/HBV Coinfection Linked to Higher Mortality, More ART Liver Toxicity
Aug 27 – Approximately 6% of people with HIV receiving antiretroviral treatment in Tanzania were coinfected with hepatitis B, which was associated with an elevated risk of death, smaller CD4 T–cell gains and greater likelihood of liver toxicity. Read more.

CDC Now Recommends All Baby Boomers Receive One–Time Hepatitis C Test
Aug 20 – CDC estimates one–time hepatitis C testing of baby boomers could identify more than 800,000 additional people with hepatitis C, and will avert major increases in liver related disease and deaths in the U.S. Read more.

Hepatitis B – What’s New On the HBV Vaccine Watch?
Aug 20 – Dr. Timothy Block from the Hepatitis B Foundation spoke about the prevention of Hepatitis B and the unmet needs in terms of both prevention and treatment of the disease at the World Vaccine Congress 2012. Read more.

Unsafe Injection, Bane of Health Care Systems
Aug 20 – Many of the 20 billion injections given annually, around the world, may be unnecessary and unsafe. Unsafe injection practices are a powerful engine to transmit blood–borne pathogens such as HBV, HCV and HIV, and may lead to disease, disability and death. Read more.

Ten Years of Hepatitis A Protection
Aug 20 – The hepatitis A vaccine remains effective for 10 years in children, according to a recent study conducted by the Centers for Disease Control in the Division of Viral Hepatitis, and published in Hepatology. Read more.

New Drug Successfully Halts Fibrosis in Animal Model of Liver Disease
Aug 13 – A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease such as hepatitis B. Read more.

A New Mexico Experiment Aims to Fix the Doctor Shortage – No New Doctors Required
Aug 13 – Project ECHO is an innovative way to manage health conditions like hepatitis C in a primary care setting, thereby increase the capacity of the current health care system without adding personnel. Read more.

Yiren Ping: Strong Condemnation to the Forceful Blockage of the Most Popular Hep B Patient Rights Website in China Just Before World Hepatitis Day
Aug 13 – After technical testing, it was determined that the popular website for people living with HBV is being blocked in mainland China by the authority of Great Fire Wall in China. Read more.

Sleep and Antibody Response to Hepatitis B Vaccination
Aug. 6 – People who regularly get more than seven hours of sleep a night are more likely to respond to vaccination against hepatitis B compared to those who get in less than six hours, according to new research. Read more.

CAPAC Marks Fifth Annual World Hepatitis Day
Aug. 6 – Members of the Congressional Asian Pacific American Caucus (CAPAC) showed their support of World Hepatitis Day by encouraging communities and governments around the world to work together against the “silent killer,” and discussed disparities among the AAPI communities in the United States. Read more.

Intern With Hep B Fights Back
Aug. 6 – Despite the People's Republic of China Employment Promotion Act, which came into effect on January 1, 2012, discrimination against those infected with hepatitis B continues, resulting in loss of employment. Read more.

Lifesaving Organ Donations are a Special Need in Asian Community
Aug. 6 – Asian Americans are reminded to help others in the API community by considering the donation of lifesaving organs and tissues, since diseases like hepatitis B disproportionately affect Asians, and may result in the need for liver transplantation. Read more.

Presidential Proclamation -- World Hepatitis Day, 2012
July 30 – President Obama rededicated the commitment of his Administration to viral hepatitis by signing a Presidential Proclamation in honor of World Hepatitis Day, 2012. President Obama encouraged citizens, Government agencies, nonprofit organizations, and communities across the Nation to join in activities that will increase awareness about hepatitis and what we can do to prevent it. Read more.

Foreign Media Disclose Hepatitis Numbers On World Hepatitis Day 2012
July 30 – With the observation of World Hepatitis Day 2012 on Saturday, July 28, media outlets globally wrote about the incredibly large numbers of people infected with viral hepatitis in their own countries. Read more.

World Hepatitis Alliance Welcomes New Global Framework Aimed at Saving the Lives of Millions Living With Hepatitis
July 30 – The World Health Organization (WHO) launched its ‘Framework for Global Action’, which provides a global vision for the prevention and control of viral hepatitis and outlines four axes for action for regions and countries to develop effective strategies and plans according to their specific hepatitis burden and challenges. Read more.

Blocking of Hepatitis B Website Raises Ire
July 30 – As hepatitis carriers were celebrating World Hepatitis Day, seeking to raise awareness about the disease, one of their main sources of support went down. Ahead of the day, a well-known public welfare website dedicated to preserving the rights and interests of hepatitis B carriers was blocked in China. Read more.

CDC, Division of Viral Hepatitis (DVH), and the Hepatitis B Foundation Raise Global Hepatitis B Awareness With a Twitter Chat
July 23 – The CDC, DVH, and HBF will be hosting a World Hepatitis Day twitter chat on Friday, July 27th at 2pm EDT. Special guest, Dr. Thomas London, will be interviewed by CDC’s Amanda Lewis regarding important hepatitis B topics. Join the conversation by using the twitter hashtag #WHDchat.

Assistant Secretary for Health Howard Koh Shares Hepatitis B Awareness Tools for AAPI Communities
July 23 – As we approach World Hepatitis Day on July 28th, we are reminded of the staggering impact of hepatitis B in the Asian American and Pacific Islander (AAPI) communities. Read more.

EASL publishes revised clinical practice guidelines for chronic hepatitis B
July 23 – The European Association for the Study of the Liver (EASL) recently revised its clinical practice guidelines for the management of patients with chronic hepatitis B virus infection. The revised recommendations reflect new data, though areas of uncertainty still exist. Read more.

Liver Cancer Cases on Increase
July 23 – Ten percent of Ugandans are said to be living with chronic hepatitis B, with as many as 25% of Northern Ugandan and 7% of Southwestern Ugandan populations infected, cited by WHO Country Advisor Expanded Program on Immunization (EPI) surveillance. Read more.

State Health Officials Warn Dentist Reused Syringes, Needles
July 16 – Patients who went to a Colorado oral surgeon over the past decade are advised to get tested for HIV, hepatitis B and hepatitis C, says the Colorado Department of Public Health and Environment. Dr. Stephen Stein re-used needles and syringes on multiple patients while injecting intravenous medications. Read more.

Substantial Pathological Differences Between HCC Patients with HBV, HCV
July 16 – Patients with hepatocellular carcinoma associated with hepatitis B may be more prone to early onset of cancer and poor prognosis than patients with carcinomas associated with hepatitis C, according to recent results that also indicated several other clinical-pathologic differences between the two. Read more.

Smoking Results In Lower Immune System Responses After Transplants
July 16 – Liver transplant recipients who continue to smoke or have smoked in the past are more likely to acquire viral hepatitis reinfection after the procedure, according to a study published in Liver Transplantation. Read more.

Shortage of Liver Donors in Taiwan Puts Focus on Prevention: Doctor
July 16 – Taiwan's liver donor shortage has heightened the importance of measures to prevent liver disease, such as screening and treatment for viral hepatitis. Read more.

Hep B Screening Urged Before TNF-Alpha Inhibitor Therapy
July 9 – All patients with psoriasis should be screened for hepatitis B prior to the initiation of tumor necrosis factor–alpha inhibitor therapy, according to research published in the Journal of the American Academy of Dermatology. Read more.

Bulgaria Launches Development of National Hepatitis Plan
July 9 – The Bulgarian Health Minister together with the European Liver Patient Association (ELPA) will initiate the development of a National Hepatitis Plan in the context of a roundtable discussion with international experts on viral hepatitis in the Bulgarian Parliament. Read more.

BioDiem Licenses Australian Hepatitis B Vaccine
July 9 – Pharmaceutical company BioDiem recently acquired a license to utilize vaccine technology for hepatitis B and D from an Australian university. Read more.

Girls as Young as 12 in Hepatitis B Scare After Being Used as Guinea Pigs by Unqualified Tattoo Artist
July 9 – A cowboy tattoo artist left kids as young as 12 facing an agonizing wait to see if they are clear of hepatitis B. HBV may be transmitted through the use of unsterilized tattoo needles and equipment. Read more .

CDC Updates Recommendations for HBV-Infected Health Care Providers and Students
July 6 – CDC released its updated HBV recommendations in today's MMWR issue to clearly state hepatitis B by itself should not prevent a person from pursuing a career in health care. With increasing reports of providers and students facing HBV-related discrimination, the CDC has taken a strong position against this by including a statement that the "CDC discourages constraints that restrict chronically infected HBV health care providers and students from the practice or study of medicine, dentistry or surgery." Read more.

State-Specific Information about ACA Implementation
July 2 – On the heels of the Affordable Care Act (ACA) ruling, the US Dept. of Health and Human Services website has updated information on implementation of the ACA, including state-specific pages on the benefits thus far. Read more.

FDA Will Review New Dynavax HBV Vaccine
July 2 – The U.S. Food and Drug Administration (FDA) has indicated that it will review for approval a new hepatitis B vaccine for adults known as Heplisav that has demonstrated higher and earlier protection with fewer doses than currently licensed vaccines. Read more.

Filipino–Americans Urged to ‘B-Free’
July 2 – A Las Vegas pilot program urges Filipino–Americans to be screened for HBV since as many as 10% of this population may be positive for hepatitis B. Read more.

Management of Hepatitis B in Ghana
July 2 – There are many challenges for those living with hepatitis B in Ghana, as shared by Theobald Owusu–Ansah of the Theobald Hepatitis B Foundation and member of the World Hepatitis Alliance. Read more.

Hepatitis B Vaccine Protects for 25 Years: Study
June 25 – Vaccination against hepatitis B seems to protect against the virus for 25 years, suggesting that booster shots are unnecessary, according to a study from Taiwan. Read more.

Cuba Says Hepatitis B Eliminated Among Minors
June 25 – Cuba has eliminated hepatitis B among the population under age 15, thanks to a locally developed vaccine and the Caribbean country’s massive immunization campaign. Read more.

HBV Genotype Affects Hepatitis B Disease Progression and Outcomes
June 25 – Hepatitis B virus genotype influences long-term outcomes including viral clearance, according to a Swedish study reported in the May edition of the Journal of Clinical Virology. Read more.

Hepatitis B and Liver Cancer Among Asian Americans
June 25 – Liver cancer is expected to become more common among the Asian American and Pacific Islanders (AAPI) population. “It’s deadly and it’s preventable,” says USCF physician and researcher, Tung Nguyen, MD, as he discusses his strategy for lowering liver cancer rates among AAPIs. Read more.

Hepatocyte Cell Transplantation Enables 'New' Liver Generation
June 18 – Researchers in Japan have found that hepatocytes can be propagated and used to regenerate liver tissue as published in a recent issue of Cell Transplantation. This ability has potential clinical value for hepatocyte transplantation or other therapies. Read more.

Scientists Show Lack of Single Protein Results in Persistent Viral Infection
June 18 – A single protein can make the difference between an infection like HBV, HCV or HIV clearing out of the body or persisting for life says the Scripps Research Institute. Read more.

Strides Made In Shielding Toddlers from Hepatitis B
June 18 – China has achieved the Asia-Pacific regional goal of reducing chronic hepatitis B infection rates to less than 1% among children up to age 5, the World Health Organization said, calling it a remarkable public health accomplishment. Read more.

Most Hepatitis B Carriers Aren’t Being Treated, Survey Finds
June 11 – Most Asian-Canadians who know they are chronically infected with hepatitis B are not being treated by a doctor, says a survey released by the Chinese advocacy group S.U.C.C.E.S.S. Read more.

HIV and HBV: Partners in Crime
June 11 – HIV and hepatitis B constitute global health threat says New England Journal of Medicine. If you have HIV, one of the most dangerous risks is becoming infected with another chronic disease such as HBV. Read more.

The Risk of Perinatal Hepatitis B Virus Transmission: Hepatitis B e Antigen (HBeAg) Prevalence Estimates For All World Regions
June 11 – HBeAg presence in childbearing-age women is a major determinant of perinatal hepatitis B transmission. This assessment looks at the perinatal transmission risk of HBV by estimation of age and region-specific HBeAg prevalence. Read more.

HBV and HCV-Associated Liver Cancer: Important Insights from the Genome
June 11 – This interesting blog discusses the integration of hepatitis B in liver cancer genomes, and genes that might provide clues to the molecular mechanism of virus-associated HCC. The review was based on two Nature Genetics (May 2012) journal articles. Read more.

Prevalence of Chronic Hepatitis B May Exceed 2 Million, Higher in US Than Previously Reported
June 4 – The prevalence of chronic hepatitis B virus infection in the U.S. may be as high as 2.2 million cases according to a new study now available in Hepatology. Findings suggest the higher prevalence of chronic HBV can be attributed to foreign–born persons who were infected in their country of origin prior to arrival in the U.S. Read more.

Addressing Viral Hepatitis Among Minority Communities
June 4 – The U.S. Office of Minority Health is taking an active role in advancing the HHS Action Plan on Viral Hepatitis and promoted on its blog their partnership with the Association of Asian Pacific Community Health Organizations and the Hepatitis B Foundation to launch Hep B United. This is a new national campaign dedicated to ending hepatitis B by supporting community-based groups in their efforts to increase awareness, screening, particularly among high-risk Asian American populations. Read more.

New Data Published From Genomics Research On Recurrent Hepatitis B Virus Integration
Jun 4 – Results from a genome–wide study of recurrent hepatitis B virus integration in hepatocellular carcinoma (HCC) were published in Nature Genetics, and may have important insights that may be used to improve diagnosis and treatment. Read more.

16th Century Korean Mummy Provides Clues to Hepatitis B Virus Genetic Code
June 4 – A liver biopsy and genetic analysis on a mummified Korean child has revealed a unique hepatitis B virus genotype C2 sequence. Study of HBV genomes may be used as a model to study the evolution of chronic HBV and help understand the spread of the virus. Read more.

May is National Hepatitis Awareness Month

CDC Initiative Aims to Improve HBV Screening Among Foreign-born U.S. Residents
May 29 – The Centers for Disease Control and Prevention (CDC) has launched a demonstration project to find, screen and treat immigrants and refugees living in the United States who come from countries where hepatitis B is endemic. The goal is to slow the spread of HBV among foreign-born residents of the U.S. who now account for the majority of chronic HBV in the country. Read more.

Sanofi to Test Cancer-Starving Compound in China in 2013
May 29 – Sanofi–Aventis plans to begin testing a novel compound that is designed to starve liver cancer to death in a phase one human clinical trial in China and possibly South Korea in 2013. Read more.

Hepatitis B Carriers May Now Work in Nurseries
May 29 – Carriers of the hepatitis B virus are now allowed to work at kindergartens and nurseries on the Chinese mainland, under new guidelines on health and hygiene at kindergartens, hopefully resulting in reduced HBV related social discrimination. Read more.

Campaign Calls for Increased Hep B Testing in Philly
May 21 – Philadelphia Mayor Nutter and Councilman David Oh were featured speakers at a media event organized by Hep B United Philadelphia, a campaign led by the Hepatitis B Foundation to get more Philadelphians tested and vaccinated against the virus. Read more.

MMWR: Multiple Outbreaks of Hepatitis B Virus Infection Related to Assisted Monitoring of Blood Glucose Among Residents of Assisted Living Facilities – Virginia, 2009-2011
May 21 – Virginia health officials said hepatitis B virus infections occurred in four assisted living facilities from 2009-2011 due to inadequate infection control practices, particularly surrounding assisted monitoring of patient blood glucose levels. Read more.

One in 10 Cambodians Have Hepatitis B
May 21 – Cambodian Americans are 25 times more likely to have a chronic hepatitis B infection than the average American, and HBV is the second leading cause of cancer for Cambodian American men. This is due to a lack of health education and translated information about HBV for Cambodians in the U.S. Read more.

Perinatal Hepatitis B: What Every Mom Should Know
May 14 – A highlight of perinatal hepatitis B transmission and the actions needed to eliminate this preventable disease, by Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, HHS. Read more.

1 in 6 Cancers Worldwide Caused by Infections That Can be Prevented or Treated
May 14 – Infections cause about 2 million cancer cases a year, and 80 percent of those cases occur in less developed areas of the world, many of which are due to potentially preventable or treatable infections, including hepatitis B, according a the study which was published in The Lancet Oncology. Read more.

Arrowhead Presents Data on DPC System and Hepatitis B Program at CLINAM 2012
May 14 – Arrowhead’s pre-clinical strategy for the development of an effective siRNA–based therapeutic for the treatment of chronic HBV infection was presented at the European Foundation for Clinical Medicine Conference. Read more.

Intensive Follow–up Reduces Mortality from Hepatocellular Cancer
May 14 – Intensive follow–up of patients who have undergone surgery for hepatocellular carcinoma reduces deaths from tumor recurrence and metastases, since HCC tends to recur locally, Dr. Timothy M. Pawlik said at a symposium sponsored by the Society of Surgical Oncology. Read more.

Scarring Cells Revert to Inactive State as Liver Heals
May 14 – Myofibroblasts, or cells that produce the fibrous scarring in chronic liver injury, revert to an inactive type as the liver heals. This discovery may ultimately lead to new therapies for reversing fibrosis in the liver and other organs. Read more.

May is National Hepatitis Awareness Month!
Visit the Hepatitis B Foundation website for more information and links to valuable resources about free resources and testing events. Read more.

May is National Hepatitis Awareness Month!
Visit the Hepatitis B Foundation website for more information and links to valuable resources about free resources and testing events. Read more.

CDC Selects Hepatitis B Foundation as Featured Partner for Month of May
May 10 – The CDC National Prevention Information Network (NPIN) Featured Partner resource offers HIV/AIDS, viral hepatitis, STD, and TB prevention–focused organizations a platform to showcase their services, programs, and materials. Our goal is to highlight the work of CDC’s prevention partners and encourage partners to connect with each other to share information and strategies. The Hepatitis B Foundation was selected for May Hepatitis Awareness Month for the valuable work they are doing to promote hepatitis B prevention through improved screening, vaccination and linkage to care. Read more.

Raising Awareness of Hepatitis B in the Asian and Pacific Islander Communities
May 7 – Dr. Howard Koh, Assistant Secretary for Health at the U.S. Department of Health and Human Services, wrote a blog to highlight the dual observance of both Asian and Pacific Islander Heritage Month and Hepatitis Awareness as an important opportunity to bring attention to the disproportionate burden of viral hepatitis among the Asian American and Pacific Islander communities in the U.S. and renew the federal commitment and call to action to address this disparity. Read more.

EASL: Having Only Wild-Type Hepatitis B Virus Predicts Response to Interferon
May 7 – Chronic hepatitis B patients who do not have two common HBV mutations are more likely to achieve an undetectable viral load and HBsAg loss when treated with pegylated interferon, according to a study presented at EASL 2012. Read more.

Combination of Two Drugs Reverses Liver Tumors, Study Suggests
May 7 – Primary liver cancer is the 5th most common cancer and the 3rd most deadly cancer. The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumor cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute. Read more.

Abatacept May Aid RA Patients with Hepatitis B
May 7 – Abatacept may be helpful for treating rheumatoid arthritis (RA) in patients with concurrent hepatitis B, as long as patients are also given antiviral prophylaxis to prevent reactivation of their HBV, according to small retrospective study presented at the rheumatology meeting sponsored by New York University. Read more.

Chronic Hepatitis B Infection Associated with Twice the Risk of liver-Related Death Compared to hepatitis C
April 30 – The risk of death due to liver disease is twice as high for patients with chronic hepatitis B infection compared to individuals with chronic hepatitis C, U.S. researchers report in the online edition of Clinical Infectious Diseases. Read more.

Family History of Liver Cancer Increases Risk of Developing the Disease
April 30 – A family history of liver cancer is reported to increase risk of developing hepatocellular carcinomas (HCC), independent of hepatitis according to findings published in the May issue of Hepatology. The study also shows 70–fold elevated risk of HCC in those with liver cancer in the family and markers for HBV or HCV. Read more.

Microbiologist Irving Millman 88 Helped Develop Hepatitis B Vaccine
April 30 – Irving Millman, a microbiologist who played an instrumental role in developing the hepatitis B vaccine on the research team of Baruch Blumberg, MD, PhD, Nobel Laureate, has died. Read more.

Doctor Raises Awareness of Hepatitis B
April 30 – Raising Hepatitis B awareness and encouraging screening among the Vietnamese community of the New Orleans Metro area is a priority for Son Nguyen, MD, a gastroenterology fellow at Tulane University. Read more.

EASL: Entecavir Plus Tenofovir for Hepatitis B Patients with Prior Treatment Failure
April 23 – A combination of entecavir plus tenofovir resulted in hepatitis B virus suppression in a majority of patients who previously experienced treatment failure, according to a study presented at the 47th Annual Meeting of the European Association for the Study of the Liver. Read more.

EASL: Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
April 23 – Data presented at EASL shows that childhood obesity is positively linked with developing hepatocellular carcinoma (HCC) even when patients with other co-morbidities are removed such as those with hepatitis B or C. Read more.

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
April 23 – This prospective study examined the diagnostic performance of FibroTest and Liver Stiffness for the prediction of histological fibrosis in Asian patients infected with chronic hepatitis B. These less invasive options may provide a good alternative to the liver biopsy, often considered the gold standard for assessing liver fibrosis. Read more.

Liver Cancer Predictors in Chronic Hepatitis B Identified
April 16 – In patients with chronic hepatitis B who are negative for hepatitis B e antigen and have low viral loads, serum levels of hepatitis B surface antigen can be used to predict risk for hepatocellular carcinoma (HCC), Dr. Tai–Chung Tseng and colleagues reported in the May issue of Gastroenterology. Read more.

B.C. to Educate Asian Immigrants About Dangers of Hep B
April 16 – The Chinese immigrant support group S.U.C.C.E.S.S. along with specialists from the University of British Columbia are launching a project to educate Asian immigrants about the danger of undiagnosed hepatitis B, and to improve treatment to prevent the emotional and financial cost of drastic treatments to the patient and the health–care system. Read more.

Telbivudine Cut Mother-to-Infant Hepatitis B Transmission
April 16 – Telbivudine taken during the second or third trimester of pregnancy reduced the mother–to–infant transmission of hepatitis B to zero in an open-label trial of 88 women who had high viral loads and elevated alanine aminotransferase levels, Dr. Calvin Q. Pan and his colleagues reported in the May issue of Clinical Gastroenterology and Hepatology. Read more.

Experts’ Picks: Best of The Liver Meeting 2011—Part 2
April 16 – Gastroenterology & Endoscopy News asked the experts: What were your favorite abstracts presented at The Liver Meeting 2011? This collection of selected abstracts and comments include the influence of age, gender and race on normal ALT values for those in the US free of liver disease, along with lamivudine use in the 2nd or 3rd trimester of pregnancy among highly infectious mothers in order to prevent vertical transmission of HBV, and other favorites. Read more.

Turning Lymph Nodes into Liver-Growing Factories
April 16 – A surprising new technique is currently under development by University of Pittsburgh stem cell researcher Eric Lagasse, which uses any of the body’s 500 lymph nodes to generate a new liver. The technique is in initial stages, but might one day help those with advanced liver disease. Read more.

Chronic Hepatitis B in Pregnancy
April 9 – New consensus recommendations for the evaluation and management of pregnant women with hepatitis B, resulting from a Hepatitis B Foundation workshop, is a featured article in The Female Patient. Read more.

Why are Some Immunized Children Still At Risk for HBV Infection?
April 9 – Despite immunization, children born to mothers with replicating HBV (marked by hepatitis B e Antigen, or HBeAg), are still at risk for infection, according to the April issue of Gastroenterology. New strategies to reduce the rate of breakthrough infection must be investigated. Read more.

New Biomarker to Identify Hepatitis B-Infected Patients at Risk for Liver Cancer April 9 – Hepatitis B–infected patients with significantly longer telomeres – caps on the ends of the chromosomes that protect our genetic data – were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson’s Kimmel Cancer Center at the American Association for Cancer Research Annual Meeting 2012. Read more.

Morriston Hospital Hepatitis B Death: Lessons Learned, Says ABM Health Board
April 9 – A cardiac patient who died after contracting hepatitis B at a Swansea hospital did not receive a high standard of care, say health chiefs. An independent external review panel was asked to investigate and a likely cause of the infection has been identified. Read more.

Increasing Routine Viral Hepatitis Testing
April 2 – Successful approaches to improving the frequency, availability and acceptability of viral hepatitis testing were explored at a day-long consultation at the Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services. Read more.

Hepatitis B Program Helps Cut Infant Infection
April 2 – A program to prevent chronic hepatitis B infection in newborns seems to be working, according to a new study from researchers at the Centers for Disease Control and Prevention. Read more.

Children Most Vulnerable to Breakthrough Hepatitis B Identified
April 2 – Pregnant women who carry the hepatitis B e antigen are at the greatest risk of transmitting hepatitis B virus infection to their children despite HBV immunization. It is suggested that novel preventive methods be targeted to these patients. Read more.

Hepatitis B Treatment
March 26 – A new publication incorporates current recommendations for hepatitis B treatment strategies that include AASLD, APASL, EASL, Belgian, Dutch, German, and Italian guidelines in Hepatology: A Clinical Textbook. Read more.

Twin Cities Somalis to Learn About Their Increased Risk for Liver Cancer
March 26 – In an attempt to raise awareness, a campaign is underway to inform the Somali community about their increased risk for liver cancer due to hepatitis B and C infection. Read more.

Marker of Active Hep B Infection Declines in Those Coinfected With HIV, Treated With Tenofovir
March 26 – According to a Dutch report presented at the 19th Conference on Retroviruses and Opportunistic Infections, prolonged therapy with antiviral regimens containing tenofovir is associated with a decline in hepatitis B surface antigen levels in people coinfected with HIV and hepatitis B. Read more.

Liver Cancer Patients Less Likely to Die On Wait List Than Candidates Without Carcinomas
March 26 – New research shows increasing disparity in mortality among candidates with and without hepatocellular carcinoma (HCC) who are on the waiting list for liver transplantation. Read more.

HHS Weighs Accepting Men Who Have Sex With Men as Blood Donors
March 19 – Due to the increased effectiveness of donor testing for HIV, HBV and other infectious agents, the Health and Human Services Department (HHS) is seeking comments on designing a pilot program to create “alternative donor deferral criteria” for gay men. Read more.

CEVHAP Hosts Agenda-Setting Meeting on Hepatitis Policy
March 19 – The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) met to discuss goals focusing on improving public health policies to reduce the health, social and economic burden of viral hepatitis in the Asia–Pacific region. Read more.

Hepatitis Alarm Jinnah Lab Quick to Process ‘Blue Blood’
March 19 – More than 1,000 blood samples for diagnosing hepatitis B and C patients have not been processed at the main laboratory of Jinnah Hospital for the last month. The reason may be due to equipment shortages, or as a result of a discriminatory policy for paying versus non-paying patients. Read more.

Nigeria: Nursing Mothers Complain Over Absence of Hepatitis B Vaccine
March 19 – Nursing mothers attempting to have their children immunized against hepatitis B find that the vaccine is unavailable at public hospitals. Read more.

4 Million NK Children Vaccinated Against Hepatitis B: Agency
March 19 – 3.7 million North Korean children aged 7 to 17 have been vaccinated against hepatitis B as part of a preventive strategy to reduce future medical costs. Read more.

Arrowhead Releases White Paper on Hepatitis B Virus and Potential RNAi Treatment
March 12 – Arrowhead Research Corporation released a white paper describing the health problems and unmet needs of those chronically infected with hepatitis B, and how their Dynamic Polyconjugate enabled RNAi therapeutic in development could potentially address current HBV treatment deficiencies. Read more.

Study Shows Nurses are Exposed to Risks From Blood Exposure During Insertion and Removal of Peripheral IV Catheter
March 12 – About one in two nurses experience blood exposure, increasing the risk of infection from pathogens such as HBV, HIV, HCV and MRSA, on their skin, or in their eyes, nose or mouth at least once per month when inserting peripheral intravenous (IV) catheters. Read more.

300 Pledge to Eradicate Hepatitis B
March 12 – Leading international and national hepatologists and other medical professionals joined together to sign an appeal to the government of India to help eradicate hepatitis B. Read more.

Complete Genomics Co-Authors Paper Demonstrating Impact of Hepatitis B Virus on Liver Cancer Genomes
Feb. 27 – Genome Research has published a paper, co-authored with Complete Genomics, which describes the effects of hepatitis B virus integration into the genomes of liver cancer patients. Read more.

Three Drugs Best to Treat Hepatitis B, Doctor Says
Feb. 27 – A doctor recommends the top three drugs for HBV, with one being the most suitable for Cambodians. Read more.

Doc: All Should Be Screened For Hepatitis B, C
Feb. 27 – Most people are never routinely screened for hepatitis B and C. Education of doctors and insurance companies is needed along with the inclusion of ICD codes. Read more.

Hepatitis C Bigger Killer than HIV
Feb. 20 – Researchers from the CDC report that more Americans now die from hepatitis C infection than from HIV. Read more.

Androgen Boosts Hepatitis B Virus Replication
Feb. 20 – According to research published in the Journal of Virology, the naturally occurring steroid hormone “androgen” enables replication of the HBV virus, making males more vulnerable to the virus than females, which supports studies that show men are 3-7x more likely to develop chronic HBV infections than women and more likely to develop liver cancer. Read more.

Gov’t on “Code Yellow” vs Hepatitis B
Feb. 20 – The Philippine government has launched a “Code Yellow” program to raise awareness about hepatitis B because 60% of the population has been infected with HBV, and approximately 10% are chronically infected. Read more.

Drive to Vaccinate 570,000 Schoolchildren Against Hepatitis Begins Today
Feb. 20 – A 10–day campaign to vaccinate 570,000 students against hepatitis B begins today in Karachi. Read more.

Stress Protein Effectively Activates Replication of HBV in Liver Cells
Feb. 20 – Research shows drugs that activate the stress protein p38 may cause reactivation of an HBV infection putting transplant recipients, and possibly cancer patients, at greater risk. Read more.

Accelerated Decrease in HBsAg Seen Before HBV Clearance
Feb. 13 – Serum hepatitis B surface antigen (HBsAg) seroclearance is preceded by significant, accelerated decreases in HBsAg levels during the 3 years leading up to the loss of HBsAg. Therefore, researchers recommended HBsAg quantified testing every 2 years. Read more.

Making History: Eliminating Viral Hepatitis Disparities in the African American Community
Feb. 13 – February is African American History Month and significant hepatitis–related health disparities exist in this community. New hepatitis B infection rates remain the highest among African Americans and HBV vaccination rates are lowest among African American children. Read more.

How Reliable is Hepatitis B Vaccination in People [With] Celiac Disease?
Feb. 13 – Some studies suggest that people with celiac disease may have high levels of resistance to the HBV vaccine when compared to the general public, and that a different immunization schedule should be developed for them. Read more.

White House Pledges Support to End Viral Hepatitis
Feb. 6 – President Barak Obama met with Chris Lu, White House Cabinet Secretary and co-chair of the White House Initiative on Asian Americans and Pacific Islanders, who says that viral hepatitis is a national concern and on the White House’s radar. Read more.

Program For Hepatitis B Patients in Tangerang
Feb. 6 – Indonesia has the 3rd highest number of hepatitis B sufferers in the world after China and India so the Tangerang administration is going to offer free treatment through local community health centers for patients. Read more.

Health Officials to Launch Campaign Against Deadly Disease
Feb. 6 – The State Health Department of Mississippi is getting ready to launch its first hepatitis B public awareness campaign, focusing primarily on the large Vietnamese community in South Mississippi. Read more.

U.S. Vaccination Coverage Remained Low in 2010
Feb. 6 – Adult vaccination rates are far below the recommendations of Healthy People2020, including that of the hepatitis B vaccine which stands at only 42% of high risk adults aged 19-49. Read more.

Statins May Stave Off Liver Cancer in People With Hepatitis B
Jan. 30 – A new study in the Journal of Clinical Oncology shows that popular cholesterol lowering statins may also lower the risk for liver cancer in people with HBV, although regular liver function tests are required to prevent a potentially dangerous rise in liver enzymes. Read more.

Test For Liver Damage Uses Blood Sample Instead of Biopsy
Jan. 30 – The Enhanced Liver Fibrosis test, developed by Siemens, is used to diagnose liver damage with a blood test rather than a biopsy and in less time. Read more.

Infection Control Training Mandated at Assisted Living Centers
Jan. 30 – State mandated training is underway in an effort to deal with an increasing number of hepatitis B outbreaks caused by faulty diabetes care in assisted living centers. Read more.

Booster Vaccination Recommended For HBV Immunity in Children With IBD
Jan. 30 – Due to the risk of HBV infection in children with inflammatory bowel disease (IBD), patients should be screened for HBV at the time of IBD diagnosis, and an HBV booster dose considered in patients without protective antibodies. Read more.

Many High-Risk Americans Don’t Get Hepatitis B Vaccine
Jan. 23 – A recent study indicates more than 50% of adults at risk for HBV remain unvaccinated despite making contact with the healthcare system, resulting in missed opportunities to vaccinate this population. Read more.

GAO Asked to Review VA Quality-of-Care Policies
Jan. 23 – Top Democrats on the House and Senate Veterans’ Affairs committees asked the Government Accountability Office to investigate the VA’s handling of incidents involving improper sterilization of reusable medical equipment that have potentially exposed more than 13,000 veterans to infectious diseases such as HBV, HCV and HIV. Read more.

Guidelines for the Detection of a Common Source of Hepatitis B Virus
Jan. 23 – Belgian researchers shed light on the relationship between prevalence rates of chronic HBV in different geographic regions with transmission patterns. Additional analyses of HBV–infected populations over a period of time can help corroborate the existence of a common source of infection, which is particularly useful when investigating outbreaks. Read more.

Beware of Hepatitis B at the Nail Salon
Jan. 23 – Nancye Swanson does her own nails these days. Six months ago, she almost died from hepatitis B, a serious liver infection, which doctors say she picked up at a nail salon. Dr. Robert Gish is interviewed and the Hepatitis B Foundation is referenced in the accompanying TV news report. Read more.

Old Antivirals Rival New for Cancer Prevention in Hepatitis B
Jan. 16 – Older antiviral agents such as lamivudine or adefovir are similarly effective at preventing HCC in patients with chronic HBV versus entecavir and tenofovir despite their low rate of drug resistance. Read more.

Apple Reveals Who Makes Its iPhones, iPads, and More
Jan. 16 – Apple audits of gadget suppliers, especially those in China, found labor, health, and health and environmental violations including testing job candidates for hepatitis B. Read more.

China Approves Hepatitis E Vaccine
Jan. 16 – China has approved a hepatitis E vaccine. Hepatitis E is shed in feces and spread via tainted water and food that can lead to serious illness and death in 3% in the general population and 25% of pregnant women. Read more.

Health Dept.: Beware of Unlicensed Home Tattooing
Jan. 16 – Licensed and regulated tattoo facilities with a clean inspection history should be safe. Home tattooing and tattoo parties pose a risk of lifelong disease such as hepatitis B. Read more.

Nail Salon Nightmare: Hepatitis B From Mani-Pedis
Jan. 9 – Robert Gish, M.D., at UC San Diego, is writing a health policy for the Vietnamese government in order to prevent the spread of hepatitis B due to the high prevalence in the Asian Pacific region and those working in salons across the U.S. Read more.

Hep B Carrier Seeks Kisses For Roses
Jan. 9 – A young Chinese activist with hepatitis B exchanges kisses for roses in an effort to raise HBV awareness and decrease discrimination against those living with HBV in China. Read more.

Researchers Identify Liver Cancer Risk Factors
Jan. 9 – Two new studies from the Mayo Clinic illuminate the importance of identifying people with risk factors in certain populations to help detect disease in its early, treatable stages including HCV, HBV, and obesity, particularly fatty liver disease. Read more.

Mothers With Hepatitis B Can Breastfeed Newborns As Long As . . .
Jan. 3 – A new study suggests that mothers with HBV can breastfeed their newborn babies without the fear of transmission as long as the newborns receive HBIG and the first dose of the HBV vaccine immediately after birth. Read more.

Free Crack Pipes Handed Out to Vancouver Drug Addicts
Jan. 3 – Free crack pipes are being distributed to Vancouver addicts in an effort to stop the spread of HIV and hepatitis B. Read more.

St. Petersburg Woman Solves Mystery of Dad's 1958 Death
Jan. 3 – A woman in Florida discovers her father died in the service of his country due to a 1942 yellow fever vaccine contaminated with HBV infected blood. Read more.


2011 News

Top News Stories of 2011


Prevalence is Higher of Chronic Hepatitis B Among Foreign-Born Persons Living In the United States by Country of Origin


Hepatitis B Community Loses Nobel Laureate Baruch S. Blumberg


VA Infection Risk Leads to 12,000 Tests


Panel Recommends Hepatitis B Vaccine for Diabetes Patients


AASLD: Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection


WHO Renews Push to Cut Hepatitis Infections in Babies in Asia


Some People with Hepatitis B May Need Liver Cancer Screening Sooner and More Often


New Hepatitis B Surface Antigen Test Helps Assess Treatment Response


Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B


Occult HBV Infection May Be the Cause of Unexplained Liver Cancer

Christmas Eve Liver Disease Awareness Campaign
Dec. 23 - A campaign to raise awareness of hepatitis B prevention will be held on Christmas Eve in Taipei to raise funds for preventive care. Read more.

AASLD: Natural History of Hepatitis B Infection and Role of HBV Genotype
Dec. 23 – People with HBeAg-positive and negative HBV disease have different levels of hepatitis B surface antigen (HBsAg), variable extent of liver fibrosis, and different distribution of HBV genotypes. Read more.

Plasma microRNA Panel Detects HBV-Related Hepatocellular Carcinoma
Dec. 23 – Research shows a seven-marker microRNA panel accurately distinguishes patients with HBV-related hepatocellular carcinoma (HCC) from those with chronic hepatitis B or cirrhosis, and also from healthy individuals without liver dysfunction. Read more.

Hair Color for the Liver Conscious
Dec. 23 – For those living with HBV, consider making life easier on your liver by learning more about coloring options that are less toxic to your health. Read more.

Doctors Find Way to Detect Liver Cancer Earlier
Dec. 19 – New research out of Shanghai uses only one milliliter of a patient’s blood to determine if the patient has liver cancer and raises the accuracy of tests for early-stage liver cancer to nearly 90%. Read more.

Chronic Hep B Doubles Risk of AIDS Illnesses and Death in People Living With HIV
Dec. 19 – Chronic HBV infection nearly doubles the risk of AIDS or death in people diagnosed with HIV infection, compared with those only living with HIV. Early diagnosis and hepatitis B prevention are essential interventions. Read more.

Santa Clara County Looks at Liver Cancer Risk For Vietnamese
Dec. 19 – The booming Vietnamese community in Santa Clara struggles with a cancer rate of 32%. Screening and treatment of hepatitis B in the community would go a long way towards reducing the rate of liver cancer in the community. Read more.

Too Promiscuous to Donate an Organ? Maybe, CDC Says
Dec. 12 – According to new proposed guidelines by the CDC, deceased and living donors who were not monogamous in the previous 12 months before donation would be considered at risk of transmitting HIV, HBV and HCV. Read more.

House Members Urges Sebelius to Include People with HIV and Viral Hepatitis in the Affordable Care Act
Dec. 12 – Congresswoman Barbara Lee (D–CA), sent a letter signed by over 50 of her colleagues in the House of Representatives to Health and Human Services Secretary Kathleen Sebelius, urging her to include comprehensive services for people living with HIV and/or HBV and HCV in the final list of Essential Health Benefits in the Affordable Care Act. Read more.

Knights of the Roundtable
Dec. 12 – An inside look at the National Viral Hepatitis Roundtable (NVHR) and their fight against Hepatitis B and C. Read more.

Japan Parliament OKs Hepatitis B Patient Bailout
Dec. 12 – Japan's House of Councillors enacted a bill to provide government compensation to people infected with hepatitis B due to the re–use of syringes during mass vaccinations. Read more.

Prevalence [is Higher] of Chronic Hepatitis B Among Foreign-Born Persons Living In the United States by Country of Origin
Dec. 5 – A study published in Hepatology (Nov. 2011) suggests that the number of foreign-born persons living with chronic hepatitis B in the U.S. may be twice the number previously reported and that the total prevalence of chronic HBV may be 2.2 million. This suggests the need for screening of all foreign-born persons, so they can be identified, monitored and treated if necessary. Read more.

Studies of Patients with Cirrhosis Uncover Limitations in Liver Cancer Screening
Dec. 5 – Two studies available in the December issue of Hepatology have uncovered limitations in screening for hepatocellular carcinoma: the patient’s preference for surveillance rather than a randomized study, and screening at 3 month versus 6 month intervals did not improve the detection of small liver cancers. Read more.

Study Supports HBV Screening, Prophylaxis in Chemotherapy Patients
Dec. 5 – Researchers from M.D. Anderson Cancer Center in Houston state that when cancer patients have the hepatitis B virus, prophylaxis to prevent HBV reactivation during chemotherapy lowers their mortality, yet only 17% of patients in this study were screened for HBV despite CDC and other recommendations. Read more.

Hepatitis B on Rise Among Pregnant Women
Nov. 28 – The incidence of HBV among pregnant women in Vietnam has been increasing in recent years and timely detection is necessary to prevent it from being transmitted from mothers to newborns. Nearly 12 million Vietnamese are currently infected with HBV and the rate among pregnant women is 10–15%. Read more.

AASLD: HBsAg Clearance Increased When Patients Successfully Treated with Entecavir Switched to Peginterferon alpha–2a
Nov. 28 – Patients who sustained a virologic response to entecavir can achieve significantly higher HBsAg clearance when switched to a finite course of Peg IFNalpha–2a compared to those who remained on entecavir. Read more.

Liver Cancer Occurs in Immigrants With Hep B Younger than Screening Guidelines
Nov. 28 – Current recommended hepatocellular carcinoma screening guidelines for chronic HBV patients with cirrhosis and select non–cirrhotic populations may be inadequate for younger Asian Immigrant hepatitis B patients with a family history of HBV or a history of smoking. Read more.

Head of Miami VA Hospital Out Following Colonoscopy Scandal
Nov. 21 – The head of the Miami Veterans hospital has been replaced as a result of the colonoscopy scandal which potentially exposed 3,000 vets to hepatitis B and other infectious agents. Read more.

South Gives Hep-B Jabs for a Million Kids
Nov. 21 – The South Korean government has agreed to offer more than one million hepatitis B vaccines to North Korean children. Read more.

HHS Viral Hepatitis Action Plan: Spotlight on Hepatitis B
Nov. 21 – The needs of Americans living with chronic hepatitis B infections addressed in the new HHS Action Plan for Viral Hepatitis in the U.S. was featured in a special blog written by Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases at the U.S. Dept. of Health and Human Services (HHS). Read more.

AASLD: Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
Nov. 14 – Researchers at the University of Texas MD Cancer Center determined that only 20% of patients with newly diagnosed cancer who had hepatitis B risk factors were screened for HBV resulting in potentially poor outcomes for those with preventable, reactivated HBV. Read more.

AASLD: Long-Term Tenofovir for HIV/HBV Coinfection
Nov. 14 – Tenofovir showed long-term antiviral activity against HBV lasting 5 to 8 years, with minimal evidence of kidney toxicity, and steadily declining HBsAg levels over time. Read more.

Abbott’s New Hepatitis B Test is More Sensitive, Can Detect Mutant Virus Strains
Nov. 14 – Abbott’s new, highly sensitive diagnostic test for detection of hepatitis B surface antigen (HBsAg) has been approved for use in Europe. The high sensitivity of the new Abbott test enables clinicians to detect in patients very low levels of HBsAg, and viral mutant strains, as well as in donated blood and plasma. Read more.

High School Students Do Graduate Level Research on Liver Cancer and Hepatitis B
Nov. 14 – Two high schools students were finalists in the national Siemens Competition with a project that involved determining whether the HBV genome can be used to detect liver cancer at an early stage of the disease in order to improve survival rates. Michael Chen worked in the Hepatitis B Foundation’s research labs on this graduate school level project for the past two years with a fellow student, Kevin Chen (no relation). Read more.

NVHR Applauds Introduction of the Viral Hepatitis Testing Act of 2011
Nov. 7 – Landmark Viral Hepatitis Testing Act of 2011 is introduced into the House of Representatives, with a parallel bill introduced in the Senate aimed at preventing deaths from liver cancer through early detection of hepatitis B and C. Read more.

Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Nov. 7 – Five-year data from Gilead shows that Viread not only helps chronic HBV patients to achieve and maintain viral load suppression, but also has the potential to reduce or reverse liver damage. Read more.

Some People with Hepatitis B May Need Liver Cancer Screening Sooner and More Often
Nov. 7 – People with chronic HBV and other risk factors such as smoking and a family history of liver cancer should be screened sooner and more frequently. Read more.

Hepatitis Transmission Risk Needs to Be Studied in Nail Salons, Barbershops
Nov. 7 – An analysis presented at the American College of Gastroenterology (ACG) 76th Annual Scientific meeting questioned the adequacy of infection practices at hair and nail salons, and barber shops, and indicated there might be a potential for transmission of bloodborne pathogens, such as HBV and HCV. Read more.

Roche Receives FDA Approval for Acute Hepatitis B Test
Nov. 7 – Roche announced that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay. The test represents the final component of the acute panel within the hepatitis test menu for the cobas 6000 series. Read more.

Panel Recommends Hepatitis B Vaccine for Diabetes Patients
Oct. 31 – Do you have diabetes? Get the hepatitis B vaccine, says the CDC’s Advisory Committee on Immunization Practices. Up to age 60, people with diabetes have twice the risk of hepatitis B as those without diabetes. Yet only 17% of those living with diabetes (and 26% of those without diabetes) have been fully vaccinated against hepatitis B. Read more.

New Research Shows Increased Hepatitis B Risk in Glucose Meters
Oct. 31 – An analysis conducted by the CDC found that patients with diabetes are at a significantly increased risk of hepatitis B infection. This is especially true for those living in long-term care facilities where HBV was transmitted through some aspect of the blood glucose testing process. Read more.

IDSA: Hep B Vaccine Benefit Persists in HIV Patients
Oct. 31 – The effects of the hepatitis B vaccine appear to last long-term in HIV-infected patients even if they have high CD4–positive cell counts. Read more.

HBV Screening Before Lymphoma Treatment Improves Outcomes, Is Cost-Effective
Oct. 31 – Researchers at the University of Toronto and St Michael’s Hospital presented compelling data at the annual meeting of the American Society of Clinical Oncology, which demonstrates screening all patients for HBV before initiating chemotherapy for lymphoma [to prevent potential reactivation] is associated with improved clinical outcomes and is economically favored. Read more.

Hmong Lack Education Resources to Combat Hepatitis B Infection
Oct. 24 – The lack of health awareness in the Hmong immigrant community coincides with a higher–than–normal incidence of hepatitis B. Read more.

Stricken Italian Tourist Leaves San Diego With New Liver
Oct. 24 – An Italian woman vacationing in California is leaving for home with a new liver from UCSD following a critical case of hepatitis B that left her comatose for almost two weeks. Read more.

San Francisco Leaders Unite to Call on Mayoral Candidates to End Hepatitis
Oct. 24 – San Francisco Hep B Free and the San Francisco Hepatitis C Task Force Campaign teamed up with the Asian American and LGBT community to call on the San Francisco mayoral candidates to determine their strategy to end the hepatitis epidemic. Read more.

European Studies On Risk of Hepatocellular Carcinoma
Oct. 24 – According to a cohort study published by the National Cancer institute, smoking, obesity, heavy alcohol consumption along with chronic hepatitis B and C contribute to a large share of hepatocellular carcinoma in Europe. Read more.

Thousands of Patients of Ottawa Clinic at Risk of HIV, Hepatitis
Oct. 17 – Ottawa Public Health is attempting to track down 6,800 people who may have been exposed to HBV, HCV and HIV viruses at an unnamed Ottawa clinic. Read more.

California Governor Signs Syringe Purchase and Needle Exchange Bills
Oct. 17 – California Governor Jerry Brown signed two harm reduction bills intended to decrease the transmission of blood-borne infections such as HIV and Hepatitis B and C among injection drug users. Read more.

Cage Warriors Implements Mandatory Blood Testing, Steroid Testing Possible in the Future
Oct. 17 – The U.K. based Cage Warriors organization has implemented its own mandatory blood testing for all fighters to identify infections such as HIV and hepatitis B and C. Read more.

Kagwe Girls Student Dies In School from HBV
Oct. 17 – A young student at Kagwe Girl's High School in Nairobi has died from hepatitis B related complications, allegedly after the school failed to take her to hospital in time. View YouTube news video.

Double Dose of Hepislav Works as Well as 3 Doses of Standard HBV Vaccine
Oct. 10 – Two injections of Dynavax’s investigational Hepislav HBV vaccine protected adults over age 40 as well as the standard regimen consisting of 3 doses of the Engerix–B vaccine given over 6 months, researchers reported at ICAAC. Read more.

Chinese Experts Working on New Ways to "Inject" Hepatitis Vaccines
Oct. 10 – Chinese scientists are developing new methods like spraying or dropping hepatitis vaccines into people’s noses to replace traditional injections in an effort to facilitate the country’s goal in controlling hepatitis B. Read more.

Team Approach Helps Tackle Health Disparities
Oct. 10 – A new pilot program in NYC for HBV screening, vaccination and low cost care is a great example of success when social agencies and medical facilities team up to offer culturally and linguistically appropriate care to fight disparities faced by disadvantaged minority communities. Read more.

Sanford Guide to Hepatitis Diagnosis and Treatment Available in Mobile App
Oct. 3 – The Sanford Guide to Hepatitis Diagnosis and Treatment is now available as a mobile app, the first of its kind for hepatitis B and C treatment, making it easy for healthcare professionals anywhere in the world to find the latest treatment guidelines instantly. Read more.

China: Where a Blood Test Determines Everything
Oct. 3 – Routine HBV testing of potential employees and students in China remains widespread more than a year after the nation banned mandatory testing, so numerous websites have sprung up offering “gunmen” for hire – uninfected people who charge $125-$300 to take the blood test for HBV-infected applicants. Read more.

Flares During HBV Treatment Do Not Predict Response, May Cause Liver Failure
Oct. 3 – Researchers report that hepatic flares, or sudden increases in liver enzymes or viral load while undergoing oral antiviral therapy for chronic HBV, did not increase sustained viral clearance and led to decompensated liver failure in some patients. Read more.

Med Students Not Adequately Protected Against Hepatitis B
Oct. 3 - Health care students are frequently exposed to blood-borne pathogens, placing them at increased risk for hepatitis B infection, but HBV vaccination rates are just below 60% among this population, which lag behind national recommendations. Read More.

Surgeons Object to New CDC Organ-Screening Guidelines
Sept. 26 – New CDC guidelines recommending that all organ donors be checked for HIV, HBV and HCV with the most sensitive screening method, known as nucleic acid testing, are raising concerns among transplant surgeons, who fear they may limit availability of organs. Read more.

Shark-Derived Drug May Treat Viruses
Sept. 26 – A unique compound originally isolated from sharks, known as squalamine, could prove to be a promising treatment for HBV and other viral diseases, researchers say, with human trials to hopefully begin within the next year. Read more.

Uganda: Medics Use ARVs to Treat Hepatitis B
Sept. 26 – Medical personnel have resorted to a desperate Plan B to treat hepatitis B after recommended drugs ran out of supply: they are now using anti-retrovirals (ARVs) meant for HIV. Read more.

Movie Puncture Exposes HBV, HCV, HIV Dangers in Needlestick Injuries for Nurses
Sept. 26 – Captain America star Chris Evans plays an attorney in the movie “Puncture” that highlights the enormous risks faced every day by nurses and healthcare workers exposed to dangerous pathogens (HBV, HCV and HIV) through accidental needlestick injuries on the job. Read more.

NJ Doctor Loses License After Hepatitis B Outbreak
Sept. 19 – New Jersey officials have revoked the license of an oncologist they say committed “gross and repeated acts of negligence” that led to an outbreak of hepatitis B among his patients. Read more.

AFP Levels Associated with HCC Survival
Sept. 19 – Although the AASLD did not include alpha-fetoprotein (AFP) testing in its most recent guidelines for HCC (liver cancer) screening, AFP testing was recommended at the 2011 Digestive Disease Week meeting. Read more.

Flares during HBV Treatment Do Not Predict Response, May Cause Liver Failure
Sept. 19 – Developing hepatic flares, or sudden increases in liver enzymes or viral load, while undergoing antiviral HBV therapy did not increase the likelihood of sustained viral clearance and led to decompensated liver failure in some patients. Read more.

Three Million Ugandans Have Hepatitis B
Sept. 19 – At least 10% of Ugandans are currently suffering from hepatitis B, and are in urgent need of antivirals for treatment. Read more.

New HBV Workshop Consensus Statement and Algorithm Published
Sept. 12 – The Hepatitis B Foundation's evidence-based algorithm and consensus recommendations for primary care providers on whom to screen for hepatitis B and when to pursue further evaluation and management was published as an online exclusive by the Journal of Family Practice (Sept. 2011, vol. 60). The recommendations were created by an expert panel of physicians in family and internal medicine, obstetrics, and pediatrics, and a leading nurse practitioner and physician assistant. Read Article.

Gay Men Blood Donor Ban Lifted
Sept. 12 – The lifetime ban on blood donations by men who have sex with men will be lifted in England, Scotland and Wales. Read more.

Occult HBV Infection May Be the Cause of Unexplained Liver Cancer
Sept. 12 – Occult HBV may account for nearly three-quarters of patients with apparently unidentifiable causes for HCC. Read more.

FDA Approves Exalenz Liver Cancer Trial
Sept. 12 – Exalenz Bioscience Lt. has received FDA approval for a clinical trial of its non-invasive BreathID device for early diagnosis of hepatocellular carcinoma. Read more.

Cancer, Rheumatism Drugs Tied to Hep B Deaths
Sept. 12 – Officials of the Japan College of Rheumatology will issue an advisory regarding testing for HBV since 17 people who recovered from past hepatitis B infections died due to a sudden and acute reactivation of the virus in their bodies after taking newly introduced drugs to treat such conditions as rheumatism and blood cancer. Read more.

Cancer-Fighting Virus Shown to Target Tumors Alone
Sept. 5 – Researchers have shown for the first time that a single intravenous infusion of a genetically engineered virus can alert the immune system to seek and destroy cancerous cells in patients without harming healthy tissue. The experimental virus, JX–954, will next be tested in a trial of patients with liver cancer due to HBV. Read more.

Cost-Effective Perinatal HBV Transmission Prevention ID’d
Sept. 5 – In hepatitis B infected pregnant women, administration of lamivudine or HBIG in the third trimester is a cost-effective method for prevention of perinatal transmission of hepatitis B, according to a study published in the September issue of Obstetrics and Gynecology. Read more.

Disease Exposure Via Medical Devices a Growing Concern, CDC Says
Sept. 5 – In the past 10 years, at least 15 hepatitis B outbreaks have been associated with providers failing to follow basic principles of infection control when assisting with blood glucose monitoring. Because of underreporting and under-recognition of infection, the number of outbreaks likely has been underestimated, the CDC says. Read more.

Ask the Expert: Employer Says No to Providing Free Hepatitis B Vaccinations
Sept. 5 – Employers with employees having the potential for occupational exposure to bloodborne pathogens must make the HBV vaccine available at no cost to the employee, according to OSHA guidelines. Read more.

Autism Not Caused by Vaccines, IOM Report Concludes
Aug 29 – There’s convincing evidence that some vaccines can cause adverse effects, but autism isn’t one of them, according to a new report from the Institute of Medicine. Read more.

Refugees, Mass Casualties, and Hepatitis B Transmission
Aug 29 – A report about HBV transmission among injured Afghan refugees serves as a reminder of the pervasive nature of HBV as a global pathogen, and the role global migration plays in HBV epidemiology. Read more.

Surgical Gowns “Virus Risk”
Aug 29 – Hospitals have been urged to buy longer gowns for surgeons to wear while operating, after a study in New Zealand found their gumboots were commonly stained inside with blood splashed from patients that pose a risk for infection with HBV, HCV and HIV. Read more.

Saffron Shows Promise in Preventing Liver Cancer
Aug 29 – Research indicates that saffron has a significant chemopreventive effect against liver cancer through its antioxidant, anti-cancer, and anti-inflammatory properties. Read more.

Chinese Hepatitis B Carriers Face Widespread Discrimination
Aug 23 – Lost opportunities to segregation at meals. A heartbreaking look at HBV discrimination in China. View now.

49,500 Facebook Friends Raise Money For Deltona Man’s Liver Transplant
Aug 22 – Social media miracle saves the day for Florida man with hepatitis B and D in need of liver transplant. Read more.

Foundation Advocates National Strategy on Liver Health
Aug 22 – Ghana needs a national strategy on liver health as the country records and upsurge in hepatitis B infection. Read more.

Panacea Biotec’s HBV and DTP Vaccines Delisted from WHO List of Prequalified Vaccines
Aug 22 – Following a routine site audit conducted by a WHO team of vaccine manufacturer, Panacea, the EnivacHB, hepatitis vaccines and other DTP based vaccines have been removed from the list of prequalified vaccines. Read more.

Early HBeAg Decrease Predicts Response to Entecavir for Hepatitis B
Aug 15 – Decreases in hepatitis B “e” antigen (HBeAg) during the first 6 months of treatment with entecavir are a better indicator than hepatitis B virus DNA levels. Read more.

‘Yellow Manifesto’ Targets Increased Awareness on Hepatitis B
Aug 15 – The Philippines gets serious about HBV and institutes a manifesto aimed at imparting information on healthy lifestyle practices, stricter medical procedures, better access to hepatitis B treatment and protecting the rights of workers living with HBV. Read more.

Deferoxamine Shows Promise for Liver Cancer in People with Advanced Disease
Aug. 15 – Deferoxamine, a cancer drug that has an anti-proliferative effect on tumor cells, led to improvement of hepatocellular carcinoma (liver cancer) in 2 out of 10 patients with moderate-to-severe liver disease, according to researchers. Read more.

Are You Inking Yourself with the Hepatitis Virus?
Aug 15 – Recent international studies have shown an alarming link between hepatitis B and C and people who sport tattoos. Read more.

Dr. Emmet Keeffe

Hepatitis B Foundation Mourns Loss of Dr. Emmet Keeffe, Distinguished Hepatologist
Aug 11 – Dr. Emmet B. Keeffe, Professor Emeritus of Medicine, Stanford University, passed away on August 8, 2011 after a distinguished career in hepatology. He was a thought leader in the field of hepatitis B who grasped all aspects of this liver disease. We will miss his active involvement and support of the Hepatitis B Foundation, but most importantly, we will miss his vital contributions to the science and medicine of chronic viral hepatitis. Read more.


Woman Tours the Country to End Discrimination Against Hepatitis B
Aug 8 – A woman living with chronic hepatitis B uses unusual tact in her battle to raise HBV awareness and fight discrimination in China. Read more.

Inflammation Markers Linked to Liver Disease, Death in Coinfections
Aug 8 – Several studies have shown that HIV/HBV and HIV/HCV coinfected individuals experience more rapid liver disease progression, have higher mortality and respond less well to interferon-based therapy than people with viral hepatitis alone. Read more.

India Becoming Hepatitis B Capital of the World
Aug 8 – Hepatitis B is responsible for the infection of 42 million people in India, and 60% of liver cancer cases. Read more.

Battling Hepatitis in West Africa
Aug 8 – West African health experts are calling for governments to take the prevalence of hepatitis B and C more seriously, and to act to reduce the cost of treatment more effectively. Read more.

CAPAC Members Speak at White House “World Hepatitis Day” Event
Aug 1 – U.S. Rep. Judy Chu, Chairwoman of the Congressional Asian Pacific American Caucus (CAPAC), Rep. Mike Honda and Rep. Barbara Lee spoke at a White House event on July 28 in honor of the first official World Hepatitis Day. Read more.

Operations Research Models of Hepatitis B Prove Decisive in Treating Millions in US and China
Aug 1 – With hepatitis B infecting as many as 10% of people of Asian descent, operations researchers at Stanford collaborated with liver transplant surgeon Dr. Sam So to develop mathematical models that verified the cost effectiveness of hepatitis B screening, treatment and vaccination. Read more.

WHO Renews Push to Cut Hepatitis Infections in Babies in Asia
Aug 1 – Nine Asia Pacific countries will not meet a 2012 target to reduce hepatitis B infections among children to below 2%, according to the World Health Organization (WHO) which plans to intensify its fight against the disease by increasing birth dose vaccination rates. Read more.

Okyeame Kwame Foundation Screens 1,000 for Hepatitis [B]
Aug 1 – Okyeame Kwame Foundation, a humanitarian organization established by rapper Okyeame Kwame organized a free hepatitis B screening event in Accra, Ghana to mark 2011 World Hepatitis Day. Read more.

World Hepatitis Day at the White House: Live Streaming Video
July 28 1:00 PM EDT – Today marks the first official World Hepatitis Day established by the World Health Organization (WHO) to call for a renewed commitment against a silent but deadly epidemic. In the United States, World Hepatitis Day will be observed at a White House event and live streaming video will be provided in its entirety on CDC’s Viral Hepatitis Website.

President Obama Issues Proclamation for World Hepatitis Day
July 28 – In an historic move, President Obama has elevated hepatitis B and hepatitis C infections as a national public health priority with his Presidential Proclamation recognizing World Hepatitis Day. He is the first U.S. President to publicly express support for the needs of the more than 5 million Americans living with chronic hepatitis. Read the Presidential Proclamation on Hepatitis.

16 Million Filipinos Afflicted With Hepatitis B
July 25 – Approximately 16 million Filipinos – or 16% of the total population – are unknowingly afflicted with hepatitis B that is often detected only during pre-employment medical examinations, said doctors in a briefing held in advance of World Hepatitis Day on July 28. Read more.

Why the CIA's Vaccine Ruse Is a Setback for Global Health
July 25 – The revelation that the HBV vaccine was used as a ruse by the CIA to get DNA evidence from [Osama bin Laden’s] kids drew a quick and angry response from health experts: the Washington Post warned that the CIA's "reckless tactics could have catastrophic consequences" and Time outlined three reasons why this is bad news for public health. Read more.

Pure Disinfectant Gets Label Expansion [to Include HBV] July 25 – Federal regulators approved expansion of the list of organisms killed by Pure Bioscience disinfectant used in hospitals: the product label will continue to claim it kills HIV in 30 seconds after contact, and HBV and HCV within a minute. Read more.

Plea for ‘Swift Action’ on Hepatitis B at Morriston
July 25 - Managers at Morriston Hospital in Swansea, where a woman who contracted hepatitis B died, have launched an inquiry after 150 heart patients were potentially exposed to HBV. Read more.

Vaccination Ruse Used in Pursuit of Bin Laden
July 18 – In the months before Osama bin Laden was killed, the Central Intelligence Agency ran a phony HBV vaccination program in Abbottabad, Pakistan, as a ruse to obtain DNA evidence from members of Bin Laden’s family, according to an American official. Read more.

HBV Antivirals, Viral Breakthrough, and Drug Resistance
July 18 – Virological breakthrough is common among people taking oral antivirals for HBV, but nearly 40% are unrelated to drug resistance. Read more.

Fine Proposed For Deadly Hepatitis B Outbreak
July 18 – A state panel recommended a $16,000 fine for an assisted living center where six died from hepatitis B … but people who knew the hepatitis victims said the fine is not strong enough. Read more.

Treating HIV/HBV Coinfection in Africa
July 11 – Some antiviral drugs active against HBV/HIV coinfected patients are better than others, which highlights the “the urgent requirement for better management of HBV disease,” according to a recent study. Read more.

Viral Dominance in HBV/HCV Dual Infection
July 11 – As much as 20% of the world’s population has hepatitis B and hepatitis C dual infection, with Asian ethnicity a significant independent predictor of HBV-dominant disease in people with this dual infection. Read more.

HKU Announces Breakthrough in Liver Cancer Research
July 11 – The University of Hong Kong has identified tumor-producing cells capable of maintaining resistance to chemotherapy and resulting in recurrences of liver cancer, which will help improve treatment results. Read more.

MedMira to Make Quick Hep B Test for U.S. Army
July 11 – MedMira received a $2.2-million contract from the U.S. Army to develop and commercialize an HBV test that will provide diagnostic results in three minutes and identify both current and past infection with the virus. Read more.

US Govt Starts Hep B Campaign Among AAPIs
July 5 – The Obama administration has started an intensive information drive to discuss the risks, treatment and prevention of hepatitis B among Asian-Americans and Pacific Islanders (AAPIs). Read more.

Accord Must Be Step Toward Better Hepatitis B Care
July 5 – A basic agreement was reached in Japan over lawsuits in which people infected with hepatitis B through reused needles in group vaccinations asked the state to pay damages. Read more.

China’s Health Care Reform Looks to Science
July 5 – China's large-scale, health care reform effort referred to as “Chinacare” will tackle hepatitis B as one of its two disease priorities in 2011. Read more.

Entecavir Effective for Hepatitis B Patients with Liver Cancer
July 5 – Initial treatment with entecavir (Baraclude) monotherapy worked well in chronic hepatitis patients with hepatocellular carcinoma, lowering viral load and improving liver health. Read more.

Plaintiffs, Gov’t Reach Settlement Over Hepatitis B Infections
June 27 – On Tuesday, Prime Minister Naoto Kan, of Japan, will acknowledge the government’s responsibility for the infections and directly apologize to hepatitis B sufferers. Read more.

Nearly 15% of Country’s Paramedics Have Hepatitis B
June 27 – The highest number in Pakistan, 14.7%, of hepatitis B cases in hospital staff were found in paramedics across the country. Read more.

Gillespie Bill to Protect Police Officers Passes State House
June 27 – Legislation that would make it a crime to attempt to expose officers to communicable diseases such as hepatitis B or HIV unanimously passed the state House of Representatives. Read more.

ACIP Considers Hepatitis B Vaccine for Adults with Diabetes
June 27 – Hepatitis B vaccination of adults with diabetes could potentially prevent more than 5,000 hepatitis B infections, according to the CDC Advisory Committee on Immunization Practices. Read more.

Hepatitis B Outbreak in Swansea Investigated
June 20 – Health officials are investigating after an outbreak of hepatitis B in Swansea with 4 people having been recently diagnosed. In 2010 there were 200 confirmed cases in Wales, UK. Read more.

Causes of Death among People with Hepatitis B and C
June 20 – Deaths due to most liver-related causes dropped among people with hepatitis B and C; however, mortality due to liver cancer remains high, with monoinfected HBV individuals dying more often from liver cancer than those with HCV. Read more.

A Life Worth Living
June 20 – Two men who benefited from the NexPAP patient assistance programme for treatment of their liver cancer due to chronic HBV infections celebrate their ‘second-chance’ in life. Read more.

Central Falls Coverup - Students Not Properly Immunized
June 13 – A number of Central Falls middle school students over a six-year period were not properly immunized for hepatitis B, according to a former nurse who says she was punished for speaking out against the error and now is suing the school district. Read more.

Agenix Remains on Course to Apply for Hepatitis B Drug Clinical Trials in China
June 13 – The company plans to file a formal application with China’s State Food and Drug Administration in the second quarter of 2012, and anticipates approval to begin Phase I human studies in late 2012 for its lead Hepatitis B drug, AGX 1009. Read more.

FDA Labeling Change Interferon alfa-2b and Peginterferon alfa-2b
FDA approved a labeling change to the WARNINGS and PRECAUTIONS section, specifically, that PegIntron or Intron A should be used with extreme caution in patients with a history of psychiatric disorders. Read more.

Natural Products Library Donation picture

Merck Donates Library to Hepatitis B Foundation’s Research Institute
June 6 – In a public ceremony today, Merck donated its entire “priceless” natural products library, along with an undisclosed grant, to the Institute for Hepatitis and Virus Research, which is the research arm of the Hepatitis B Foundation. The Merck donation is considered to be one to the most diverse and best curated natural products libraries in the world and represents approximately 60% of all known plant genera in the world. Read more.

Killing Us Softly: What Americans Don't Know & Why It Will Kill Them
June 8 – Huffington Post blog addresses viral hepatitis which has for too long been an epidemic that doesn't make headlines even though more than 5 million Americans are suffering from chronic HBV and HCV. Read more.

Untreated Hep B to Send Liver Cancer Rate Soaring
June 6 – Deaths from liver cancer are liable to triple in the next decade, with the rise largely caused by untreated hepatitis B infections, experts say. Read more.

94,000 Cops Tested for Hepatitis
June 6 – Tests for hepatitis B and C have already been completed for about 94,000 policemen while efforts are under way to complete the screening of the remaining cops to achieve 100%. Read more.

VA Infection Risk Leads to 12,000 Tests
May 31 – The Department of Veterans Affairs is under political fire because about 13,000 veterans have been warned in the last two years that their blood should be tested for potentially fatal infections after possible exposures by improper hygiene practices at five VA hospitals in Ohio, Florida, Georgia, Missouri, and Tennessee. Read more.

Pennsylvania's Urology Practice Notifies Patients About Reused Needles
May 31 – Urology Associates of Chambersburg, PA has mailed letters to patients who recently underwent prostate biopsies, alerting them of possible infection from reused needles during the procedure and the recommendation for hepatitis B, C and HIV testing. Read more.

Mother-to-Mother Milk Sharing Concept
May 31 – In 1980, due to transfer of hepatitis B and C, HIV and CMV infection through breast milk, breast milk banks were closed down. But now in Australia, the same concept has resumed, however, the milk is first screened for viruses, just like donor blood. Read more.

Owly Images

“B A Hero” Flash Mob Takes Over City Hall
May 24 – The HBF mobilized the Hep B Free Philadelphia coalition to host a public awareness event at Philadelphia’s City Hall to launch the “B A Hero” theme that promotes testing and vaccination in the fight against hepatitis B during May National Hepatitis Awareness Month! See more photos.

Take the Nordstrom HBV Survey Now to Stop Liver Cancer!
May 24 – It only takes 30 seconds of your time to answer a few simple questions and Nordstrom will donate $35 per survey to promote Hep B Free! The goal is to reach 10,000 by May 31 and we’re more than halfway there. Take the survey now!

Two Oral Hep C Drugs Approved
On May 13 the U.S. FDA approved Merck’s HCV protease inhibitor boceprevir (Victrelis), the first direct-acting hepatitis C drug. Read more.

On May 23 the U.S. FDA approved Vertex's HCV protease inhibitor telaprevir (Incivek), the second direct-acting hepatitis C drug launched this month. Read more.

HHS Announces Action Plan to Prevent and Treat Viral Hepatitis
May 16 - The U.S. Department of Health and Human Services launched its action plan to prevent and treat viral hepatitis, a silent epidemic affecting 3.5 – 5.3 million Americans. “These infections have fueled a tragic cascade of human suffering,” said Howard K. Koh, MD, MPH. “The new HHS action plan on viral hepatitis represents an unprecedented call to action for better education, treatment and prevention.”

The plan’s success is contingent on leadership of government at all levels and the active and informed participation of communities, non-governmental organizations, health care providers, and the private sector.

“No one government agency can fight viral hepatitis alone, and here at CDC, we believe this action plan will not only strengthen the work we’ve been doing, but help all of us across the government collaborate to take our nation’s prevention efforts to the next level,” said CDC Director Thomas R. Frieden, MD, MPH. “Far too many Americans are unaware of the serious impact of viral hepatitis and the devastating consequences that can result from leaving it untreated. The time for action is now.” Read more

More News

HHS Announces Action Plan to Prevent and Treat Viral Hepatitis
May 12 – The U.S. Department of Health and Human Services today launched its action plan to prevent and treat viral hepatitis, a silent epidemic affecting 3.5 - 5.3 million Americans. Download Report

HHS Briefing on New Action Plan for Viral Hepatitis
May 12 – A briefing will be held at The National Press Club in Washington, DC on Thursday May 12 from 1:00 – 2:00 pm by Dr. Howard Koh, Assistant Secretary for Health and Human Services, to announce his new action plan to prevent, care and treat chronic viral hepatitis. Free and open to the public, so RSVP now!

Breastfeeding OK for Moms with Hepatitis B
May 8 – New mothers with hepatitis B can safely breastfeed their babies, as long as they take a few important precautions, according to a new study. Read more.

Alaska's History of Handling Hepatitis
May 8 – In the 1970s, Alaska had some of the nation's highest levels of hepatitis A and B infections. Nearly 40 years later, Alaska health care providers are world leaders in prevention, control and treatment of viral hepatitis, according to Dr. Brian McMahon who has led the effort in Alaska. Read more.

Screening for Hepatitis B May be Cost Effective for More of the Population
May 8 – Research at the University of Cincinnati provides evidence that current prevention and screening standards are worth the cost and may even need expansion to include more of the population, further helping prevent the spread of this life-threatening disease. Read more.

Switch to Lamivudine Not as Effective as Staying on Entecavir
May 8 – Hepatitis B patients who switch to cheaper lamivudine after achieving undetectable HBV viral load and normal ALT on entecavir are more likely to experience viral rebound. Read more.

HHS Briefing on New Action Plan for Viral Hepatitis
May 12, 2011 - A briefing will be held The National Press Club in Washington, DC on Thursday May 12 from 1:00 – 2:00 pm by Dr. Howard Koh, Assistant Secretary for Health and Human Services, to announce his new action plan to prevent, care and treat chronic viral hepatitis. Free and open to the public, so RSVP now!

Breastfeeding OK for Moms with Hepatitis B
May 8 – New mothers with hepatitis B can safely breastfeed their babies, as long as they take a few important precautions, according to a new study. Read more.

Alaska's History of Handling Hepatitis May 8 – In the 1970s, Alaska had some of the nation's highest levels of hepatitis A and B infections. Nearly 40 years later, Alaska health care providers are world leaders in prevention, control and treatment of viral hepatitis, according to Dr. Brian McMahon who has led the effort in Alaska. Read more.

Screening for Hepatitis B May be Cost Effective for More of the Population
May 8 – Research at the University of Cincinnati provides evidence that current prevention and screening standards are worth the cost and may even need expansion to include more of the population, further helping prevent the spread of this life-threatening disease. Read more.

Switch to Lamivudine Not as Effective as Staying on Entecavir
May 8 – Hepatitis B patients who switch to cheaper lamivudine after achieving undetectable HBV viral load and normal ALT on entecavir are more likely to experience viral rebound. Read more.

Rebound Common For Some Patients
May 2 – In clinical practice, the hepatitis B virus often rebounds in patients taking nucleoside or nucleotide analogues, researchers reported; however, the cause of the rebound may be poor drug adherence, not genetic resistance. Read more.

AAPCHO Releases New Hepatitis B Product Series
May 2 – The Association of Asian Pacific Community Health Organizations (AAPCHO) just released a three–part series, entitled “B Activated Resource Guide” that highlights successful hepatitis B programs Asian American, Native Hawaiian, and Pacific Islander Communities and provides a toolkit of information and resources to help reach out to policymakers and the media. Read more.

NIH Launches Web Resource on Complementary and Alternative Medicine
May 2 – A new online resource, designed to give health care providers easy access to evidence-based information on complementary and alternative medicine, was launched by the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health. Read more.

Passionate Hearts For Livers: Students Take Stand Against Hepatitis B
May 2 – Kevin Hur, a UC Berkeley student noticed the lack of hepatitis B services for low socioeconomic populations in the Oakland neighborhood, and with the support of other students and a community clinic initiated the creation of The Hep B Project that has to date provided screenings for almost 900 people. Read more.

Watch a Music Video and Raise Money for Hep B!
April 25 – For every view in the month of April that the indie rock band Rooftop Pursuit receives for their latest single "Why I Sing," which follows the story of a girl with hepatitis B, sponsors will each donate a penny towards the Hep B Free America campaign. View now!

Kidney Toxicity Uncommon among People Taking Tenofovir for Hepatitis B
April 25 – People taking tenofovir to treat chronic hepatitis B seldom experience kidney impairment, and this population does not appear predisposed to bone problems, according to researchers. Read more.

Thousands of VA Dental Patients Should Be Tested for HBV, HCV and HIV
April 25 – A task force recommends thousands of Dayton VA Medical Center patients be tested for exposure to hepatitis B, hepatitis C and HIV due to exposure from a dentist failing to change his gloves and sterilize equipment between patients. Read more.

Influenza and HBV Vaccination Coverage Among U.S. Health Care Personnel
April 25 – Influenza and hepatitis B vaccination coverage among health care personnel remain well below the Healthy People 2010 objectives with marriage being associated with influenza vaccination and higher education level s associated with hepatitis B vaccination coverage. Read more.

Watch a Music Video and Raise Money for Hep B!
pril 18 – For every view in the month of April that the indie rock band Rooftop Pursuit receives for their latest single "Why I Sing," which follows the story of a girl with hepatitis B, sponsors will each donate a penny towards the Hep B Free America campaign. View now!

Immune-Based Therapy GS-9620 Shows Promise for Hepatitis B
April 18 – Gilead's GS–9620, an experimental TLR7 agonist, stimulated interferon production and activated B–cells and T–cells in laboratory and human studies, and was active against hepatitis B, researchers reported at EASL 2011. Read more.

Bills Would Test Accused Rapists Sooner for HIV, Hepatitis B
April 18 – South Carolina’s legislature has passed two separate but similar bills that would enable survivors of sexual assault to require that their attackers be tested for HIV and hepatitis B within 48 hours of being charged or indicted. Read more.

First New Hepatitis B and D Treatment in Many Years
April 11 – Entry inhibitors that prevent hepatitis virus from entering liver cells represent a new mechanism of action that limit the issue of viral resistance and could provide new HBV and HDV treatments include SALPs and Myrcludex-B. Read more.

Asian Ethnicity May Predict Hep B-Dominant Dual Infection
April 11 – Asians who are co-infected with HBV and HCV are more likely to have hepatitis B-dominant disease, compared to co-infected non-Asians, according to a recent study in Hepatology. Read more.

FDA Approves Labeling Changes for Telbivudine
April 11 – The U.S. FDA has made changes to the labeling of the antiviral drug telbivudine that are "related to a higher risk of developing resistance-associated substitutions in treated patients." Read more.

PlantPharm Biomed on Target to Introduce First Plant-Based Oral Hepatitis B Vaccine
April 11 – There is global demand for a low-cost, shelf-stable, orally administered HBV vaccine and PlantPharm Biomed is seeking FDA approval of its vaccine produced completely in potato plants that has proven effective against HBV in Phase I human clinical trials. Read more.

The Hepatitis B Community Loses Cherished Friend and Advocate
April 6 – This is a sad day for the hepatitis B community. Fox Chase Cancer Center Senior Advisor and Hepatitis B Foundation Co-founder and Trustee Distinguished Scholar, Dr. Baruch S. Blumberg passed away on April 5, 2011. Read more.

Mongolia's Struggle with Liver Cancer
April 4 – Mongolia has the world's highest rate of liver cancer mortality - six times the global average - and the number is increasing due to high rates of hepatitis C and B infection along with widespread alcohol use. Read more.

Home Tattoo Kits ‘Are Putting Teenagers at Risk from Disease’
April 4 – Teenagers are putting themselves at risk of debilitating and potentially deadly blood diseases by buying “do it yourself” or DIY tattoo kits over the internet, which come with inks, needles and designs. Children have caught hepatitis from such kits, which are cheaper than visiting a professional, particularly if used several times. Read more.

Abbott Introduces Hepatitis B Sequencing Test in Europe
April 4 – The Abbott HBV Sequencing test has been approved for use in Europe, which is used to identify genomic sequences of the hepatitis B virus that offers physicians a highly precise method for managing HBV patients and select or change antiviral therapies based on known drug resistance of specific viral genotypes. Read more.

Public Campaign Ad Featuring HBV Patient Draws Criticism
April 4 – A new HBV awareness campaign, sponsored by the Korean Association for the Study of the Liver, has aired a TV advertisement that’s being criticized as too vivid and intense. Read more.

Dark Side to Children’s School Games
March 28 – Durban school children who are dabbling in occult practices have been warned that their activities, which start out as “games”, could lead to HIV/Aids and hepatitis infections and serious psychological trauma. Read more.

Hepatitis B Patients Increase in Korea
March 28 – A study done by Korea's National Health Insurance Corporation shows that more than 300,000 HBV patients visited the hospital in 2009 up 40,000 in 2006. Read more.

Board Says Doctor Admitted He Reused Biopsy Needle Guides
March 28 – The Nevada State Board of Medical Examiners (BME) recently suspended a doctor for allegedly reusing needle guides during prostate and rectal biopsies. Read more.

First Annual Meeting of the European Hepatitis B and C Surveillance Network
March 28 – Last week the first annual meeting was held to establish a network for hepatitis B and C surveillance by carrying out a survey on prevention and surveillance activities in the Member States. Read more.

Test All Chemo Patients for Hepatitis B
March 21 – Every cancer patient should be tested for HBV infection before starting chemotherapy since 5% to 40% of reactivation cases die of liver failure, said a Memorial Sloan Kettering oncologist at the National Comprehensive Cancer Network 16th Annual Conference. Read more.

China's Hepatitis B Market to Double by 2012
March 21 – The market for hepatitis B drugs in China is expected to grow 135% by 2012 - from $340 million in 2007, sales of HBV treatments will increase to $800 million over the five years, according to a new report from Decision Resources. Read more.

Employee Fear May Have Put Veterans’ Health At Risk
March 21 – A culture of fear may have kept workers and supervisors at the Dayton VA Medical Center’s dental clinic from disclosing the unsafe practices of one dentist over 18 years. Of the 535 patients who underwent invasive dental procedures and have now been tested, 7 patients are positive for HCV and 2 for HBV. Read more.

Hepatitis B: Top 10 Treatment Centers
March 21 – An independent news outlet has rated Johns Hopkins Hospital as among the best hepatitis B treatment centers in the country. Read more.

New Hepatitis B Surface Antigen Test Helps Assess Treatment Response
March 11 – Roche Diagnostics announced the launch of a new hepatitis B surface antigen (HBsAg) test to help clinicians evaluate patient response to treatment of chronic HBV infection. Reduction or clearance of HBsAg is one indicator of good response, along with decreased HBV DNA viral load. Read more.

More Liver-Related Death for HIV Coinfections with HBV than HCV
March 11 – HIV positive gay and bisexual men in the long-running Multicenter AIDS Cohort Study were significantly more likely to die of liver-related causes than HIV negative participants, and those coinfected with HBV had about double the risk of death than those with HCV. Read more.

Tulane Medical Center Puts Patients at Risk for HBV, HCV and HIV
March 11 – Hundreds of Tulane Medical Center's patients have received letters warning them they may have contracted HBV, HCV or HIV because the hospital didn't properly sterilize their equipment used for different GI procedures. Read more.

HBV Infection Decreases Risk of Liver Metastasis in Colorectal Cancer Patients
March 11 – A new report looks at the link between HBV infection and liver metastasis of colorectal cancer and results showed a decrease in the number of metastases in the HBV infected group (14.2%) compared to the non-infected group (28.2%). The authors suggest that HBV infection could be used as a prognostic factor in terms of whether liver metastasis will occur in colorectal cancer patients. Read More.

Pregnant Women in China to be Tested for HBV
March 2 – Starting this year, pregnant women across China will receive free screenings for HIV, syphilis, and HBV. If they test positive, they will be treated at hospitals to prevent them from transmitting the diseases to their children. The Ministry of Health will spend at least $106 million a year on this program. Read more.

Prevalence of Acute HBV Higher Among Adults with Diabetes
March 2 – Data presented at the Advisory Committee on Immunization Practices meeting shows that incidence of acute hepatitis B is significantly higher among adults with diabetes compared to those without diabetes, especially in those aged 23 to 59 years. Read more.

Hep B Free Las Vegas!
March 2 – Hep B Free Las Vegas has been launched with a former Las Vegas headliner as the face of the new campaign to advocate for hepatitis B screening and vaccination. At the launch event, coalition coordinator Aurora Wong urged the National Federation of Filipino American Associations to coordinate screenings to reach the 80,000 Filipino-American residents of Southern Nevada. Read more.

Medicare May Pay for STD Tests for Sexy Seniors
March 2 – As Americans live longer, they are sexually active for a longer period of time; therefore, preventative care is important and Medicare might pay for STD tests for diseases such as syphilis and hepatitis B. Currently Medicare pays for HIV tests. Read more.

Benitec Hepatitis B RNAi Drug Program Moves to Next Stage
Feb. 24 – Benitec announced that following the success of the first stage of its antiviral program to develop an RNA interference (RNAi)-based therapy against HBV it has reached an agreement with Biomic to proceed to the next stage of pre-clinical studies. Read more.

Hepatitis B Vaccination Still India’s Challenge
Feb. 24 – In India, surveys indicate that around 30 million people are infected with hepatitis B but with a cheap and effective vaccine, millions of lives could be saved. Read more.

Tenofovir Remains Effective against HBV after 5 Years in HIV Coinfected Patients
Feb. 24 – Tenofovir continues to potently suppress both HBV and HIV in coinfected patients for at least 5 years, according to a recent which supports guidelines recommending that HIV/HBV coinfected people should receive drugs with dual action against both viruses. Read more.

President’s Budget Includes $5 Million Increase at CDC for Viral Hepatitis
Feb. 14 – The Obama Administration released its 2012 budget that includes a $5MM increase for the CDC’s Division of Viral Hepatitis to expand state surveillance, screening and treatment programs. Read more.

Study Finds HBV 10 Times Likelier In Koreans
Feb. 10 – Korean-Americans living in North Jersey are at least 10 times more likely to have the hepatitis B virus than the general population, according to a screening program finished late last year. Read more.

VA to Test 535 Dental Patients for Infections
Feb. 10 – At least 535 patients of a Veterans Affairs dental clinic in Dayton, OH will be offered free testing for blood-borne infections, including HBV, after it was discovered that a dentist there failed to change gloves or sterilize instruments between patients. Read more.

Possible Risk of HBV Transmission During In Vitro Fertilization
Feb. 10 – A study to define the risk of HBV transmission through oocytes and embryos from chronic HBV carriers resulted in data that suggests the possibility of vertical transmission of HBV via the germ line. Read more.

53 Patients Injected with Same Needle
Feb. 10 – Fifty-three people on the NSW Central Coast could have been exposed to HIV, HBV and HCV after they received injections using the same needle. Read more.

Some Vaccines May Protect Children Against Cancer
Feb. 4 – A study in J. of Pediatrics showed that children born in areas where most children had been vaccinated for hepatitis B had about 20 percent lower odds of all types of childhood cancer than those born in areas where fewer were vaccinated. Read more.

Shot At Life: All Newborns to Get HBV Vaccine
Feb. 4 – The New Delhi, India health ministry has finally given the go-ahead to introduce the shot in its national immunization program and is in the process of procuring 100 million doses of hep B vaccine since there are 26 million births annually. Read more.

An Estimated 10,000 Births to HBV-Infected Women Were Missed
Feb. 4 – According to a CDC study that estimated births to HBV-infected women in 22 states during 2006, approximately 10,000 births to HBV-infected women were not identified by the state and local health departments. Read more.

Hepatitis B Foundation Celebrates 20th Anniversary!

HBF 20th Anniversary Birthday Celebration

Jan. 28 – On January 28, 2011 the Hepatitis B Foundation was officially incorporated as a 501(c)3 nonprofit organization in New Hope, PA. Today, we are proud to be celebrating our 20th anniversary as the only national nonprofit research and disease advocacy organization solely dedicated to hepatitis B! Read more.

Nucleic Acid Testing Detects HBV Sooner in Donated Blood
Jan. 28 – Use of nucleic acid testing, which directly detects hepatitis B virus genetic material in the blood, can identify people with potentially infectious virus earlier than tests that look for anti–HBV antibodies, according to an analysis of nearly 4 million donated blood samples. Read More.

New HBV Legislation to Protect Emergency and Law Enforcement Officers
Jan. 20 – Pennsylvania state senator Stewart Greenleaf introduced new legislation (SB 133) to provide HBV screening, diagnosis, treatment and follow-up for first responders and state and local law enforcement officers on January 12. Read Senate Bill 133.

New Emergency and Law Enforcement Officer HBV Vaccination Bill
Jan. 20 – Pennsylvania state senator Stewart Greenleaf introduced legislation (SB 133) to provide HBV screening, diagnosis, treatment and follow-up for first responders and state and local law enforcement officers on January 12. Read Senate Bill 133.

Man Discovers Transplant Patients Face Huge Costs
Jan. 18 – Dale Shaylor, a Deltona father of three who has hepatitis B, journeyed to Florida in search of a life-saving liver transplant, only to find the surgery has a price tag far out of the missionary pilot's reach. Read more

Healthcare Stumbling in Indonesia’s Hepatitis B Fight
Jan. 18 – Poor access to healthcare means that most Indonesians infected with hepatitis B do not get treatment – or even know they have the disease – because of a lack of facilities and trained healthcare personnel. Read more.

Government Considering Hepatitis B Relief Fund
Jan. 18 – The Japanese government will seek to have a bill jointly sponsored to create a 1 trillion yen relief fund for hepatitis B patients and asymptomatic carriers believed to have contracted the disease through group vaccinations. Read more.

Successful Citywide Prevention Campaign to be Replicated
Jan. 18 – New research findings demonstrate that the San Francisco Hep B Free campaign has increased awareness, testing and vaccination for chronic hepatitis B – a silent killer and the leading cause of liver cancer – in the city's Asian and Pacific Islander community. Read more.

Bill Would Protect Police From Body Fluids Assault
Jan. 12 – A state senator in Nebraska has introduced bill designed to protect police from assault with bodily fluids that can transmit diseases such as HIV and hepatitis B or C. Read more.

Guidelines on Hepatitis B in Workplace Issued by Philippine Government
Jan. 12 – To prevent the spread of HBV in the workplace without discriminating against infected workers, the Philippine Department of Labor and Employment issued a seven-point guideline on dealing with the situation. Read more.

36 Millions Indians Suffer from Hepatitis B
Jan. 12 – The number of Indians infected with and succumbing to HBV has increased with the country ranking second in the list of countries with the most hepatitis. Read more.

Hep B Organ Recipient Shares Good Word About Gift of Life
Jan. 3 – Roughly ten years into his career, Dr. Hagan contracted hepatitis B from a patient, and after three relapses was put on a transplant list. He still remembers the first time he met his donor family and says it’s one of the single most important experiences of his entire life. Learn more.

New Study Upends Thinking About How Liver Disease Develops
Jan. 3 – researchers present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis which includes the existence of a previously unknown kind of inflammatory white blood cell. Learn more.

Dynavax Reports Phase 1B Results for Hepatitis B Therapy Candidate
Jan. 3 – Dynavax Technologies reported safety and immunogenicity data from its Phase 1b clinical trial of DV-601, its proprietary hepatitis B therapeutic vaccine, which may offer an alternative therapeutic option for patients chronically infected with HBV. Learn more.

2010 News

Government Proposes Raising Amount of Damages for Hepatitis B Sufferers
Dec. 27 – The Japanese government has proposed raising the maximum amount of damages for the families of individuals who were infected with hepatitis B through mass vaccinations almost 20 years ago and are now suffering from liver cancer or end-stage cirrhosis (or have died). Read Full Article.

Artificial Liver Device Improves Survival for Hepatitis B and C Patients with Decompensated Disease
Dec. 27 – An artificial liver device known as ELAD – which runs a patient's blood through cartridges containing human liver cells – conferred a significant survival advantage for people with acute decompensated liver disease related to chronic hepatitis B or C, according to a Chinese study. Read Full Article.

Is Chronic Hepatitis B Being Undertreated in the United States?
Dec. 15 – Despite the fact that there are up to 2 million Americans chronically infected with HBV, fewer than 50 000 people per year receive prescriptions for HBV antiviral medications, according to a new Hepatitis B Foundation publication. Learn more.

Is Chronic Hepatitis B Being Undertreated in the United States?
Dec. 15 – Despite the fact that there are up to 2 million Americans chronically infected with HBV, fewer than 50 000 people per year receive prescriptions for HBV antiviral medications, according to a new Hepatitis B Foundation publication. Learn more.

Is Chronic Hepatitis B Being Undertreated in the United States?
Dec. 15 – Despite the fact that there are up to 2 million Americans chronically infected with HBV, fewer than 50 000 people per year receive prescriptions for HBV antiviral medications, according to a new Hepatitis B Foundation publication. Learn more.

Patient Voices Features Hepatitis B Stories
Dec. 15 – Three adults living with chronic hepatitis B in the U.S. are now sharing their videotaped stories on Patient Voices featured on the New York Times website. Listen now.

Does Previous Hepatitis B Exposure Increase Liver Cancer Risk?
Dec. 15 – Researchers find that people who were previously exposed to HBV have an increased likelihood of developing hepatocellular carcinoma (HCC or liver cancer) even if they clear the virus, which suggests these individuals could benefit from regular liver cancer monitoring as well as those chronically infected. Learn more .

New Treatments for Hepatitis B
Dec. 8 – A researcher and his team at the University of Alberta have discovered a new class of drugs that could one day be used to treat people with hepatitis B. Read Full Article.

NPR Radio Show Features Hepatitis B
Dec. 8 – NPR Host Michel Martin of "Tell Me More" featured an interview about hepatitis B and liver cancer with Dr. Jennifer Lee, Hepatitis B Initiative of Washington, DC, and Leslie Hsu Oh, co-founder of the Hepatitis B Initiative of Boston. Download Interview.

Alcohol and Diabetes Increase Risk of Liver Disease Progression in Hepatitis
Dec. 8 – Researchers at Kaiser Permanente in California followed 12,000 adult HBV patients for at least 2 consecutive years during 1999-2007 and data suggests that alcohol contributes to the risk of liver cancer and both alcohol abuse and diabetes contribute to the risk of decompensation. Read Full Article.

Does Antiviral Therapy for Hepatitis B and C Prevent Hepatocellular Carcinoma?
Dec. 8 – A research study indicates that treatment might be of greater benefit if instituted earlier in the course of chronic HBV in order to prevent progression to liver cancer. Read Full Article.

Typical Acetaminophen Dose No Threat to Kids' Livers
Dec. 1 – Concerns about liver injuries in kids who take the common painkiller acetaminophen (Tylenol) are unfounded, researchers reported. With more than eight million American kids taking the drug every week, acetaminophen is the nation's most popular drug in children. Read Full Article.

Hospital's Transplant Program a Big Draw for Hispanics
Dec. 1 – Hispanics in Americas see a high incidence of obesity, hepatitis B and C, all of which may lead to organ transplants. Northwestern Memorial Hospital in Chicago has the only known transplant program conducted all in Spanish in the U.S. Read Full Article.

Effectiveness of Tenofovir in Real-world Clinical Practice
Dec. 1 – Tenofovir produced good HBV suppression in routine clinical practice, indicating that clinical trial outcomes extend to real life, according to findings presented at the recent AASLD 2010 meeting. Read Full Article.

Anti-HIV Pill Protects Against AIDS
Nov. 23 – For the first time, a study has demonstrated that taking a combination anti-HIV pill (Truvada) can protect uninfected people from contracting the AIDS virus through sex with transmission rates cut nearly in half. Read Full Article.

Health Inquiry: Negligence Led to Hepatitis B Scare
Nov. 23 – Negligence on the part of staff at a free dental clinic contributed to an HBV outbreak that infected five people last year, and put nearly 2,000 people in five states and the nation's capital at risk. Read Full Article.

HBV Vaccination Included in 2011 Medicare Rules
Nov. 23 – Traditional Medicare will pick up the tab for certain preventive care services, including annual wellness visits, the hepatitis B vaccine, mammograms and colorectal cancer screenings. Read Full Article.

Arizona Man Denied Life-Saving Liver Transplant
Nov. 17 – Felix was in the surgery room, prepped and ready for his life-saving liver transplant when doctors told him the state's Medicaid plan wouldn't cover the procedure due to recent cuts in funding for some services such as liver transplants. Read Full Article.

Source of North Carolina Hepatitis B Outbreak Revealed
Nov. 17 – State officials confirmed that investigators believe the improper use of blood glucose level testers are most likely behind the cause of a hepatitis B outbreak at a Mount Olive, North Carolina, nursing home that killed 5 residents. Read Full Article.

BMS Enhances Co-Pay Assistance Program for HBV Drug Entecavir
Nov. 17 – Bristol-Myers Squibb (BMS) expanded its co-pay benefit program for individuals receiving or wishing to use entecavir who have private insurance policies with out-of-pocket costs and will save eligible patients up to $200 per month for 4 years. Read Full Article.

Dr. Howard Koh: National Strategy for the Control of Viral Hepatitis and Liver Cancer
Nov. 10 – Dr. Howard Koh, the Assistant Secretary for Health, described the steps the U.S. administration is taking in response to the recent Institute of Medicine (IOM) report on viral hepatitis in his President's Choice Lecture at The Liver Meeting 2010, the annual meeting of the American Association for the Study of Liver Diseases (AASLD). Read Full Report.

Telbivudine and Elective Cesarean Section Help Prevent Perinatal HBV Transmission
Nov. 10 – Treatment with telbivudine (Tyzeka) and elective C-section births both reduced the likelihood of HBV transmission from mothers to infants during pregnancy and delivery, according to two separate research reports. Read Full Article.

Breastfeeding and Chronic HBV
Nov. 10 – A new study reviews current data about preemptive antiviral therapy during pregnancy and breastfeeding with an eye towards assessing safety and the long-term follow up of breast-milk HBV concentrations and correlation with serum viral load. Read Full Article.

Which Pegylated Interferon alfa-2b Regimen Works Best for Chronic HBV?
Nov. 10 – A Chinese study reported that patient with e-antigen negative chronic HBV respond best to PegIFN alfa-2b at 1.5 mcg/kg/week for 48 weeks, compared with a lower dose and/or shorter duration. Read Full Article.

From Podium to Practice: Updates in HBV Treatment from AASLD
Nov. 2 – Capsule Summaries from the 2010 Annual Meeting of the American Association for the Study of Liver of key oral and poster presentations have been selected by leading experts in the field. Read Full Article.

China Earmarks 800 Million Yuan for Mother-to-Child Transmission Prevention
Nov. 2 – China has designated more than 800 million yuan (US $120 million) for efforts to prevent mother-to-baby transmission of HIV, syphilis, and HBV, which is a 10-fold increase above 2009, which addressed only perinatal HIV transmission. Read Full Article.

Men Make Better Liver Donors
Nov. 3 – Men may be higher-quality liver donors than women, potentially a result of differences in life expectancy and causes of death, researchers report. Read Full Article.

Dr. John Ward: Screening Asian Patients for Chronic Hepatitis B
Nov. 3 – Dr. John Ward, Director of the Division of Viral Hepatitis at CDC, speaks about the expanded HBV screening recommendations for Asians living in the U.S. View CDC Expert Commentary Series.

Police Snatch Two HBV Runners from Beijing Marathon
Oct. 26 – Two runners were pulled out of the Beijing Marathon and held for questioning by police for advocating against the discrimination of hepatitis B sufferers. Almost 30 runners wore green vests with the slogan "Eliminating HBV (discrimination) is still on the way." Read Full Article.

Cluster of Hepatitis B Cases Kills Four at Nursing Home
Oct. 26 – State and local health officials are investigating a series of deadly hepatitis B cases in North Carolina at a senior assisted living center that have killed four residents. Read Full Article.

National Pediatric HBV Treatment Recommendations Published by Expert Panel
Oct. 26 – An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation established the first national recommendations for the treatment of children with chronic hepatitis B virus (HBV) infections that was published in Hepatology (online). Read Full Article .

Major 4,000 Patient Study Validates GP73 Biomarker for HCC Detection
Oct. 26 – An NIH registration trial with 4,000 individuals has validated GP73 (discovered by Hepatitis B Foundation scientists) as an accurate serum marker for the detection of HCC and its recurrence after surgery with higher sensitivity and specificity than AFP. The researchers also recommend that GP73 measurement should be implemented in the clinic as a standard test for HCC. Read Full Article .

HM Cycling Club Fights Hepatitis B
Oct. 18 – A three member team will embark on a two week cross-country cycling tour of Ghana to educate people on the dangers of hepatitis B and to promote testing. Read Full Article.

Hep B Drug Gets New Indication
Oct. 18 – The U.S. FDA has approved the chronic hepatitis B drug entecavir for adult patients with evidence of liver decompensation, a typically difficult group to treat. Read Full Article.

Experts Rally for European Commitment to Halt Hepatitis B and C Epidemic
Oct. 18 – Leading physicians, scientists and patient groups demanded policy action from European Union officials to halt the epidemic of viral hepatitis. Read Full Article.

Vaccines: A New Alternative for Cancer Treatment
Oct. 18 – Cancer continues to affect millions of Americans each year…and one of the newest treatment modalities warranting a closer look is the use of vaccines for cancer treatment. Read Full Article.

Major 4,000 Patient Study Validates GP73 Biomarker for HCC Detection
Oct. 11 – An NIH registration trial with 4,000 individuals has validated GP73 (discovered by Hepatitis B Foundation scientists) as an accurate serum marker for the detection of HCC and its recurrence after surgery with higher sensitivity and specificity than AFP. The researchers also recommend that GP73 measurement should be implemented in the clinic as a standard test for HCC. Read Full Article.

New Treatment Recommendations for Children with HBV
Oct. 11 – An expert panel of pediatric liver specialists convened by the Hepatitis B Foundation established consensus recommendations regarding selection of children who may benefit from treatment, appropriate timing of treatment, and the choice of antiviral therapy (published in Oct. Hepatology). Read Full Article.

New Deadly Types of Virus Found in Papua
Oct. 11 – Scientists announced recently the discovery of three new subtypes of the hepatitis B virus in Papua where four infected patients are now receiving extensive treatment. Read Full Article.

Majority of Baby Boomers Not Concerned About Contracting STD's
Oct. 11 – When it comes to the birds and the bees, a recent study suggests some baby boomers aren't practicing what they preach and are taking too many risks; thus, are at increased risk for sexually transmitted diseases, including hepatitis B. Read Full Article.

AASLD and Trust for America's Health Call for Action
on Hepatitis B and C

Oct. 5 – HBV & HCV: America's Hidden Epidemics examines how new measures included in the Patient Protection and Affordable Care Act (ACA) combined with scientific advancements could be used to spare the lives of millions of infected Americans…and lead to billions of dollars in health care savings. Read Full Article.

Researchers Find 19 Million-Year-Old Genomic Fossils of Hepatitis B-Like Viruses in Songbirds
Oct. 5 – Biologists have uncovered virus fragments from the same family as the modern Hepatitis B virus locked inside the genomes of songbirds such as the modern-day zebra finch. Read Full Article.

CDC Chief Picks 6 'Winnable Battles' in Health
[and Hepatitis is not Included]

Oct. 5 – Dr. Thomas Frieden has chosen six priorities, or "winnable battles," that include smoking, AIDS, obesity/nutrition, teen pregnancy, auto injuries and health care infections, which has invigorated some, infuriated others. Read Full Article.

High HBV Awareness, Low Action Among Asian Americans
Sept. 27 – A new study reveals that despite high awareness about hepatitis B among Asian American providers, screening rates are still low and only 40% were familiar with current treatment guidelines; and in the community, there is also high disease awareness, but more education is still needed about prevention and treatment. Read Full Article.

National Hep B Community Gathers in San Francisco to Honor Nobel Laureate Dr. Baruch Blumberg and SF Hep B Free
Sept. 27 – Nobel Laureate Dr. Baruch Blumberg, discoverer of the hepatitis B virus and first vaccine, was honored with the 3rd Annual San Francisco Hep B Free Super Hero Award at its gala event co-chaired by Chinese Hospital and produced by AsianWeek Foundation. Read Full Article.

Nearly 20% of New HBV Infections May Occur in Healthcare Settings
Sept. 27 – As many as 1 in 5 cases of acute HBV infection in the U.S. may be attributable to exposure in healthcare settings, especially long-term care facilities, according to research presented last week at the 50th ICAAC meeting. Read Full Article.

Texas Children's Hospital Conducts First Study to Record Hepatitis B Incidence in Houston Children
Sept. 21 – Physicians will begin a study to estimate the true incidence and distribution of hepatitis B in children living in Houston. Read Full Article.

Hepatitis B Prevention Program Gaining Traction in San Francisco
Sept. 21 – A unique community-based program aimed at preventing hepatitis B in the high-risk Asian population is effectively combining provocative advertising with electronic medical records (EMRs) to maximize its success. Read Full Article.

Obesity Key Cause of Liver Problem in India
Sept. 21 – Obesity, combined with a high prevalence of hepatitis B and C, is contributing to a steep rise in liver problems and liver transplants in India every year. Read Full Article.

New National Hepatitis B and Liver Cancer Campaign Launched
Sept. 14 – The U.S. Office of Minority Health, Hepatitis B Foundation and AAPCHO are launching a new campaign to address the growing epidemic of hepatitis B and liver cancer that affects up to 1 million Asian Americans in a new television PSA campaign. Read Full Article.

Laotian and Hmong Americans Suffer Liver Cancer Disproportionately
Sept. 13 – Laotian and Hmong Americans have higher numbers and are more than twice as likely as other Asian Americans to die of hepatitis B and liver cancer as result of being diagnosed at later stages and less likely to receive treatment, reported UC Davis researchers. Read Full Article.

Meat and Fat Intake Associated with Liver Disease and Liver Cancer
Sept. 13 – A new study suggests that red meat and saturated fat may be associated with increased risks for chronic liver disease and hepatocellular carcinoma (primary liver cancer), whereas white meat may be associated with reduced risk. Read Full Article.

Renowned Liver Expert Robert G. Gish Joins UC San Diego Health System
Sept. 13 – Robert G. Gish, MD, world-renowned Hepatologist, has been recruited to the U. California San Diego School of Medicine to co-direct the Center for Hepatobiliary Disease and Abdominal Transplantation (CHAT), a multidisciplinary program designed for adult and pediatric patients. [Dr. Gish serves on the Hepatitis B Foundation's Medical and Scientific Advisory Board]. Read Full Article.

FDA Approves Abbott's Automated Hepatitis B Viral Load Test
Sept. 7 – The Abbott RealTime HBV assay for measuring HBV viral load was approved by the U.S. FDA as the first and only approved test capable of automating HBV viral load testing from sample extraction to final results. Read Full Article.

New Partnership Forms to Address Hepatitis Epidemic in Europe
Sept. 7 – A unique Partnership has formed to drive the first European Union–wide initiative to address the needs of the more than 23 million EU citizens currently living with hepatitis B or C comprised of key international public and private stakeholders. Read Full Article.

Cirrhosis Outcomes Better When Treatment Guidelines Followed
Sept. 7 – Current guidelines recommend screening liver cirrhosis patients for esophageal varices and beta-blocker treatment or variceal ligation, along with periodic follow-up endoscopy, for lower-than-expected rates of variceal hemorrhage. Read Full Article.

Bloodborne Pathogens and Their Threat to School Safety
Aug. 30 – According to the CDC, while there are 300,000 new cases of exposure to bloodborne diseases reported each year, the greatest risk to school personnel is from the hepatitis B virus. Read Full Article.

Meta-analysis Finds Tenofovir and Entecavir Are Most Effective Antiviral Drugs for Chronic Hepatitis B
Aug. 30 – A systematic review revealed the oral antiviral drugs tenofovir and entecavir demonstrated the most potent activity against HBV and its consequences in HBeAg positive patients during the first year of treatment. Read Full Article.

Fingerstick Device Infection Warning Issued by FDA and CDC
Aug. 30 – Federal regulators are warning nursing homes, hospitals and health care providers that they are seeing an alarming number of hospital infections, most notably hepatitis B, caused by the use of fingerstick devices (such as glucose monitors) on multiple patients. Read Full Article.

Fargo Shows Promise as Vaccine Center
Aug. 30 – The fledgling Center for Biopharmaceutical Research and Production at North Dakota State University, headed by Dr. Satish Chandran, seeks to establish Fargo as a center for developing biotechnology products and vaccines such as a therapeutic vaccine to treat hepatitis B. Read Full Article.

American Cancer Society Encourages Asians to Get
Screened for Hep B

Aug. 23 – The American Cancer Society is teaming up with the Salvation Army to offer free hepatitis B screenings as a result of the AMA statement that Asian and Pacific Islanders have the highest rates of the disease, which can lead to liver cancer if not treated. Read Full Article.

No Deportation for Expats with Hepatitis
Aug. 23 – New expatriate workers in the United Arab Emirates who are found to have hepatitis B when they undergo their medical test will not be deported but will be given treatment, according to the Ministry of Health. Read Full Article.

Hepatitis Carriers Will Get Right to Be Teachers
Aug. 23 – Hepatitis B carriers in Beijing will now be able to work as kindergarten teachers in the future, as authorities have cancelled restrictions against them. Read Full Article.

New Campaign for Hep B and C Tests in Pharmacies
Aug. 23 – Those working in pharmacy jobs may soon be part of a new screening and vaccination service for hepatitis B and C, thanks to a new campaign. Read Full Article.

Kerry & Honda: Disrupting a Deadly Disease
Aug. 16 – Sen. John Kerry (D-Mass.) and Rep. Michael Honda (D-Calif.) write in a Washington Times opinion piece that viral hepatitis is "more common than HIV/AIDS" and is "the leading cause of liver cancer – thus, Kerry has sponsored a bill (S3711) in the Senate, based on the bill that Honda sponsored (H.R.3974) in the House that would boost funding for prevention, surveillance and education programs related to the viruses. Read Full Article.

Treating Hepatitis B Runs Up Against Hmong Culture
Aug. 16 – In the Hmong/Laotian community, 17% have hepatitis B and most don't know they are infected; however, even if they did, they wouldn't treat it because they believe diseases are viewed as a spiritual problem. Read Full Article.

Long-Term Entecavir Therapy Results in Reversal of Fibrosis/Cirrhosis in HBV
Aug. 16 – The majority of nucleoside-naive patients with chronic hepatitis B who were treated with entecavir in a long-term study achieved substantial histological improvement and regression of fibrosis or cirrhosis. Read Full Article.

Sherburne to Vaccinate Adults without Full Health Coverage
Aug. 16 – Stimulus funds will be used by the Minnesota Department of Health will be used to vaccinate eligible adults who are uninsured or underinsured, including hepatitis B. Read Full Article.

Hepatitis B Linked to Lymphoma Study
Aug. 6 – People with hepatitis B infection have about twice the risk of developing non-Hodgkin lymphoma, finds a new study. Read Full Article.

Kerry Pushes $600 Million Bill to Create National Hepatitis Strategy
Aug. 6 – U.S Senator John Kerry introduced a sister bill to HR 3974 to authorize funding of almost $600 million over five years to combat the hepatitis B and C, which affects more than 5 million Americans. Read Full Article.

Doctors Target Hepatitis B in Boston's Chinatown
Aug. 6 – Targeting hepatitis B, known as the “silent killer,” a group of local doctors will provide outreach in Boston's Chinatown as part of an effort by the local chapter of Liver Health Project, started by Harvard students. Read Full Article.

Grim numbers on World Hepatitis Day
Aug. 2 – A staggering number of Indonesians — as many as 30 million people — are infected by hepatitis, said the government and researchers at events for the country's first observance of Hepatitis Day on July 28. Read Full Article.

EC Launches HIV/AIDS and Hepatitis B, C Prevention Campaign
Aug. 2 – The European Commission will finance an HIV/AIDS and Hepatitis B and C prevention campaign targeted to those 15-24 years old with 11 EU member states. Read Full Article.

Seattle: At-Risk Groups Urged To Get Tested for Hepatitis B
Aug. 2 – An estimated 10% of foreign-born Asian Americans suffer from chronic hepatitis B infection, a rate 20 times greater than the rest of the U.S. population. For those native to some Asian countries, such as Vietnam, Korea or China, rates are even higher. Read Full Article.

No End in Sight for Adult Hepatitis B Vaccine Shortage
Aug. 2 – The lengthy and ongoing shortage of adult hepatitis B vaccine has baffled some public health doctors, which began in January 2009 when Merck announced that equipment upgrades would disrupt production of the adult version of its hepatitis B vaccine. Read Full Article.

Taiwan Researchers Find Way to Predict Hepatitis B Virus Activity
July 26 – After analyzing HBV infections for the past 17 years, researchers found two intercellular mediators in the immune system that can “predict” activity of the hepatitis B virus which could help “customize” treatments for patients. Read Full Article.

Nicaragua to Use Hepatitis B Vaccine Donated by Cuba
July 26 – Cuba donated 140,000 doses of HBV that will be used to vaccinate Nicaraguan children as well as troops, policy officials and those in the Penitentiary System. Read Full Article.

Anesthesia Contamination Tied to Hepatitis
July 26 – U.S. researchers found patients can be infected with hepatitis B and hepatitis C via intravenous administration of anesthesia and that anesthesia contamination — not endoscopy contamination — was the cause of recent hepatitis outbreaks. Read Full Article.

HIV and HBV in Liver Cells May Contribute to Accelerated Liver Disease
July 19 – Interactions between HIV and HBV within liver cells appear to promote enhanced HIV replication and increased levels of HBsAg, though not HBV viral load, which may help explain worse liver disease progression observed in co-infected individuals. Read Full Article.

Risk Behaviors for Hepatitis B High, Vaccination Remains Low Among Adults
July 19 – About one-fifth of 18- to 44-year-olds in the U.S. have reported engaging in risky behaviors that indicate the need for the hepatitis B vaccine; however, more promotion is needed to boost vaccination rates among adults. Read Full Article.

56 kids get HIV, hepatitis after blood transfusion
July 19 – At least 56 children suffering from thalassaemia tested positive for HIV, hepatitis B and hepatitis C after receiving blood transfusion at government-run hospital in India. Over the past 18 months, 8 children were found to be HIV positive while 46 others were infected by HBV. Read Full Article.

Hep B Free Philadelphia Featured on CBS3
July 12 – HBF executive director Joan Block and former Philadelphia Health Commissioner Dr. Walter Tsou were interviewed on "Speak Up" of the CWPhilly show about the new HBV awareness campaign.

Better Than Sci Fi
July 12 – University of New Mexico researchers have developed a hand-held device that can detect HBV, HCV and other viral infections in blood, saliva and urine within 5 seconds. Read Full Article.

Twilight Effect: Talk About Unsafe Sex!
July 12 – Some teens are taking the vampire thing WAY too far. There have been recent reports of teens biting each other as a sign of love and passion… even drawing blood. Read Full Blog.

18,000 Veterans Exposed to Hepatitis and HIV
July 7 – The VA has urged nearly 2,000 veterans to return for blood tests because inadequately sterilized equipment may have exposed them to viral infections during dental procedures. Read Full Article.

Come and Dine with Hepatitis B Carrier
July 7 – A girl nicknamed Chucao invites people to have dinner with her on the streets of China to promote awareness that hepatitis B is not transmitted by having meals with infected persons. Read Full Article.

Clues to Preventing Return of Liver Cancer
July 7 – A small study finds antiviral therapy halts recurrence of liver cancer in patients with chronic hepatitis B, according to researcher Dr. Hie-Won Hann. Read Full Article.

Florida State's Solomon Alabi Tested Positive for Hepatitis B
June 28 – Former Florida State star center Solomon Alabi's precipitous fall in the recent NBA draft was due in part to a diagnosis of Hepatitis B. Read Full Article.

Screening Cancer Patients for Hepatitis B: Should it Be Routine?
June 28 – The American Society for Clinical Oncology concludes there is no need to screen all cancer patients prior to chemotherapy and immunosuppressive drugs, despite the risk of potentially fatal results due to reactivation of hepatitis B. Read Full Article.

Hepatitis: A Major Public Health Concern in Cameroon
June 28 – Some two million people in Cameroon suffer from hepatitis - 10% with HBV and 13% with HCV – with concerns that it is fast becoming a public health hazard, if not checked. Read Full Article.

Congressional Hearing on Viral Hepatitis Draws Attention to HR 3974
June 21 – A Congressional hearing on chronic viral hepatitis held on June 17 in Washington, DC calls for passage of HR 3974 to increase testing and treatment for hepatitis B and C. Read Full Article.

Blueberry Ameliorates Hepatic Fibrosis
June 21 – A new study suggest that blueberry consumption is beneficial for hepatic diseases (including fibrosis). Read Full Article.

China FDA Approves Domestic Company to Manufacture Entecavir
June 21 – A leading company in China announced that they have obtained manufacturing approval for Entecavir from the China FDA with brand name "HeDing" and "HeEn". Read Full Article.

Exalenz BreathID System
June 21 – A feasibility study to test the effectiveness of a BreathID device to diagnose the severity of liver disease in people with HBV was conducted in Hong Kong with a 91% accuracy rate. Read Full Article.

Five People at Free W.VA Dental Clinic Developed Hepatitis B
June 14 – Three patients and two volunteers at a free dental clinic developed hepatitis B and hundreds of people who received treatment or volunteered there are encouraged to be tested. Read Full Article.

Cuba's Prevention Against Acute HBV Achieves Success
June 14 – Cuba reported only four cases of acute hepatitis B in 2009, due to the massive and systematic immunization campaigns promoted by the national health system. Read Full Article.

Do We Need to Determine Viral Genotype in Treating Chronic HBV?
June 14 – A recent paper concluded that determination of HBV genotype should form part of the management in treating chronic hepatitis B. Read Full Article.

Hepatitis B: Sex Hormone Explains Higher Liver Cancer Risk in Men
June 14 – Men with hepatitis B are more likely than women to develop liver cancer, and serum concentrations of male sex hormones may play a part, a new study suggests. Read Full Article.

Chronic Hepatitis B Covered by National Broadcasts
June 3 – An eight minute segment featuring the global and national significance of chronic hepatitis B infection will be televised on “PBS NewsHour” this evening and on June 4 a radio report will be broadcast as part of NPR's "Morning Edition." View PBS NewsHour and Listen to NPR Morning Edition.

NVHR Applauds World Health Organization Resolution on Viral Hepatitis
June 3 – A World Health Organization (WHO) resolution was approved to develop a comprehensive global approach to the prevention and control of chronic viral hepatitis as well as an historic WHO-sponsored World Hepatitis Day beginning next year on July 28, 2011. Read Full Article.

Government Battles Liver Cancer with Monitoring Program
June 3 – More than 1,000 people are participating in a government project aimed at fighting liver cancer with a reward system to encourage hospitals to enroll and routinely monitor high-risk patients. Read Full Article.

Researchers Fine-Tune Hepatitis B Trials
May 25 – Top clinicians and researchers from the U.S. and Canada met in Pittsburgh for three days to work on designs for two multisite treatment trials for hepatitis B, one for adults and one for children. Read Full Article.

Green Light for “While-You-Wait” Hepatitis B Test
May 25 – An inexpensive new test for the rapid detection of the hepatitis B virus has been given regulatory approval for use in the European Union, which will enable doctors to take immediate action from the test results. Read Full Article.

Sex Hormone Explains Higher Liver Cancer Risk in Men
May 25 – Male sex hormones may explain why men who suffer from the hepatitis B liver disease are more likely to develop liver cancer than women, researchers in Taiwan have found. Read Full Article.

World Hepatitis Day Rally May 19, 2010

World Hepatitis Day Rally Attracts
Almost 500

Almost 500 people traveled across the country for the first World Hepatitis Day rally held on May 19 at the U.S. Capitol in Washington, DC. The rally was organized by the National Viral Hepatitis Roundtable, in partnership with the Hepatitis B Foundation and other member organizations. Amidst multiple chants – 3—9—7—4 . . . Hepatitis no more! Hey, hey, ho, ho … Hepatitis go away! 1—2—3 … Liver cancer free! – speakers fired up audience. Three Members of Congress – Mike Honda, Charles Dent and Bill Cassidy – spoke, as well as patients who introduced themselves as “I am the face of hepatitis.” The bottom line .. we CANNOT be silent anymore! Too many Americans are dying from chronic hepatitis which is preventable and treatable. Learn more.

Presidential Message on World Hepatitis Day
May 19 – President Obama sent warm greetings to all those observing World Hepatitis Day and concluded with: “On World Hepatitis Day, we renew our support for people living with hepatitis and their loved ones, and for those who are working to improve treatment and prevention. I wish you all the best as you join together to take action against this terrible disease.” Read the Presidential Message on the White House blog. A copy of the Presidential Message is available here.

500 Million People Await WHO Assembly Decision on Viral Hepatitis
May 19 – Hundreds of patient groups await the World Health Organization's decision on a resolution that would provide global endorsement of World Hepatitis Day as the primary focus for national and international awareness-raising efforts. Read Full Article.

Dine with A Stranger with Hepatitis B?
May 19 – A girl with Hepatitis B took to the streets in China holding a sign saying "Will you have dinner with a HBV carrier" in a bid to raise awareness about the virus. Read Full Article.

Hepatitis Infections Behind U.S. Rise in Liver Cancer
May 10 – Liver cancer rates are increasing in contrast to most other major forms of cancer due to chronic hepatitis and more people need to be vaccinated, diagnosed and treated says a new CDC report. Read Full Article.

Some Patients with HBV Faring Better after Liver Transplant
May 10 – Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes, with approximately 50% drop in need for a second transplant according to a Mayo Clinic study. Read Full Article.

Women More Likely to Die while Awaiting Liver Transplants under the MELD System
May 10 – The MELD system, which prioritizes patients with end-stage liver disease for liver transplantation based on 3 laboratory measures, appears to favor men over women who are less likely to receive a donor liver. Read Full Article.

In Ads, Plea for Asians to Get Tests for Hepatitis
May 5 – In a new ad, 10 young Asian beauty queens are asked, "Which one deserves to die?" The new campaign sponsored by San Francisco Hep B Free intends to jar Asian Americans into taking action to combat the spread of hepatitis B. Read NYT Article and View Video.

Diabetes Is Leading Cause of Attributable Cases of Hepatocellular Carcinoma
May 5 – A new study sheds light on the risk factors for primary liver cancer (HCC) and found that although chronic HBV and HCV have the highest odds ratios for HCC, more cases of HCC overall are attributable to diabetes than any other risk factor. Read Full Article.

Hepatitis B: A Family Story
May 5 – A moving video about a family's struggles with hepatitis B from the nonprofit organization PKIDs. View Video .

NanoBio Launches Program for Intranasal Vaccine for the Treatment of HBV
April 26 – NanoBio and the University of Michigan are funded by an NIH grant to work on a Phase I potential therapeutic intranasal vaccine for the treatment of HBV in patients. Read Full Article.

World Hepatitis Alliance Releases Report at EASL Meeting
April 26 – Research commissioned by World Health Organization finds 80% of governments regard hepatitis B and C as an urgent public health issue, according to the first major policy report on viral hepatitis from the World Hepatitis Alliance. Read Full Article.

500 Patients Warned of Possible Blood-Borne Virus Infection
April 26 – Nearly 500 people in Canada are being warned to get tested for hepatitis and HIV after contaminated medical gear used at Victoria General Hospital was linked to an elderly man's infection. Read Full Article.

IOM Report Says Primary Care Docs Lack Knowledge About Hepatitis B, Hepatitis C
April 12 – Many primary care health professionals are unaware of the high prevalence of HBV or HCV infection in some U.S. populations and often fail to identify infected so they can be managed appropriately. Read Full Article.

Traditional Chinese Medicine May Perform Better than Interferon or Lamivudine for Chronic HBV
April 12 – A joint U.S./Chinese review of clinical trials of traditional Chinese medicine formulations were found to work as well as or better than interferon and lamivudine for people with chronic HBV, according to Hepatology publication. Read Full Article.

Ailing Chinese Dissident Is Denied Early Release
April 12 – One of China's best-known dissidents has been denied early release from prison despite being seriously ill with HBV and possible liver cancer. Read Full Article.

More Hepatitis B Patients Sue State
April 2 – Six hepatitis B patients in western Japan filed a lawsuit, joining nearly 400 other people engaged in legal battles, for the government's failure to warn of the risk posed by shared needle use in group vaccinations. Read Full Article.

Curry Ingredient Shows Promise Against Liver Damage
April 2 – A compound found in the common curry spice turmeric appears to delay the liver damage that eventually causes cirrhosis. Read Full Article.

GSK Offers Free Vaccines to Uninsured Adults
April 2 – GlaxoSmithKline has launched the GSK Vaccines Access Program to provide its adult vaccines – including HBV - free of charge to help those over the age of 18 who lack insurance coverage for vaccines. Read Full Article.

New 5-Year Strategic Plan from CDC
March 5 – The 2010 plan describes the agency's overarching goals and strategies for preventing HIV/AIDS, viral hepatitis (A, B, and C), STDs, and TB over the next 5 years. Read Full Report.

Man with Hepatitis B Jailed for Sexual Assault
March 5 – An Ontario man who had unprotected sex with 2 women without telling them he had HBVwas sentenced to one year in jail. Read Full Article.

Woman Needs Doctors Note To Attend Church
March 5 – Doctors notes may be needed to get out of school or work. But what about a doctor's note to get back into church? One woman needed such a note after being diagnosed with hepatitis. Read Full Article.

£1.37m Battle to Combat Hepatitis
March 5 – A plan to prevent, screen and improve care for people living with HBV and HCV in Wales, UK, will be backed by £1.37 million in funding. Read Full Article.

Changing the Face of Research and Science: A Nonprofit Biotech Incubator
Feb. 26 - Huffington Post featured an article about a unique nonprofit organization that created a biotech center to extend its research mission, which has expanded even in this tough economy. Read Full Article.

Inactive Hepatitis B Virus Can Still Cause Liver Cancer
Feb. 26 – Despite a belief by researchers that inactive carriers of hepatitis B virus (HBV) are not at high risk of disease progression, a new study suggests that such patients are still at increased risk of hepatocellular carcinoma (HCC) and liver-related death. Read Full Article.

Transplants That Do Their Job, Then Fade Away
Feb. 26 – Jonathan Nuñez was 8 months old when a liver transplant saved his life. Three years later, his body rejected the transplant, attacking it so fiercely that it wasted away and vanished. That result, seemingly a disaster, was exactly what his doctors had hoped for. Read Full Article.

Mouse With Human Liver May Lead to Cure for Hepatitis B and C
Feb. 26 – How do you study - and try to cure in the laboratory - an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver that is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies. Read Full Article .

Age at Time of eAg Seroconversion Predicts Chronic HBV Prognosis
Feb. 19 – People who experience hepatitis B "e"" (HBeAg) seroconversion before age 30 have better long-term outcomes – including lower rates of cirrhosis and liver cancer - than those who seroconvert 10 years later. Read Full Article.

Zimbabwan Long Distance Runner Nhauro Dies
Feb. 19 – Crack former Zimbabwe long–distance runner Patrick Nhauro died at 52 years last week after battling hepatitis B for a long time. Read Full Article.

Estimation of Healthy Upper Limits for ALT in Asian Populations
Feb. 19 – The healthy ALT thresholds in biopsy-proven normal Asians were clearly lower than the previously accepted thresholds, as has also been noted in Europeans. Read Full Article.

Hepatitis: Are You At Risk?
Feb. 19 – Parade magazine covers hepatitis B and C which impacts 5 million Americans (1 in 60 people) as a result of the recent Institute of Medicine report on Hepatitis and Liver Cancer. Read Full Article.

Short Needle May Short HBV Protection for Obese
Feb. 12 – Obese adolescents and young adults may not generate an adequate immune response to the HBV vaccine because the needles used to vaccinate them are too short. Read Full Article.

14 Million Registered Hepatitis Patients in Pakistan
Feb. 12 - There are an estimated 14 million people suffering from the hepatitis epidemic in the country, of which 5.6 million are infected with HBV, says the Health Minister. Read Full Article.

Entecavir Improves Liver Function in Decompensated Chronic HBV
Feb. 12 – The antiviral drug entecavir (Baraclude) worked as well in chronic HBV patients with decompensated cirrhosis as it did in individuals with less severe liver damage, and over 1 year, it improved liver function in these patients with the most advanced disease. Read Full Article.

Dynavax Starts Hepatitis B Trial
Feb. 12 – Dynavax will start a 2,000-patient trial in Canada and the U.S. to show that Heplisav is just as good as Engerix-B (GlaxoSmithKline) eight weeks after the last active dose. Read Full Article.

NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap for Viral Hepatitis
Feb. 5 – “If policymakers are serious about reducing US cancer rates, including liver cancer, they should act immediately … to fully fund viral hepatitis education, screening, and surveillance programs for five million Americans,” says NVHR Chairperson. Read Full Article.

Going To Help In Haiti? Don't Forget Shots
Feb. 5 – Relief workers and others traveling to Haiti are being advised to get vaccinated against several potentially life-threatening illnesses, including HBV which is endemic in the country. Read Full Article.

Man with HBV Bit Pub Landlord
Feb. 5 – A man with hepatitis B bit a landlord on the arm during a pub brawl which erupted when he was caught selling extreme pornography DVDs. Read Full Article.

Perinatal HBV Transmission May Occur Despite Newborn Vaccination and Immune Globulin
Feb. 5 – Babies born to mothers with HBV infection may become chronically infected even if they receive the HBV vaccine and hepatitis B immune globulin (HBIG), according to a Dutch study. Read Full Article.

We Honor the Groundhog One Day Each Year
Feb. 1 – Why would a hairy little critter be so honored as to have a special day? And why is it so valuable for studying liver disease in humans, particularly hepatitis B and liver cancer? Read Full Article.

Bill, Melinda Gates Pledge $10 Billion for Vaccines
Feb. 1 – The Bill and Melinda Gates Foundation will commit $10 billion over the next decade to vaccinate 90 percent of children in developing nations (including HBV), and to help develop vaccines for the world's poorest countries. Read Full Article.

Government Urged to Subsidize Anti-Hepatitis B Drugs
Feb. 1 – Adding anti-hepatitis B drugs to Beijing's medicine insurance list would solve severe health concerns, says a senior medical expert, and “the government has a responsibility to pay for treatment...before the financial burden becomes much heavier.” Read Full Article.

NVHR: Don't Leave 5 Million Americans with Chronic Hepatitis Out in the Cold with Budget Freeze
Feb. 1 – NVHR issues a challenge to the White House and Congress: “It is critical that policymakers understand that a budgetary freeze would leave more than 5 million Americans afflicted with chronic viral hepatitis out in the cold … and it's time to address these diseases with the full force of decisive federal action that they deserve.” Read Full Article.

More Couples Calling Off Marriage After Tests
Jan. 25 -Iin 2009, three cases of HIV/AIDS, 76 cases of HCV, and 308 HBV were discovered in premarital testing, and the higher rate of couples calling off marriages following positive test results was due to Advisory Clinics persuading them to cancel their plans. Read Full Article.

10% of Executives at High Risk of Serious Liver Disease Due to HBV
Jan. 25 - One out of every 10 executives of medium-sized and large companies in Taiwan have chronic HBV but have taken no steps to treat the condition, leaving them vulnerable to serious liver disease, according to the results of a survey. Read Full Article.

Reduced Response to HBV Vaccine in Celiac Disease Patients
Jan. 25 - Celiac disease patients do not produce adequate protective antibody levels after receiving the HBV vaccine, which may represent a significant public health problem that needs to be addressed. Read Full Article.

Are You Safe In Your Salon?
Jan. 18 - Just because your salon boasts of a swanky ambience and high-priced services, it doesn’t mean you are safe since viral infections including HIV, hepatitis B and C, etc. are things to watch out for. Read Full Article.

Landmark IOM Report on Hepatitis & Liver Cancer Finds Inadequate Federal Funding Thwarting Education, Surveillance Efforts
Jan. 18 – The National Viral Hepatitis Roundtable (NVHR), a coalition of more than 150 groups, renews its call for the U.S. to take immediate and decisive action to implement the report’s key recommendations since about 1 in 50 Americans are affected. Read Full Article.

Notes from JPMorgan: Gilead's [HBV] Combos
Jan. 18 - Keep an eye on Gilead's partnership in Asia with GlaxoSmithKline for marketing rights for tenofovir (Viread) to treat HBV in China, and possible talks about a fixed-dose combination in Asia, which would be a first for HBV treatment. Read Full Article.

Neither Diabetes nor Overweight Is a Risk Factor for Hepatocellular Carcinoma
Jan. 18 - On the basis of the community-based studies, neither diabetes nor being overweight was a risk factor for liver cancer in a dual HBV and HCV endemic area. Read Full Article.

IOM Report on Hepatitis and Liver Cancer Released
Jan. 11 – The Institute of Medicine (IOM) has released its report on the current approach to the prevention and control of hepatitis B and C in the U.S., and concludes that it is not working. With more than 5 million Americans suffering from these chronic diseases, more needs to be done to improve federal and state resources. Read Full Article.

Hep B Activists Named 2009 Top Ten Legal Figures in China
Jan. 11 – Civil right activist Lu Jun, director of  the Beijing Yirenping Center, a nonprofit organization dedicated to fighting anti-HBV discrimination, was named one of the  Top 10 Legal Figures in China by state-administered legal websites in December 2009. Read Full Article.

Increased Caffeine Consumption is Associated with Reduced Hepatic Fibrosis
Jan. 4 – An NIH study demonstrated that caffeine consumption, particularly from regular coffee, above 2 cup equivalents per day, was associated with less severe fibrosis. Read Full Article.

High Risk of Hepatitis for Hospital Scavengers
Jan. 4 - Sanitary workers and scavengers (particularly children collecting garbage) of hospitals and clinics are at a high risk of getting infected with viruses like hepatitis B, C and HIV because of their pilferage of hospital waste. Read Full Article.

Villanova Yarou Cleared to Practice
Jan. 4 - Villanova freshman center Mouphtaou Yarou was cleared to resume practice with the Wildcats after missing 10 games since being diagnosed with hepatitis B on Dec. 1. Read Full Article.

Number of Tattoo-Parlor Permits Rises
Jan. 4 - Tattoo shops appear to be recession-proof- more people are getting skin ink, and more places are opening. However, zoning restrictions are not enough to guarantee safety and cleanliness. It's a big concern,” says one owner. “They are hepatitis factories." Read Full Article.


Older News Archives (2005-2009) »


For more information, visit the Hepatitis B Research List. For the latest news from journal articles, abstracts, and more, subscribe to this free electronic list at HBV_Research-on@mail-list.com.


Page last modified December 28, 2014

amazon smile

Connect with Us

facebook twitter youtube linkedin
Hep B Blog
Bookmark and Share
Site design by Ferguson Lynch  FL logo